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B cells recognize a wide range of antigens by their specific surface B cell receptor. BCRs 
are immunoglobulin polypeptides and made up of heavy chain (IGH) and light chain. Light 
chains are of two types: kappa (IGK) or lambda (IGL). The variable regions of 
immunoglobulin chains are generated by somatic rearrangement of V, D and J segments to 
generate a diverse repertoire of BCRs. The aim of this thesis is to analyze features of 
immunoglobulin gene rearrangements in the context of heavy and light chain pairings and 
light chain gene expression. 
Mature naïve B cells generated in blood or tissues have a ratio of IGK:IGL expression of 
approximately 2:1.  In contrast IgA plasma cells exhibit IGK:IGL ratio of  approximately 1:1. 
Such a bias could be acquired by antigen selection or by changes in light chain gene 
rearrangements such as light chain revision.  In order to better understand this, IGL genes 
were PCR amplified, cloned and sequenced from the DNA of transitional, naïve and IgA 
expressing B cells.  Unusual biases in genetic reading frame were observed in the IgA 
expressing cells of the most commonly used IGL families.  This was further investigated 
using a high throughput sequencing method that identified biases in the IGL genes of IgA 
with preferential selection of IGLV2-14 in IgA subsets (Chapter 3).   
In the bone marrow, IGL gene rearrangement starts only if the rearrangement at IGK locus is 
non-functional. However, approximately 25% to 30% of IGL expressing cells have previously 
undergone apparently functional IGK gene rearrangement, but for some reasons these 
productive rearrangements were not expressed. In order to better understand the regulation 
of the IGK locus, IGK gene rearrangements were sequenced from naïve B cells expressing 
either IGK or IGL. Sequences were divided into productive and non-productive according to 
the characteristics of the junction. The actual expressed genes in cDNA were also amplified 
from IGK expressing B cells. Overall results identified selection and expression biases 
operating at the time of establishment of IGK repertoire (Chapter 4).  
During B cell development, IGH rearrangements that pair better with surrogate light chains 
are selected at the pro-B cell stage. Therefore, it was decided to investigate if there is any 
possibility that later during B cell development, rearranged light chains could show 
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preferences for particular IGH gene segments. If so, this will help in identifying additional 
factors shaping the IGH repertoire of naïve B cells. Rearranged IGH were sequenced from 
naïve B cells expressing either IGK or IGL. The relative usage of IGHV, IGHD and IGHJ and 
CDR-3 characteristics were compared. It was found that there is no preference of IGH to be 
associated with either IGK or IGL (Chapter 5). 
This thesis has identified some unusual features of light chain gene rearrangements. The 
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IgA   Immunoglobulin A 
IgD   Immunoglobulin D 
IgE   Immunoglobulin E 
IgG   Immunoglobulin G    
IGH   Immunoglobulin heavy chain locus 
IGH   Immunoglobulin heavy chain protein 
IGHC   Immunoglobulin heavy chain constant exon gene 
IGHC   Immunoglobulin heavy chain constant exon protein 
IGHD   Immunoglobulin heavy chain diversity exon gene 
IGHD   Immunoglobulin heavy chain diversity exon protein 
IGHJ   Immunoglobulin heavy chain joining exon gene 
IGHJ   Immunoglobulin heavy chain joining exon protein 
IGHV   Immunoglobulin heavy chain variable exon gene 
IGHV   Immunoglobulin heavy chain variable exon protein 
IGK   Immunoglobulin kappa light chain locus 
IGK   Immunoglobulin kappa light chain protein 
IGKC   Immunoglobulin kappa light chain constant exon gene 
IGKC   Immunoglobulin kappa light chain constant exon protein 
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IGKJ   Immunoglobulin kappa light chain joining exon gene 
IGKJ   Immunoglobulin kappa light chain joining exon protein 
IGKV   Immunoglobulin kappa light chain variable exon gene 
IGKV   Immunoglobulin kappa light chain variable exon protein 
IGL   Immunoglobulin lambda light chain locus 
IGL   Immunoglobulin lambda light chain protein 
IGLC   Immunoglobulin lambda light chain constant exon gene 
IGLC   Immunoglobulin lambda light chain constant exon protein 
IGLJ   Immunoglobulin lambda light chain joining exon gene 
IGLJ   Immunoglobulin lambda light chain joining exon protein 
IGLV   Immunoglobulin lambda light chain variable exon gene 
IGLV   Immunoglobulin lambda light chain variable exon protein 
IgM   Immunoglobulin M 
IL   Interleukin 
ILF   Isolated lymphoid follicle 
iRSS   Intronic recombination signal sequence  
ITAM    Immunoreceptor tyrosine based activation motif  
J chain   Joining chain 
kDa   Kilo Dalton 
KDE   Kappa deleting element  
LN   Lymph node 
LP   Lamina propria 
LZ   Light zone 
M cell   Microfold cell 
MAdCAM-1  Mucosal vascular addressin cell adhesion molecule-1 
MALT   Mucosa associated lymphoid tissue 
MHC   Major histocompatibility complex  
MID   Multiplex identifier 
MLN   Mesenteric lymph node 
mRNA   Messenger ribonucleic acid 
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N nucleotide  Non templated nucleotide 
NBD   Nonamer binding domain  
NH2   Amino terminal 
NHEJ    Non homologous end joining  
NK cell   Natural killer cells 
OH
-
   Hydroxyl group 
ORF   Open reading frame  
P nucleotide  Palindromic nucleotide  
PAMP    Pathogen associated molecular pattern 
Pax5   Paired box 5 protein 
PD-1    programmed cell death-1 
PHD   Plant homeodomain 
PP   Peyer’s patch 
pIgR   Polymeric immunoglobulin receptor 
Pre B cell   Precursor B cell 
Pre BCR  Pre B cell receptor 
Pro B cell  Progenitor B cell 
RA   Retinoic acid 
RA   Rheumatoid arthritis 
RAG-1   Recombination activating gene-1 enzyme 
RAG-2    Recombination activating gene-2 enzyme 
RALDH   Retinaldehyde dehydrogenase enzyme 
RBC   Red blood cell 
REC   Recombination excision circle  
ROS    Reactive oxygen species  
RSS   Recombination signal sequence  
S region   Switch region 
SHM   Somatic hypermutation 
SLE   Systemic lupus erythematousus 
SLyRT    Sort lysis reverse transcriptase  
24 
 
ssDNA   Single stranded DNA 
STAT   Signal transducer and activator of transcription  
Syk   Spleen tyrosine kinase  
TACI   Transmembrane activator 
TCR   T cell receptor  
TD   T dependent 
TdT   Terminal deoxynucleotidyl transferase enzyme 
Tfh    T follicular helper cell 
TGF-β   Transforming growth factor beta 
TID   T independent 
TNF   Tumour necrosis factor 
V   Variable exon gene segment 
VCAM   Vascular cell adhesion molecule 
YY1    Yin Yang 1  
ZDD   Zinc binding dimerization domain  
Zn   Zinc 
γδ T cell  Gamma delta T cell 




























The immune system has evolved to protect living organisms from the damaging effects of 
infectious agents, harmful substances such as toxins and altered self tissues such as 
tumours. Abnormal functioning of the immune system results in a wide range of 
immunopathologies. The first immune barrier is provided by the innate immune system. 
Innate immune mechanisms mainly include recognition of pathogen associated molecular 
patterns (PAMPs) by a fixed repertoire of pattern recognition receptors (PRRs), complement 
activation, phagocyte recruitment and production of antimicrobial proteins besides physical 
barriers provided by the epithelium and mucosal layers. Adaptive immunity that comes into 
play later generates antigen specific and long lasting immune responses. It culminates in the 
activation of B and T lymphocytes after recognition of antigens via B cell receptors (BCRs) 
and T cell receptors (TCRs) respectively. The effector functions of B cells are mediated by 
secretory proteins called antibodies. Antibodies are produced by differentiated B cells 
(plasma cells) to eliminate the antigen from the system. Antibodies are the secreted form of 
the BCRs. These soluble proteins are secreted in large quantities.  
1.1 The structure of human immunoglobulin molecules 
Immunoglobulins are members of the immunoglobulin superfamily of proteins. When they 
are expressed on the surface of the cells they form the BCR and when they are secreted 
they may be referred to as antibodies. The immunoglobulin molecule is made up of two 
different types of protein chains: heavy chain proteins (IGH) which are covalently linked by 
disulphide bonds and light chains linked to IGH by disulphide bonds (Figures 1-1 and 1-2) 
(Edelman and Benacerraf 1962, Sela-Culang, Kunik et al. 2013). Light chains are of two 
types (or isotypes): kappa (IGK) and lambda (IGL). Each immunoglobulin molecule is 
comprised of either IGK or IGL chain associated with the IGH chain on the cell surface 
generally (Neuberger, Caskey et al. 1989). The ratios of IGK to IGL vary in different species. 
In mice, the average IGK:IGL ratio is 20:1, whereas in humans it is 2:1 (Ghia, Gratwohl et al. 
1995).   
The amino (-NH2) terminal of the immunoglobulin molecule is highly variable in both IGH and 
light chains called VH and VL respectively. After pairing of IGH chain with either IGK or IGL 
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chain, variable domains (VH and VL) together constitute the antigen binding sites. Within 
each variable domain, there are 6 hypervariable loops (3 in each) called complementary 
determining regions (CDR) separated by conserved β-pleated sheets called frame work 
regions (FWR) (Dreyer and Bennett 1965, Wu and Kabat 1970, Sela-Culang, Kunik et al. 
2013). The carboxyl (-COOH) terminal of IGH constitutes constant region (CH) (Dreyer and 
Bennett 1965, Putnam, Liu et al. 1979). The constant region is further divided into domains 
(CH1 to CH3 or CH4). There are 5 different isotypes of the immunoglobulin molecule that 
are defined according to CH region: μ, γ, α, δ and ε. These different IGH isotypes have 
different effector functions and determine the class and functional properties of 
immunoglobulins [immunoglobulin M (IgM), immunoglobulin G (IgG), immunoglobulin A 
(IgA), immunoglobulin D (IgD) and immunoglobulin E (IgE)] respectively. These 
immunoglobulins have different distribution in tissues and are specialized to mediate 









Figure 1-1: Diagrammatic representation of an immunoglobulin molecule. Each 
immunoglobulin is made up of two heavy chains (green) joined by disulphide bonds (black) 
and two light chains (blue). Each heavy chain is also linked to the light chain by the 
disulphide bond. Heavy and light chains are divided into variable and constant region 














Antigen recognition site 








The structure of a membrane bound BCR and its corresponding secreted antibody is 
identical except that membrane bound BCR has a hydrophobic transmembrane portion at 
the -COOH terminal and a small hydrophilic tail extending into cytoplasm. The switching 
from transmembrane cell receptor to secreted antibody takes place by alternative splicing of 
the IGH transcript (Rogers, Early et al. 1980). The IGH chain is also non covalently linked to 
the invariant signalling proteins Igα and Igβ (Schamel and Reth 2000). These signalling 
proteins are antigen non specific and each has a single immunoreceptor tyrosine based 
activation motif (ITAM) in their cytoplasmic tails that enables them to transduce signal when 
the BCR is ligated with its cognate antigen (Reth 1989). Igα and Igβ are connected to each 
other by a disulphide bond (Hombach, Lottspeich et al. 1990, Reth, Wienands et al. 1991, 















Figure 1-2: Diagrammatic representation of the BCR complex. Each immunoglobulin 
molecule is made up of two heavy chains (green) and two light chains (blue) joined by 
disulphide bonds (black). The BCR is expressed along with Igα and Igβ joined by disulphide 
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Complement 
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Table 1-2: The distribution of various immunoglobulins and IgG subclasses of human 
immunoglobulins 



























1.2 Human gene loci encoding IGH, IGK and IGL chains 
Dreyer and Bennett showed by protein sequencing that immunoglobulin molecules consist of 
variable and constant regions. Later, Tonegawa and Hozumi provided empirical evidence 
that during B cell development, functional protein of BCR is encoded by somatic gene 
rearrangement of widely separated variable and constant region gene segments (Dreyer and 
Bennett 1965, Hozumi and Tonegawa 1976). Years later, it was shown that functional 
variable region exon of light chain is generated by gene rearrangement of two gene 
segments: V (variable) and J (joining) and variable region exon of heavy chain is encoded by 
bringing together three gene segments: V (variable), D (diversity) and J (joining) (Bernard, 
Hozumi et al. 1978, Early, Huang et al. 1980).  
1.2.1  Heavy chain locus 
The human immunoglobulin heavy chain locus (IGH) is located at chromosome 14q32.33 
(Figure 1-3). There are 123 to 129 IGHV genes: 38 to 44 functional IGHV genes, 4 open 
reading frame (ORF), 79 pseudogenes, one gene segment (IGHV3-11) could be in the 
category of either functional or pseudogene, one gene segment (IGHV4-61) could be either 
functional or ORF potentially. The potential repertoire of BCR is encoded by 38 to 46 
functional IGHV genes belonging to 7 families defined by sequence homology (IGHV1 to 
IGHV7). There are 23 IGHD, 6 IGHJ and 9 IGHC gene segments (Lefranc, Giudicelli et al. 
2015).  
1.2.2  Kappa light chain locus 
The human immunoglobulin kappa light chain locus (IGK) is located at chromosome 2p11.2 
(Figure 1-4). There are 76 IGKV genes segments: 34 functional IGKV genes, 8 ORF, 30 
pseudogenes, 4 genes (IGKV1-13, IGKV1-39, IGKV2-29 and IGKV3D-15) could be either 
functional or pseudogenes potentially. The potential BCR repertoire is encoded by 34 to 38 
functional IGKV genes divided in to 5 families defined by sequence homology (IGKV1 to 
IGKV5). There are 5 IGKJ and 1 IGKC gene segments (Lefranc, Giudicelli et al. 2015).
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1.2.3  Lambda light chain locus 
The human immunoglobulin lambda light chain locus (IGL) is located at chromosome 
22q11.2 (Figure 1-5). There are 73 to 74 IGLV gene segments: 29 to 30 functional, 5 ORF, 
35 pseudogenes, 3 genes segments (IGLV3-9, IGLV3-22, and IGLV7-46) could be either 
functional or pseudogenes, one gene segment (IGLV1-41) could be either ORF or 
pseudogene. The potential BCR repertoire is encoded by 29 to 33 functional IGLV genes 
classified in to 10 families defined by sequence homology (IGLV1 to IGLV10). There are 4 




Figure 1-3: Schematic representation of human IGH locus located on chromosome 14q32.33. Various functional gene segments, pseudogenes and 
open reading frames are shown (http://www.imgt.org/IMGTrepertoire/index.php?section=LocusGenes&repertoire=locus&species=human&group=IGH). 
 
 
 IGHV gene segment (Functional) 
 IGHD gene segment (Functional) 
 IGHJ gene segment (Functional) 
 IGHC gene segment (Functional) 
 IGHV gene segment (ORF) 
Genes not related 













Figure 1-4: Schematic representation of human IGK locus located on chromosome 2p11.2. Various functional gene segments, pseudogenes and open 
reading frames are shown (http://www.imgt.org/IMGTrepertoire/index.php?section=LocusGenes&repertoire=locus&species=human&group=IGK). 
 IGKV gene segment (Functional) 
 IGKJ gene segment (Functional) 
 IGKC gene segment (Functional) 
 IGKV gene segment (ORF) 
 IGKV gene segment (Pseudogene) 
Genes not related 
 IGKV gene segment having reverse transcription 





Figure 1-5: Schematic representation of human IGL locus located on chromosome 22q11.2. Various functional gene segments, pseudogenes and open 
reading frames are shown (http://www.imgt.org/IMGTrepertoire/index.php?section=LocusGenes&repertoire=locus&species=human&group=IGL). 
 
 
 IGLV gene segment (Functional) 
 IGLJ gene segment (Functional) 
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 IGLV gene segment (ORF) 
 IGLV gene segment (Pseudogene) 
Genes not related 
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1.3  V(D)J gene rearrangement 
V(D)J gene rearrangement is a lineage specific developmental process that assembles the 
variable set of exons of immunoglobulin genes to encode a functional BCR that can be 
expressed on the cell surface to recognize antigens (Alt, Yancopoulos et al. 1984). In order 
to mount an efficient adaptive immune response, it is of cardinal importance to generate a 
diverse repertoire of B cells (Bassing, Swat et al. 2002, Schatz and Ji 2011). The process of 
V(D)J gene rearrangement involves recognition and breaking of recombination signal 
sequences (RSSs) flanking IGH (IGHV, IGHD, IGHJ), IGK (IGKV, IGKJ) and IGL (IGLV and 
IGLJ) gene segments by recombination activation gene enzyme (RAG) protein complex and 
subsequent ligation of gene segments resulting in a functional unit of exons that can encode 
a BCR to be expressed on the cell surface. This recognition, breaking and ligation occurs at 
specific stages of B cell development and are tightly regulated (Schatz, Oettinger et al. 1989, 
Oettinger, Schatz et al. 1990, Oettinger 2004). 
1.3.1 RAG enzymes and recombination signal sequences   
The RAG enzyme complex is a nuclear protein complex comprising of RAG-1 and RAG-2 
enzymes (Schatz, Oettinger et al. 1989, Oettinger, Schatz et al. 1990). The structure of the 
RAG complex is well conserved among vertebrates. The expression of RAG-2 enzyme is 
lower during S, G2 and M phases of mitosis and RAG-1 predominantly bind accessible 
RSSs.  Later as cells enter the G1 phase, RAG2 levels increase and it is subsequently 
recruited to the locus that is pre-bound with RAG-1 enzyme (Lin and Desiderio 1994, Lee 
and Desiderio 1999, Swanson 2004). The crystal structure of the RAG enzyme complex has 
been determined recently suggesting the RAG enzyme complex (230 kDa) forms a Y-
shaped structure where the active site is in the middle. Various mutations in the active site 
are linked to immunodeficiency diseases (Kim, Lapkouski et al. 2015).   
RAG-1 enzyme: Various domains of the RAG-1 enzyme are associated with different 
functions during V(D)J gene rearrangement as shown in Figure 1-6. The non-core domain of 
the RAG-1 protein at the -NH2 terminal regulates the stability of many other cellular proteins, 
co-ordinates zinc (Zn
++
) and thus enhances V(D)J gene rearrangement (Cortes, Ye et al. 
1994, McMahan, Difilippantonio et al. 1997). The -NH2 terminal contains several pairs of 
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conserved cysteine (C2) residues. Zn
++
 binding dimerization domain (ZDD) spans from 
amino acid 265 to 380. This region mainly regulates interaction with the histone H3 
(Rodgers, Bu et al. 1996). The ZDD is followed by the core region. The core region is the 
minimal portion of RAG protein required for V(D)J recombination (De and Rodgers 2004). 
The core region is further divided functionally into the following three main regions:  
1. Nonamer binding domain (NBD) (from amino acid 384 to 458)  
2. Central domain (from amino acid 528 to 760) 
3. C-terminal domain (CTD) (from amino acid 761 to 1008) 
The NBD forms a dimer and interacts with the nonamer of the RSS. The central domain has 
nicking activity and is also involved in making contact with the heptamer of the RSS. The 
CTD binds the double stranded DNA (dsDNA) and mediates contact with the coding 
sequence flanking the RSS and contains Zn
++
 binding sites (Difilippantonio, McMahan et al. 







Figure 1-6: Schematic representation of RAG-1 enzyme. The position of various 
structural domains of protein and associated functions are indicated. 
 Zn binding 
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RAG-2 enzyme: Various structural domains of the RAG-2 enzyme associated with various 
functions are shown in Figure 1-7. The RAG-2 enzyme can be divided into following three 
notable regions:  
1. Core region at the -NH2 terminal (ranging from amino acid 1 to 387) 
2. Flexible acidic hinge region (from amino acid 360 to 408) 
3. Plant homeodomain (PHD) at the -COOH terminal (from amino acid 414 to 487)  
The core region of the RAG-2 protein is critical for the cleavage of DNA.  It also interacts 
with the RAG-1 enzyme and enhances the DNA binding affinity and specificity of the RAG 
complex. The PHD domain binds specifically to trimethylated histone H3 lysine 4 (H3K4me3) 
and enhances the catalytic activity of the RAG complex. Moreover, it directs RAG-2 to the 
region of active chromatin (Roldan, Fuxa et al. 2005, Liu, Subrahmanyam et al. 2007, 






Figure 1-7: Schematic representation of RAG-2 enzyme. The position of various 
structural domains of proteins and associated functions are indicated. 
Recombinational signal sequences: Gene segments of all immunoglobulin loci are flanked 
by RSSs (Hozumi and Tonegawa 1976, Rogers, Early et al. 1980). These sequences are 
recognized by RAG enzymes (Schatz, Oettinger et al. 1989, Oettinger, Schatz et al. 1990). 
Structurally each RSS consists of specific DNA elements: heptamer, nonamer and spacer 
DNA (Figure 1-8). The DNA sequence of the heptamer and nonomer are well conserved but 
the DNA sequence of spacer region is variable and it can be either 
NH2 COOH 
 Critical for DNA cleavage 
 Enhances DNA binding 
 Binds H3K4me3 
 Phosphoinositide binding 
 Enhances catalytic activity of RAG 
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12 base pair (bp) or 23 bp which define 12-RSS or 23-RSS respectively (van Gent, 
Ramsden et al. 1996). The initial three nucleotides of heptamer are critical during the 
rearrangement process (Hesse, Lieber et al. 1989, Ramsden, McBlane et al. 1996). The 
NBD of the RAG-1 enzyme binds nonamer (ACAAAAACC) and mediates anchoring of RAG 
proteins on the DNA. The heptamer (CACAGTG) sequence enhances anchoring of the RAG 
complex and specifies the site of DNA cleavage. The length of spacer DNA is important for 
efficient V(D)J gene rearrangement as it is involved in the alignment of heptamer and 
nonamer. It also plays an important role in protein-DNA interactions (Swanson, Kumar et al. 










Figure 1-8: Schematic representation of RSS flanking all gene segments of 
immunoglobulin loci. Each RSS has conserved heptamer and nonamer along with non 






















1.3.2  Mechanism of V(D)J gene rearrangement 
During V(D)J gene rearrangement the “12-23 rule” is followed that ensures specific and 
precise gene rearrangements. According to this rule, there is a restriction of gene 
rearrangement between 12-RSS and 23-RSS only (van Gent, Ramsden et al. 1996). 
Theoretically, the process of V(D)J gene rearrangement can be divided into two phases as 
described below (Fugmann, Lee et al. 2000, Gellert 2002): 
1.3.2.1  Cleavage phase 
RAG enzymes recognize both 12-RSS and 23-RSS and introduce nicks on the DNA strands. 
Nicking of the DNA results in the alignment of the two gene segments and leads to the 
formation of a stable multi subunit synaptic complex (Jones and Gellert 2002, Mundy, 
Patenge et al. 2002, Curry, Geier et al. 2005). RAG enzymes first introduce a nick on one of 
the DNA strands by catalyzing the hydrolysis of a phosphodiester bond adjacent to the RSS. 
Free 3’ hydroxyl (OH) group liberated as a result of nicking attacks on the opposite strand of 
the DNA and thus a double stranded break is generated. It is then followed by hairpin 
formation on both coding strands resulting in a blunt signal end (McBlane, van Gent et al. 
1995) (Figure 1-9). RAG proteins remain bound transiently with the broken ends of the DNA 
that are produced after cleavage (Hiom and Gellert 1998). The coding ends dissociate from 
RAG proteins before the signal ends. Later there is a progression to the next phase that 

















Figure 1-9: Steps involved during cleavage of the DNA by RAG enzymes. The first nick 
is introduced on one of the DNA strands adjacent to the RSS by hydrolyzing the 
phosphodiester bond catalyzed by RAG enzymes. As a result of nicking OH
-
 is generated 
that attacks on the opposite strand of the DNA resulting in a double stranded break. Later 
there is a formation of hairpin at the end of both coding and blunt ends of the DNA. 
1.3.2.2  Joining phase 
The first step to join the broken DNA is the resolution of hairpin loops at the end of coding 
DNA which is mediated by DNA dependent protein kinase (DNA-PKs) and Artemis (Ma, 
Pannicke et al. 2002, Rooney, Alt et al. 2005). These proteins are structure specific and 
process hairpin loops. It results in the processing of coding and signal ends and subsequent 
joining via classical non homologous end joining (NHEJ) (Taccioli, Rathbun et al. 1993, 
Ramsden and Gellert 1995). Various important proteins involved in this DNA repair pathway 
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joining, random non templated nucleotides (N) are added at the junction mediated by Pol X 
family of polymerases (TdT, polμ and polλ) (Bertocci, De Smet et al. 2006). N nucleotides 
are added before the ends are joined randomly mediated by the terminal deoxynucleotidyl 
transferase (TdT) enzyme. The TdT enzyme is maximally expressed at the progenitor (pro) 
B cell stage therefore adds random nucleotides between both IGHV-IGHD and IGHD-IGHJ 
junctions (Desiderio, Yancopoulos et al. 1984). P (palindromic) nucleotides can also be 
inserted at the junctions. RAG proteins can generate DNA hairpins at the coding ends of V, 
D and J gene segments after which Artemis enzyme catalyzes a single stranded cleavage at 
a random point within the coding sequence. As a result, a single stranded tail is formed from 
a few nucleotides of the coding sequence plus the complimentary nucleotides from the other 
DNA strand. In most light chain gene rearrangements, DNA repair enzymes then fill the 
complimentary nucleotides on the single stranded tails, which would leave short palindromic 
nucleotides at the joint if the ends were rejoined without any further exonuclease activity.  
Because the total number of nucleotides added by these processes is random, added 
nucleotides can disrupt the coding sequence beyond the joint. Such frameshifts may result 
in non productive DNA gene rearrangements (Figure 1-10). At the end of V(D)J gene 
rearrangement two joints are formed:  the coding joint as a result of joining of two gene 
segments while signal joint represents fusion of two RSSs as shown in Figure 1-11 (Schatz 











A: Productive gene rearrangement  
DNA          IGLV2-14  tgc   agc   tca   tat   aca   aac   agc   agc  gtg ata ttc  IGLJ2  
Protein                           C      S      S     Y      T      N      S       S     V    I    F  
(Functional) 
B: Non productive gene rearrangement 
DNA          IGLV2-14  tgc   agc   tca   tat   aca   aac   agc   agc ggt gat  att c  IGLJ2  
Protein                           C      S      S     Y      T      N      S       S    G    D    I  
(Non Functional) 
 
Figure 1-10: Examples of productive and non productive CDR-3 junctions as a result 
of gene rearrangement between gene segments IGLV2-14 and IGLJ2.  
(A) CDR-3 junction is defined as productive if the reading frame of triplet codons remains 
intact and results in a functional protein. (B) Random addition or removal of nucleotides (in 
this example ‘g’ is inserted) generates non productive gene rearrangement as the reading 
frame of triplet codon at the junction has been disrupted consequently functional protein 


















Figure 1-11: Overview of various stages involved during V(D)J gene rearrangement 
process.  Gene segments are flanked by either 12RSS or 23RSS. In the first phase 
involving cleavage, RAG1 and RAG2 proteins bind to 12RSS or 23RSS and form 12 signal 
complex or 23 signal complex respectively. Capture of a second RSS (synapsis) result in the 
formation of the paired complex, within which RAG proteins induce double strand breaks 
between the gene segments and RSSs. In the second phase that involves joining, the RAG 
proteins along with other repair proteins rejoin the DNA ends. Gene segments ends typically 
undergo P and N nucleotides addition by TdT and nucleotides loss by exonucleases before 
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1.4 B cell development 
The development of B cells takes place in the fetal liver and the adult bone marrow both in 
mice and humans (Ryser and Vassalli 1974, Galy, Travis et al. 1995). Haematopoietic stem 
cells (HSCs) are pluripotent cells residing in the bone marrow and are precursors of all types 
of blood cells. Common lymphoid progenitors (CLPs) are descendents of HSCs and 
progenitors of T, B and natural killer (NK) cells with little or no capacity to differentiate into 
nonlymphoid lineages such as myeloid and erythroid cells (Galy, Travis et al. 1995). The 
developmental relationships between HSCs, CLP and potential lymphoid lineages are 









Figure 1-12: Derivation of various blood cells lineages from HSCs. The CLP can 
differentiate into the specific lineage of both B cells in the bone marrow and a lineage that 
retains the potential to develop into T, NK and DCs in thymus. 
Early B cells are characterized by the initiation of IGHD-IGHJ gene rearrangement at the 
IGH locus and the expression of B lineage specific proteins such as VpreB and Igα 
(Bertrand, Billips et al. 1997, Davi, Faili et al. 1997, Dworzak, Fritsch et al. 1998). The CLP 
can also differentiate into tri lineage precursor cells which are defined by expression of CD7 
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these tri lineage precursors into progenitors of the specific lineages of dendritic (DC), T and 
NK takes place in the thymus. The process of B cell development takes place within the 
bone marrow in adult humans (Spits, Blom et al. 1998). The characteristic phenotypic and 
temporal features of gene rearrangements at distinct developmental phases are summarized 
in the Table 1-3.  





V(D)J gene rearrangement takes place in a stepwise fashion during B cell development (Alt, 
Yancopoulos et al. 1984, Ehlich, Schaal et al. 1993, Ehlich, Martin et al. 1994, ten Boekel, 
Melchers et al. 1995). It begins at the IGH locus in early pro B cells when IGHD gene 
segment is rearranged with IGHJ gene segment on both alleles as evident by the 
juxtaposition of gene segments for efficient long distant interaction (Alt, Yancopoulos et al. 
1984, Yancopoulos and Alt 1985). In humans most IGHD to IGHJ joints are potentially useful 
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encountering a stop codon (Benichou, Glanville et al. 2013). In the next step, IGHV gene 
segment rearranges to IGHD-J on only one allele and stops further IGHV to IGHD-J gene 
rearrangement (Alt, Yancopoulos et al. 1984). However, if the process of rearrangement on 
the first allele does not result in a functional protein then it is followed by the gene 
rearrangement on the second IGH allele (Vettermann and Schlissel 2010). The productive 
exon results in the production of an intact cytoplasmic μ heavy chain (μHC) and is necessary 
for the transition of pro B cells into precursor (pre) B cells (Lutz, Heideman et al. 2011). 
However, pro B cells that fail to get a productive gene rearrangement after successive gene 
rearrangements on either allele undergo apoptosis (Lutz, Muller et al. 2006).  
The acquisition of cytoplasmic μHC marks the transition to the next developmental stage of 
B cell differentiation called pre B cells. In pre B cells, μHC is tested for functionality by 
pairing with the surrogate light chain (Loken, Shah et al. 1987, LeBien, Wormann et al. 1990, 
Ghia, ten Boekel et al. 1996). The surrogate light chain is composed of two invariant proteins 
(VpreB and λ5) that form a tight but non covalent pair with μHC and are expressed on the 
pre B cell surface as a pre BCR along with invariant proteins Igα/Igβ (Melchers, Karasuyama 
et al. 1993, Keyna, Beck-Engeser et al. 1995, Kline, Hartwell et al. 1998, ten Boekel, 
Melchers et al. 1998). Biochemical studies reveal that pre BCR is activated by the ligand 
independent oligomerization (Bankovich, Raunser et al. 2007). The BCR repertoire is largely 
shaped at this step as it has been found that μHC with the potential to generate 
autoantibodies undergo negative selection at this step (Keenan, De Riva et al. 2008). More 
than half of all μHC are potentially unable to pair with surrogate light chain in spite of having 
a productive gene rearrangement and thus affect IGH repertoire (ten Boekel, Melchers et al. 
1998). The production of surrogate light chains is turned off after the cell surface expression 
of pre BCR (Melchers, ten Boekel et al. 2000). Pre B cell stage marks a selection checkpoint 
during B cell development. This checkpoint ensures that early B cell development is 
stringent and cells have not undergone any abnormal transformation. The selection of B 
cells at the pre B cell checkpoint is regulated by a balance between the two important 
transcription factors: basic leucine zipper transcription factor 2 (BACH2) and B-cell 
lymphoma 6 protein (BCL6). The transcription factor BCL6 mediates positive selection of pre 
B cells and thus allows the cell to cross this checkpoint. On the other hand, transcription 
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factor BACH2 induces negative selection. (Swaminathan, Duy et al. 2014). Human pre B 
cells are classified into two subsets based on their proliferative capacities: pre BI cells and 
pre BII cells. The pre BI cells are large proliferating cells while pre BII cells are small post 
mitotic cells (Ghia, ten Boekel et al. 1996). Overall, the expression of pre BCR orchestrates 
survival, proliferative expansion of early pre B cells expressing μHC and the subsequent 
developmental transition to the late pre B cell stage and leads to the initiation of gene 
rearrangement at the IGK locus (Shapiro, Schlissel et al. 1993, Vettermann and Schlissel 
2010).  
The process of gene rearrangement at the IGK locus starts on any one allele randomly in 
pre BII cells and during this process the IGL locus remains in germline configuration 
(Beishuizen, Verhoeven et al. 1994). Once pre B cells have successfully joined IGKV and 
IGKJ segments to generate a productive IGKVJ exon, its functionality is tested by pairing 
and expressing with the μHC on the cell surface as a BCR (Alt, Yancopoulos et al. 1984). 
Pre B cells having IGK chain that could not pair with the μHC or encode for an autoreactive 
receptor may undergo further secondary gene rearrangements termed receptor editing. As a 
result of secondary gene rearrangements upstream IGKV gene segments may rearrange 
with downstream IGKJ gene segments to create a different specificity (Feddersen and Van 
Ness 1985, Chen, Prak et al. 1997, Pelanda, Schwers et al. 1997). After receptor editing 
various gene rearrangements can accumulate in the cell on the chromosome and as 






















Figure 1-13:  Schematic representation of mechanisms leading to the accumulation of 
multiple gene rearrangements in the same cell. In this example, initial non productive 
gene rearrangements (involving IGKV4 and IGKV3) have been followed by the secondary 
gene rearrangement of an upstream IGKV2 and a downstream IGKJ3 gene segment. 
Theoretically if this gene rearrangement (second) is again either non productive or 
functionally autoreactive it may lead to the third gene rearrangement on the same allele 
provided there are unused upstream IGKJ gene segments along with the accumulation of 
excised gene rearrangements. 
When either a functional IGKV-IGKJ gene rearrangement is obtained or the cell gets 
exhausted after utilizing all possible options of the secondary gene rearrangements on that 
allele then it results in the inactivation of the IGK locus due to the deletional rearrangement 
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by kappa deletion element (KDE) as shown in the Figure 1-14. The KDE can be rearranged 
via one of the two pathways (Siminovitch, Bakhshi et al. 1985, Klobeck and Zachau 1986): 
1. KDE undergoes RSS-mediated site-specific recombination with intronic 
recombination signal sequence (iRSS) located between the distal IGKJ and IGKC 
gene segments. 
2. The alternative KDE rearrangement takes place to an upstream, unrearranged IGKV 
gene segment.  
Both RSS-mediated recombination events result in deletion of the IGKC region and its 
enhancers (iEK and 3’EK); though in the latter instance the IGKV-IGKJ joint is also removed. 
Thus as a result the IGK locus loses its potential for further gene rearrangements or 
expression (Langerak, Nadel et al. 2004, Das, Nikolaidis et al. 2009). 
Alternatively, in a minor unconventional pathway, the iRSS can rearrange with the RSS 
flanking IGKJ gene segments. If there is no deletion at this joint then it can undergo further 
rearrangements either to an upstream RSS element flanking IGKV gene segment 
(IGKVRSS-iRSS pseudohybrid joint) or to the downstream RSS of the KDE (IGKJRSS-KDE 
pseudohybrid joint). This joint, can further recombine in two different ways: 
1. Recombination between IGKV segment and IGKJRSS-KDE pseudohybrid joint 
results in IGKV-iRSS coupling. 
2. Recombination between KDE and IGKJRSS-iRSS joint results in IGKJRSS-KDE 
coupling. 
As long as the iRSS of IGKV-iRSS pseudohybrid joint is still intact, further recombination to 














Figure 1-14: Schematic overview of the IGKV-IGKJ gene rearrangement and 
subsequent inactivation of IGK locus by the classical pathway. (A) Either functional or 
exhausted gene rearrangements (IGKV-IGKJ) at the IGK locus lead to further 
rearrangements that result in the inactivation of IGK locus. (B) Recombination of KDE to an 
isolated heptamer in the intron between the IGKJ and IGKC segments results in the deletion 
of the IGKC region (solid line), whereas recombination between KDE and upstream IGKV 
gene segment deletes the entire IGKJ-IGKC region (C). Both types of KDE rearrangements 
(B and C) also result in the deletion of IGK enhancers (iEk and 3’Ek) and thus preclude 
further rearrangements in the human IGK locus.   
Thus inactivation of IGK locus helps in establishing allelic and isotypic exclusion (Langerak, 
Nadel et al. 2004). If a cell fails to get any desired specificity from one IGK allele then gene 
rearrangement starts on the second IGK allele. If both alleles fail to produce any functional 
specificity then gene rearrangement proceeds to the IGL locus. Like the IGK locus, gene 
rearrangement can start on the second IGL allele if the functional gene rearrangement is not 
obtained from the first allele (Hieter, Korsmeyer et al. 1981, Korsmeyer, Hieter et al. 1982, 
van der Burg, Tumkaya et al. 2001). The BCR signal is essential for cell survival therefore 
failure to rearrange and express both functional IGH with either IGK or IGL results in the 
death of the cell by apoptosis (Lam, Kuhn et al. 1997). 
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Immature or transitional B cells express functional IgM BCR on the cell surface. At this stage 
of B cell development, BCR is first tested for reactivity against self antigens. It has been 
found that after primary gene rearrangement, up to 10
11
 specificities of BCRs can be 
generated and some of these can be autoreactive (Grimaldi, Hicks et al. 2005). Cells 
passing this checkpoint are selected to mature further in the periphery. Cells that react 
against self antigens undergo apoptosis. However, this early checkpoint was found to be 
defective in some autoimmune diseases such as systemic lupus erythematousus (SLE) (Su 




1.5 Molecular factors affecting V(D)J gene rearrangement 
Immunoglobulin gene loci harbour multiple gene segments but not all are rearranged with 
the same frequencies. This suggests there are inherent biases that determine the base level 
of gene rearrangement irrespective of selection pressure. Following are some factors that 
could affect the overall process of V(D)J gene recombination. 
1.5.1 Differential locus accessibility  
Like all cellular DNA, antigen receptor loci exist as nucleosomes. Nucleosomes are the basic 
building blocks of chromatin. Each nucleosome is composed of an octamer of histone 
proteins (H2A, H2B, H3 and H4) wrapped by 2 rounds of DNA. Covalent modifications of N-
terminal tails of H3 and H4 regulates accessibility to DNA within specific chromatin. 
Promoters of active genes are enriched with trimethylation of H3K4 (H3K4me3). H3K4me3 
is present only at the pro B cell stage. These patterns of H3K4me3 are recognized by the 
PHD finger of the enzyme RAG-2 (Jiang, Chang et al. 2005). Locus accessibility increases 
by non-coding RNA transcription. Non-coding RNAs constitute a broad family including 
miRNAs, siRNAs, piwiRNAs, tiRNAs, cryptic unstable transcripts and long non coding RNAs. 
These RNAs regulate different aspects of gene regulation. However, in VDJ gene 
recombination, a role for long non coding RNAs has been implicated. These transcripts are 
specifically expressed from the particular region of the IGH locus that is organized for VDJ 
recombination (Corcoran 2010). Thus differences in methylation pattern and other epigenetic 
regulatory processes can vary the accessibility of individual gene segments to the RAG 
machinery which may contribute to skewed utilization of individual gene segments.  
1.5.2 Variation in RSS 
Studies have revealed that the efficiency and specificity of V(D)J gene rearrangement 
process is influenced by nucleotide variability within RSS. The first three base pairs of the 
heptamer are crucial for RSS binding to RAG proteins (Akamatsu, Tsurushita et al. 1994, 
Nagawa, Hirose et al. 2004, Schatz and Swanson 2011). The frequency of VDJ 
recombination can also be changed enormously by variation in the spacer sequence of RSS. 
It may result in the reduction of binding affinity of RAG proteins and resultant cleavage of 
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RSS from gene segments is dramatically reduced (Montalbano, Ogwaro et al. 2003). Thus 
biases in gene usage can also be generated by differences in RSSs associated with 
individual gene segments.  
1.5.3 Transcription factors  
Transcription factors are of fundamental importance in regulating various aspects of V(D)J 
gene rearrangements. The ectopic expression of E2A is sufficient to promote 
recombinational accessibility of immunoglobulin genes in non B cells (Hsu, Liang et al. 2004, 
Johnson, Pflugh et al. 2004, Murre 2005). STAT-5 and IL-7 signalling play an essential role 
in regulating the order of gene rearrangement in pro B cells by suppressing IGK gene 
rearrangement at this stage (Reynaud, Demarco et al. 2008). Ikaros is another important 
transcription factor that not only affects the expression of RAG enzymes but also regulates 
the accessibility of various gene segments at the IGH locus that can result in biased usage 
(Reynaud, Demarco et al. 2008). During gene rearrangement at the IGH locus, contraction is 
mediated by transcription factor Pax5 and enzyme PDK1 bringing together IGHV with IGHDJ 
(Reynaud, Demarco et al. 2008, Venigalla, McGuire et al. 2013).   
1.5.4 Intergenic sense and antisense transcription 
VDJ gene recombination is also regulated by intergenic and antisense transcription. 
Intergenic transcription increases the efficiency of accessibility and thus utilization of 
segments at the IGH locus by recruiting remodelling factors (Chakalova, Debrand et al. 
2005). It occurs when the IGH locus is actively engaged in VDJ recombination. Intergenic 
transcripts are expressed on the majority of IGHD-IGHJ recombined alleles in pro B cells 
and is lost following IGHV to IGHD-J recombination (Johnston, Wood et al. 2006). In addition 
to this, anti sense transcription also occurs throughout the IGH locus before IGHV to IGHD-J 
recombination (Chakalova, Debrand et al. 2005). Sense and antisense transcripts are 
regulated by the Eμ enhancer at the IGH locus (Puget, Hirasawa et al. 2015).  
1.5.5 Locus contraction and long range interaction 
Immunoglobulin loci generally span several hundred kilobases, with distances between 
IGHV and IGHDJ segments of up to 500 kilobases. Therefore, locus compaction might 
improve efficient synapsis of widely separated gene segments (Atchison 2014). Subnuclear 
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repositioning and locus contraction regulate both recombination and transcription of 
immunoglobulin loci during lymphocyte development. It has been found that IGH and IGK 
loci are preferentially positioned at the nuclear periphery in immunoglobulin non expressing 
cells such as hematopoietic precursors and T cells. However, in pro B cells as a result of 
chromosomal contraction these loci are located centrally (Kosak, Skok et al. 2002). The 
transcription factor Pax5 plays a pivotal role in locus contraction in pro B cells and distal 
IGHV-IGHDJ gene rearrangements (Fuxa, Skok et al. 2004). DNA-binding zinc-finger protein 
called CCCTC-binding factor (CTCF) is another protein regulating long range chromatin 
interactions (Ribeiro de Almeida, Stadhouders et al. 2012). In the absence of CTFC, more 
usage of proximal than the distal gene segments was observed (Ribeiro de Almeida, 
Stadhouders et al. 2011). YY1 (Yin Yang 1)  is another protein regulating not only the 
assembly of gene segments during VDJ gene recombination but also during class switching 
by controlling non-coding antisense RNA transcripts, recruitment of proteins to DNA, and 
interaction with complexes involved in long-distance DNA interactions including the cohesin 
and condensin complexes (Pan, Papasani et al. 2013, Atchison 2014). 
1.5.6 Inhibition of gene rearrangement on the second allele 
Every B cell carries 2 alleles (maternal and paternal) for each of IGH, IGK or IGL loci. 
Therefore, there is a possibility of encoding BCRs of multiple specificities theoretically if 
allelic exclusion fails. Such polyspecific B cells could recognize a wide range of antigens 
including self and potentially various pathological conditions could develop. However, it does 
not normally happen as there are regulatory mechanisms that allow only one IGH allele to 
be expressed with one allele of either IGK or IGL to constitute a BCR. The surface 
expression of BCR from a single allele copy of corresponding genetic loci is called allelic 
exclusion. As a result of allelic exclusion each B cell expresses a BCR of single specificity 
(Pernis, Chiappino et al. 1965, Vettermann and Schlissel 2010).  
In pro B cells, the process of gene rearrangement is initiated on IGH locus when IGHJ 
rearrange with IGHD on both alleles. However, the next step of IGHV gene rearrangement 
with IGHD-IGHJ happens on only one allele. Subsequently the functional expression of μHC 
on the cell surface by the first allele inhibits IGHV to IGHDJ gene rearrangement on the 
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second allele by feedback inhibition (Krangel 2009, Brady, Steinel et al. 2010).  Various 
mechanisms including DNA methylation, asynchronous replication and epigenetic 
modifications have been implicated in establishing allelic exclusion (Goldmit, Ji et al. 2005). 
Chromosomal decontraction and centromeric recruitment of the non-functional allele also 
play a significant role in the maintenance of allelic exclusion because the RAG complex 
eventually becomes reactivated during development and/or in peripheral lymphocytes 
(Roldan, Fuxa et al. 2005). 
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1.6 Censorship of B cells in the bone marrow 
As discussed above, specificities of BCRs are generated by imprecise V(D)J joining that 
may result in non functional or autoreactive receptors. It has been found that approximately 
50% to 75% of immature B cells can recognize self antigens both in mice and humans. 
These self reactive B cells have shown polyreactivity and anti nuclear specificities. However, 
at later developmental stages such as the transitional and mature naïve B cells there is 
much lower frequency (approximately 20% to 40%) of autoreactive B cells in the spleen and 
blood suggesting transitional B cells marks a checkpoint for identifying and removing 
autoreactive B cells (Grandien, Fucs et al. 1994, Wardemann, Yurasov et al. 2003). Some 
autoimmune diseases such as SLE and rheumatoid arthritis (RA) are associated with an 
increase in polyreactive B cells both immature and naïve suggesting some early defects in 
the mechanism of central tolerance (Samuels, Ng et al. 2005, Yurasov, Wardemann et al. 
2005).  
On the other hand, some autoreactive B cells having low avidity for self antigens can bypass 
this early checkpoint (Hayakawa, Asano et al. 2003, Wardemann, Yurasov et al. 2003, Wen, 
Brill-Dashoff et al. 2005). Such weak self reactive B cells could be considered beneficial 
potentially as they provide immunity against a broad spectrum of foreign antigens during 
infection (Mouquet, Scheid et al. 2010). 
This central tolerance is a fundamental phenomenon that ensures negative selection of a 
large proportion of autoreactive B cells produced during initial stages of B cells development. 
However, how this negative selection is achieved and regulated is still an active area of 
research. In 1959, Frank Macfarlane Burnet proposed the hypothesis of clonal selection. 
According to this concept, specificities of B cells are predetermined by random V(D)J gene 
rearrangement and after recognition of foreign antigens the selected clones are expanded. 
On the other hand, interaction of B cells with self antigens is detrimental to B cells. Based on 
this theory it was assumed that immune response is only regulated by either proliferation or 




Further studies suggested that proliferation and expansion are not the only two options for 
regulating tolerance and deciding the future of particular B cells. It was later proposed that 
the fate of B cells is determined according to the relative affinity of B cells for self antigens. 
The antigen recognition of ubiquitous self antigens with high avidity by immature B cells can 
arrest further development of B cells and results in the apoptosis of B cells (Nemazee and 
Buerki 1989, Hartley, Crosbie et al. 1991, Hartley, Cooke et al. 1993). On the other hand, 
recognition of self antigens with low avidity does not halt the development process but 
causes a shortened life span and deletion in the periphery (Goodnow, Crosbie et al. 1988).  
It is now considered that the elimination of autoreactive B cells to maintain central tolerance 
is achieved by three major mechanisms in the bone marrow: receptor editing (Gay, 
Saunders et al. 1993, Tiegs, Russell et al. 1993, Prak, Trounstine et al. 1994, Retter and 
Nemazee 1998, Nemazee and Weigert 2000), anergy (Nossal and Pike 1980, Adams, 
Basten et al. 1990, Fulcher and Basten 1994, Mandik-Nayak, Bui et al. 1997, Roark, Bui et 
al. 1997) and clonal deletion (Nemazee and Buerki 1989, Norvell, Mandik et al. 1995, Nossal 
and Pike 2007, Goodnow, Crosbie et al. 2009). 
The importance of clonal deletion is well documented for self antigens major 
histocompatibility complex (MHC) class 1, red blood cells (RBCs) and DNA (Nemazee and 
Buerki 1989, Okamoto, Murakami et al. 1992, Chen, Nagy et al. 1995). Anergy is the state of 
non-responsiveness to the antigen. Anergic B cells cannot respond to cellular cognate 
antigens under optimal conditions of stimulation (Nemazee 2006).  
The data accumulated over ensuing years has revealed that clonal deletion and anergy are 
not the only mechanisms to get rid of autoreactive B cells. Rather clonal deletion is a default 
process that operates when receptor editing fails to silence the specificity of autoreactive B 
cells (Pelanda and Torres 2012). The concept of receptor editing was first proposed by the 
two independent research groups led by Martin Weigert and David Nemazee in 1993 (Gay, 
Saunders et al. 1993, Tiegs, Russell et al. 1993). Receptor editing means if an autoreactive 
B cell encounters with self antigens, secondary gene rearrangements can be initiated via 
signalling through the autoreactive receptor. These secondary gene rearrangements destroy 
the primary receptor gene rearrangement that confers autoreactivity and replace it with a 
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new innocuous receptor gene rearrangement. So in this way by receptor editing 
autoreactivity can be avoided without losing the cell (Nemazee 2006). The secondary gene 
rearrangements usually involve rearrangement of upstream IGKV or IGLV gene segments 
with downstream IGKJ or IGLJ respectively (Tachibana, Haruta et al. 1999, Monestier and 
Zouali 2002). Thus secondary gene rearrangements alter the BCR specificity and extinguish 
autoreactivity, allowing the primary B cell repertoire to develop in the secondary lymphoid 
organs (Radic and Zouali 1996).  
The process of secondary gene rearrangements can occur on either allele or locus. As a 
result of secondary gene rearrangements allelic and isotypic exclusion can be violated and 
resulting cells would be polyspecific (Vettermann and Schlissel 2010). Three different 
outcomes of potential BCRs could be expected theoretically (Figure 1-15 A-C): 
Single non autoreactive specificity: If the secondary gene rearrangement takes place on 
the same IGK allele then resulting cells would only have single non autoreactive specificity: 
innocuous BCR (Figure 1-15A).  
Allelically included dual specificities: If the secondary gene rearrangement takes place 
on the second IGK allele (previously non rearranged) then resulting cells would have 
allelically included dual specificities: autoreactive and innocuous BCRs (Figure 1-15B). 
Isotypically included dual specificities: If the secondary gene rearrangement takes place 
at IGL locus then resulting cells would have isotypically included dual specificity: both 





) dual specificities expressing B cells have also been reported 
both in healthy humans and mice (Rezanka, Kenny et al. 2005). Dual light chain expression 
is an indication of B cells going through the process of receptor editing (Pauza, Rehmann et 
al. 1993, Ghia, Gratwohl et al. 1995, Giachino, Padovan et al. 1995, LeBien 2000, Pelanda 
2014). Such B cells expressing dual specificities could be considered as “trojan horses” 
where expression of the innocuous receptor facilitates maturation, activation and terminal 
differentiation of B cells and the autoreactive receptor can recognize self antigens and 












Figure 1-15: Consequences of the secondary gene rearrangements. (A) If the secondary gene rearrangements are initiated on the same allele to replace 
the potentially autoreactive gene rearrangement then it results in non autoreactive gene rearrangement along with other allele in a germline configuration. (B) 
If the secondary gene rearrangement happens on the second allele then a cell can harbour two specificities of same isotype. (C) If the secondary gene 
rearrangement occurs on the other locus then cell could have two specificities of different isotypes. 
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1.7 B cell responses in the periphery 
Transitional B cells represent the final stage of B cell development in the bone marrow 
before emigration into the periphery. These cells are defined by phenotype expression of 
IgM and lack CD27 and ABCB1 transporter protein. Transitional B cells can be divided into 
two subsets (T1 and T2). T2 subset is more mature than T1 (Sims, Ettinger et al. 2005, 
Wirths and Lanzavecchia 2005). Recent evidence has shown that the T2 subset of 
transitional B cells in blood show preferential tropism towards the gut. The migration towards 
gut is mediated by interaction between gut homing receptor β7 on T2 subset with the 
endothelial ligand called mucosal vascular addressin cell adhesion molecule-1 (MAdCAM-1) 
that is expressed by endothelium in gut associated lymphoid tissue (GALT). The T2 subset 
has higher expression of gut homing receptor β7 than naïve B cells. Moreover, these cells 
were in activated state as evident by phosphorylation of Bruton’s tyrosine kinase (Btk), 
extracellular signal regulated kinase (Erk) and spleen tyrosine kinase (Syk). Activated 
transitional B cells in GALT may be the precursors of IgA lineage (Vossenkamper, Blair et al. 
2013).   
Naïve B lymphocytes migrate to the secondary lymphoid organs such as lymph nodes (LN), 
Peyer’s patches (PP) and spleen. Naïve B cells use L-selectin (CD62L) to roll over 
specialized capillaries called high endothelial venules (HEVs) present in LN, mesenteric 
lymph nodes and PPs (Bargatze, Jutila et al. 1995). HEVs also produce certain chemokines 
such as CCL21 and CCL19 to bind CCR7 on naïve B cells and trigger the activation of 
integrins LFA-1 and/or α4β7 and lymphocyte arrest in HEVs (Warnock, Campbell et al. 
2000).  
During unimmunized conditions, the secondary lymphoid organ such as LN is comprised of 
primary follicles of resting naïve follicular B cells surrounded by T cell rich zones and DCs 
(Figure 1-16). These B cell follicles are also intersected by follicular dendritic cells having 
high expression of vascular cell adhesion molecule 1 (VCAM-1), intracellular adhesion 
molecule 1 (ICAM-1), Fc and complement receptors for the retention of immune complexes 






    
 
Figure 1-16: Primary B cell follicle in the secondary lymphoid organ. Naïve B cell 
follicular cells are intersected with FDCs and surrounded by naïve T and DCs.  
 
B cells get activated after exposure to antigens within these primary follicles (Figure 1-16).  
Later antigen specific activated B cells relocate to the interfollicular zone (between B cell 
follicles) and this migration is dependent on G protein coupled receptor (GPCR) EB12 
(Okada, Miller et al. 2005, Gatto, Paus et al. 2009). On the other side, T cells are primed in 
the T cell zone after getting activation signals from the DCs. T cells also migrate towards the 
interfollicular zone by upregulating chemokine receptor CXCR5. These activated B and T 
cells interact and form stable interactions (CD40 and CD40L) with each other in the 
interfollicular zone and upregulate transcriptional repressor Bcl6 (Kerfoot, Yaari et al. 2011, 
Kitano, Moriyama et al. 2011).  
The interfollicular zone provides a specialized microenvironment for the differentiation of 
both T and B cells. A subset of T cells start to differentiate into T follicular helper cells (Tfh) 
by up regulating CXCR5 and PD-1 (programmed cell death-1) and subsequently Tfh and B 
cells home into the centre of primary follicle (Kerfoot, Yaari et al. 2011). It has been found if 
the interaction between B cells and antigen is very strong then in these circumstances, B 
cells may also differentiate into short lived plasmablasts in the interfollicular zone after 
getting activation signal from Tfh cells. These plasmablasts provide immediate protection 
(Paus, Phan et al. 2006). 
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1.7.1 Establishment of the germinal centre 
Antigen specific Tfh cells migrate from the interfollicular region to the centre of the primary 
follicle on day 3 post immunization, followed by migration of B cells one day later (Kerfoot, 
Yaari et al. 2011). On day 4 after immunization these antigen specific B cells start to 
proliferate rapidly within a meshing network of follicular dendritic cells (FDCs). As a result, 
resident naïve follicular B cells are pushed aside to form an early germinal centre (or 
secondary follicle), which consists of B cell blasts surrounded by the mantle zone of naïve 
follicular B cells. On days 5-6, the GC rapidly expands as a result of fast proliferation of B 
cell blasts. The formation of GC is an imperative phase to establish long lasting humoral 
immune responses to T cell dependent antigens (Figure 1-17) (Kerfoot, Yaari et al. 2011, De 










Figure 1-17: Initiation and evolution of the germinal centre. On day 4, antigen specific B 
cells migrate from the interfollicular region into the centre of the primary follicle, begin to 
proliferate and push the resident follicular B cells aside to form an early GC, which consists 
of B cell blasts surrounded by the mantle zone. The structure is also referred to as the 
secondary follicle. On days 5-6, the GC expands as a result of fast proliferation of antigen 
specific B cell blasts.  
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Extensive proliferation takes place until day 7 and B cells in the GC gets polarized into 
microenvironments: dark zone (DZ) and light zone (LZ) (Victora and Nussenzweig 2012) 
(Figure 1-18). The DZ is comprised of densely packed blasts called centroblasts that 
proliferate within a interconnected network of reticular cells that express CXC chemokine 
ligand 12 (Bannard, Horton et al. 2013). The LZ is sparsely populated by smaller B cells 
called centrocytes, Tfh, FDCs and macrophages (Victora and Nussenzweig 2012). 
Centroblasts and centrocytes are polarized into separate zones due to specific chemokines. 
Centroblasts have higher expression of chemokine receptor CXCR4. The CXCR4 ligand 
CXCL12 is abundant in the DZ of the GC. On the other hand, centrocytes express 
chemokine receptor CXCR5 that responds to chemokine CXCL13 produced most 
abundantly in the LZ (Allen, Ansel et al. 2004). Tfh cells are also attracted to the LZ due to 
the presence of chemokine receptor CXCR5 on the cell surface which responds to CXCL13 








Figure 1-18: Establishment of dark and light zones in the mature germinal centre. On 
day 7, dark and light zones form which results in the establishment of the mature GC. The 
dark zone is mainly comprised of densely packed B cell blasts, whereas the light zone 
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1.7.2 Selection of high affinity B cells 
Centroblasts not only multiply rapidly in the DZ but also undergo hypermutation that 
introduces point mutations into the variable region of immunoglobulin IGV genes and 
associated amino acid substitutions. This somatic hypermutation (SHM) results from the 
deamination of deoxycytidines residues to deoxyuridines in IGV genes of single stranded 
DNA (ssDNA) and is mediated by activation induced deaminase (AID) enzyme (Muramatsu, 
Kinoshita et al. 2000). The SHM process introduces a single nucleotide exchange per 1,000 
bases into the rearranged IGV gene per division within the DZ of the GC. Thus as a result of 
SHM a wide range of BCRs is generated having different affinities for antigens (Di Noia and 
Neuberger 2007, Victora and Nussenzweig 2012).  
In the next phase, high affinity antibody producing cells are selected for clonal expansion by 
Tfh cells in the LZ of GC. B cells capture antigen from FDCs via their BCR and after 
processing present to Tfh cells via MHC class II on the cell surface. High affinity BCRs 
capture more antigen that results in higher density of peptide presentation on MHC class II 
and thus drives positive selection (Victora, Schwickert et al. 2010, Gitlin, Shulman et al. 
2014). During interaction, influx of Ca
++
 increases in Tfh cells along with co expression of 
cytokines IL-4 and 21 (Shulman, Gitlin et al. 2014). B cells in the LZ that are unable to 
retrieve sufficient antigen undergo apoptosis. After positive selection, a subset of B cells 
recirculates to the DZ or may undergo class switch recombination (CSR) before migrating to 
the DZ. In the DZ, these selected cells proliferate again and undergo further SHM. The 
extent of back and forth migration between the DZ and LZ is directly proportional to the 
affinity of B cells for antigen and the amount of the antigen they present to Tfh cells.   
Eventually a pool of high affinity memory B cells and plasmablasts is generated in the LZ 
(Allen, Okada et al. 2007, Gitlin, Shulman et al. 2014). CSR will be discussed in the section 














Figure 1-19: Schematic representation of dynamics and selection in the germinal centre reaction at various stages. (1) Sensitization of T and B cells 
in the respective T and B follicles (2) Interaction of sensitized B and T cells at the T:B border (3) Entry of B cells into the DZ (4) Proliferation of centroblasts (5) 
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1.8 Immunoglobulin A  
The gut mucosal surface is constantly exposed to a wide range of microbiota. It gets 
colonized with microorganisms shortly after birth (Macpherson 2006). The frequency of 
bacterial flora increases along the gastrointestinal tract. The proximal parts including 










microorganisms per gram. These microbes constitute highly diversified communities 
belonging to more than 1000 species. This indigenous bacterial flora is mainly comprised of 
obligate anaerobes (Bacteriodes and various species of bifidobacteria, fusobacteria, 
peptostreptococci) as well as both obligate and facultative aerobes, such as enterobacteria 
and lactobacilli. These commensals compete with pathogens for the attachment to the gut 
and also stimulate the growth of intestinal epithelial cells and thus facilitate the development 
of a healthy immune system (Macpherson and Harris 2004, Rakoff-Nahoum, Paglino et al. 
2004, Rhee, Sethupathi et al. 2004, Hooper, Littman et al. 2012, Kato, Kawamoto et al. 
2014). It has been reported recently that IgA coating identifies inflammatory commensals 
that preferentially drive intestinal disease. This property could be advantageous in 
translational research as by specifically designing antibodies against such bacteria 
progression of colitis or even initiation might be checked (Palm, de Zoete et al. 2014).  
Overgrowth of segmented filamentous bacteria has been reported throughout the small 
intestine in IgA deficient mice (Suzuki, Meek et al. 2004). IgA can also cause activation of 
eosinophils and subsequent degranulation and release of reactive oxygen species (ROS) 
suggesting implications in allergy (Pleass, Lang et al. 2007).  
The gastrointestinal tract harbours distinct mucosal lymphoid microenvironments:  organized 
mucosa associated lymphoid tissue (MALT), diffuse connective tissue of lamina propria (LP), 
regional mesenteric lymph nodes, intraepithelial lymphocytes (IELs) (Brandtzaeg and Pabst 
2004, Brandtzaeg 2009, Spencer, Klavinskis et al. 2012). MALT can be defined by the 
juxtaposition of organized lymphoid tissue to specialized lymphoepithelium called follicle 
associated epithelium (FAE). The FAE acts as a barrier between the intestinal lumen and 
the internal environment of the body. Most MALT is located in the gastrointestinal tract called 
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GALT in either clusters of PP or isolated lymphoid follicles (ILFs) (Gibbons and Spencer 
2011).The FAE is interrupted by some specialized epithelial cells called microfold cells (M 
cells) that are involved in sampling antigens from the lumen and presenting to lymphocytes 
in the GALT (Owen 1977, Kadaoui and Corthesy 2007). The GALT can also be induced in 
response to an infection for example MALT is acquired in the stomach in response to 
Helicobacter pylori infection (Wotherspoon, Ortiz-Hidalgo et al. 1991, Acheson and Luccioli 
2004). On the other hand, the LP is composed of diffused connective tissue and is infiltrated 
with effector cells that includes cytokine producing T cells, immunoblasts and plasma cells 
(Spencer, Klavinskis et al. 2012).  
During a mucosal immune response IgA is the predominant isotype produced (Elson and 
Ealding 1984). The distinct protein fraction of IgA was first noticed in 1958 when Gugler and 
co workers reported that not all myeloma proteins can be classified according to the 
prevailing classification system that is based on the carbohydrate contents: the 7S (low 
carbohydrate content) and the 16S (high carbohydrate content). They found in milk 
secretions there were some proteins that had relatively higher carbohydrate contents 
(Gugler, Bokelmann et al. 1958). A year later Heremans and co-workers found there is a 
protein in secretions having a different characteristic mobility pattern. This fraction of protein 
tends to migrate towards β globin region during immunoelectrophoresis. Subsequently, this 
fraction of protein was defined as IgA (Heremans, Heremans et al. 1959). Later studies 
revealed that the presence of this isotype is predominant in exocrine secretions (Tomasi, 
Tan et al. 1965, Hanson and Brandtzaeg 1993).  Although in the serum, IgA is a relatively 
small component of antibodies but it is found in much abundance in normal mucosal 
surfaces where it may account for at least 70% of all immunoglobulins produced in 
mammals (Macpherson, McCoy et al. 2008).  
IgA is often regarded as a non inflammatory and neutralizing antibody. It down modulates 
the expression of proinflammatory bacterial epitopes. It also blocks the attachment of 
microbial components to the cell surface, facilitates intraepithelial neutralization of incoming 
pathogens and microbial inflammatory products (Fagarasan, Kinoshita et al. 2001, Phalipon, 
Cardona et al. 2002, Peterson, McNulty et al. 2007). It also helps in eliminating the 
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pathogenic microorganisms that breach the epithelial barrier by transporting them back into 
the lumen through polymeric Ig receptor (pIgR). It also promotes clearance of pathogens by 
antibody dependent cell mediated cytotoxicity (ADCC) via FcαRI receptor. FcαRI is a Fc 
receptor for IgA that is expressed by DCs, neutrophils and other phagocytes (Geissmann, 
Launay et al. 2001, Pasquier, Launay et al. 2005).  
1.8.1 Mucosal and systemic IgA 
Systemic IgA generally exists in the monomeric form though IgA polymers also exist in 
serum in humans. In contrast, IgA is present in mucosal secretions in dimeric form. After 
production of dimeric IgA by plasma cells it is translocated across epithelial surfaces via 
interaction between J chain and pIgR protein receptor (Vaerman, Langendries et al. 1998). 
pIgR is a transporter present on the basolateral surface of epithelial cells mainly present in 
the intestinal crypts as membrane secretory component. IgA is transported into the lumen 
with bound secretory component that is produced by apical cleavage of pIgR. J chain of 
polymeric immunoglobulins enables binding to pIgR (Brandtzaeg 2013). Certain amino acid 
motifs in Cα2 and Cα3 domains are of considerable importance for pIgR binding and 
transcytosis of IgA. It was found that disruption of Cys311 in Cα2 resulted in reduced binding 
of IgA to pIgR. Combined mutagenesis of Phe411, Val413, and Thr414 residues in Cα3 
domain obviated interaction of IgA with pIgR (Lewis, Pleass et al. 2005). The receptors for 
IgA are present on granulocytes, monocytes, macrophages, DCs, eosinophils, FDCs, 
hepatocytes, hepatic kupffer cells and renal mesangial cells. The receptor FcαRI has been 
implicated in facilitating internalization of IgA opsonised bacteria by phagocytic cells (Cerutti 
2008, Macpherson, McCoy et al. 2008, Brandtzaeg 2013). 
1.8.2 IgA subclasses 
In humans there are two subclasses of IgA: IgA1 and IgA2 encoded by two functional 
IGHCα1 and IGHCα2 gene loci respectively on chromosome 14 (Flanagan and Rabbitts 
1982). IgA1 subclass is predominant in serum in monomeric form while IgA2 forms stable 
dimers and is present in secretions increasing in relative amount from small intestine 
towards large intestine (Crago, Kutteh et al. 1984, Kett, Brandtzaeg et al. 1986). There are 
also some structural differences between the subclasses such as a deletion of 13 amino 
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acids in the hinge region of subclass IgA2 that makes it relatively more resistant to the 
enzymatic digestion by proteases (Kilian, Reinholdt et al. 1996, Brandtzaeg and Johansen 
2005, Macpherson, McCoy et al. 2008). The subclass IgA2 has better Fcα mediated 
mannose dependent agglutinating properties against enteric microorganisms and is more 
glycosylated than IgA1 (Tomana, Niedermeier et al. 1976, Woof and Mestecky 2005, Cerutti 
2008). 
1.8.3  Inductive sites for class switch recombination to IgA 
The mucosal immune system can be divided into two compartments based on involvement 
in immune responses: inductive sites and effector sites. Inductive sites denote the region 
where naïve B and T cell encounter with antigen and get activated e.g. palatine tonsils, 
adenoids, PP (located mainly in the distal ileum), MLN and ILFs most abundantly in the large 
bowel (Brandtzaeg and Pabst 2004, Brandtzaeg 2010). PPs are the major sites of IgA 
induction followed by the MLN (Macpherson and Slack 2007). The effector sites mark the 
region where final differentiation to plasma cells takes place e.g. subepithelial lamina propria 
of various mucosae, stroma of exocrine glands, and the surface epithelia (Brandtzaeg and 
Johansen 2005, Brandtzaeg 2009, Brandtzaeg 2010).  
 
1.8.4  Mechanism of class switch recombination to IgA 
CSR to IgA takes place by the activation of the AID enzyme in activated B cells (Muramatsu, 
Kinoshita et al. 2000). The immunoglobulin IGH locus of mature B cells contains a VDJ exon 
encoding the antigen binding domain of immunoglobulin. B cells produce intact IgM and IgD 
receptors through a transcriptional process driven by a promoter upstream of the VDJ exon 
following rearrangement of the light chain. Therefore, in order to produce downstream 
isotypes such as IgG, IgA or IgE having identical antigen specificities only constant regions 
are changed by the process of CSR. The CSR from IgM to IgA takes place as a result of 
transcription from the intronic α promoter 5’ of the IGHα locus mediated by AID in the GC. 
The intervening DNA is excised as a circular DNA and remaining exons splice together to 
form a functional transcription unit for IgA production as shown in Figure 1-20 (Chaudhuri 
and Alt 2004, Kumar, DiMenna et al. 2014). The CSR involves an exchange of upstream 
donor Cμ and Cδ genes with a downstream acceptor CH gene through a recombinational 
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process that is guided by switch (S) regions (Kotnis, Du et al. 2009). The S region (1 to 
12kb) consists of highly repetitive sequences that are rich in G. Each S region is preceded 
by a short intronic (I) exon and a promoter that initiates germline transcription on the 
reception of activation signals (Chaudhuri and Alt 2004, Muramatsu, Nagaoka et al. 2007). 
During germline transcription, Iα-Cα transcript is produced as result of splicing. The primary 
sterile transcript physically associates with the template strand of the DNA to form a stable 
DNA-RNA hybrid (Reaban and Griffin 1990). Subsequently AID deaminates cytosine 
residues on both strands of S region DNA, thereby generating multiple DNA lesions that are 
ultimately processed into ds DNA breaks. Fusion of ds DNA breaks at Sα and Sμ through 
NHEJ pathway induces looping out and deletion of the intervening DNA thereby juxtaposing 
VHDJH to Cα. This process yields a chromosomal VHDJH-Cα sequence, which encodes the 
IgA protein, and an extrachromosomal switch circle (Kinoshita, Harigai et al. 2001, 















Figure 1-20: Recombinational and transcriptional events during IgA class switching. Appropriate stimuli induce germline transcription of the Cα gene 
from the promoter Pα of the intronic Iα exon through the switch Sα between Iα and Cα exons. In addition to yielding sterile transcript, germline transcript 
renders the Cα gene substrate for AID. By generating and repairing DNA breaks at Sμ and Sα, the CSR machinery rearranges IGH locus, thereby yielding 
excision switch circle. Post switch recombination generates mRNAs for both membrane and secreted forms.    
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1.8.5 T cell dependent and T cell independent IgA 
The prerequisite to initiate the process of CSR from IgM to IgA are as follows (Stavnezer 
1996, Muramatsu, Kinoshita et al. 2000): 
1. Enzymatic help by AID  
2. Two activation signals 
The first signal is usually provided by the cytokines that start the transcription of the 
promoter upstream of the IGHC exons and the second signal is given by T cells when CD40 
on B cells interacts with CD40L on T cells. The important cytokines for IgA class switching 
are transforming growth factor β (TGF-β), A proliferation inducing ligand (APRIL), IL-2, IL-4, 
IL-5, IL-6 and IL-10 (Islam, Nilsson et al. 1991, Shockett and Stavnezer 1991, Borsutzky, 
Cazac et al. 2004). Although the activation signal by T cells is important but CSR can also 
take place without the T cell help. In such cases, a co stimulatory signal is given by other 
cells such as macrophages, monocytes and dendritic cells (Macpherson, Hunziker et al. 
2001, Barone, Patel et al. 2009, Bergqvist, Stensson et al. 2010, Berkowska, Driessen et al. 
2011). On this basis there are two major pathways of IgA production: 
1.8.5.1 T cell dependent IgA production 
T cell dependent antibody response involves activation of B cells by antigens in the 
organized lymphoid tissue of PPs, MLNs and ILFs (Fagarasan and Honjo 2003, 
Macpherson, McCoy et al. 2008). T dependent (TD) IgA generation takes place in the GC 
when activated B cells get a co stimulatory signal by T cells (Casola and Rajewsky 2006).  In 
humans IgA expressing B cells are mostly generated in the GC of PPs (Lin, Du et al. 2014). 
The TD IgA is characterized by phenotypic expression of CD27 on the surface of IgA 
expressing B cells. The GC B cells in PPs are biased for CSR to IgA possibly because of 
cytokines that drives IgA class switching (Cerutti and Rescigno 2008, Suzuki and Fagarasan 
2009).  TGFβ is an essential cytokine for IgA class switching. TGFβ along with IL-21 
produced by Tfh synergistically enhances both proliferation and differentiation of precursors 
for IgA plasma cells. However, IL-4 produced by activated T cells suppresses IgA production   
(Dullaers, Li et al. 2009, Tsuji, Komatsu et al. 2009). The essential steps for the production 
of IgA dependent on T cells are summarized in Figure 1-21.  DCs located beneath M cell 
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uptake luminal antigens and sensitize Tfh cells in the T cell zones. B cells also process and 
present invading antigens. The activated B cells in GALT are characterized by the 
phosphorylation of Btk and Erk, down regulation of CD22, upregulation of signalling proteins 
(Fos and Jun), and translocation of Lyn to the cell membrane. These sensitized B cells later 
interact with T cells and get activated after reception of two signals: Specificity signal (MHC 
class II on B cells interact with TCR) and co stimulatory signal (CD40L on B cells interact 
with CD40 on T cells). As a result of these interactions, under the influence of TGFβ 
activated B cells class switch to IgA expressing B cells and this enzymatic process is 











Figure 1-21: Schematic representation of mechanisms for generating T dependent 
IgA. DCs capture luminal antigens by interacting with M cells (1 and 2). Activated DCs 
present antigens to CD4
+ 
T cells and cause differentiation into Tfh cells that secretes IgA 
inducing cytokines (3). As a result of interaction between activated B and T cells CSR to IgA 




























1.8.5.2 T cell independent IgA production 
It has been suggested that T independent (TID) IgA could be characterized by the absence 
of phenotypic expression of CD27 on the cell surface. It can be generated in CD40L 
deficient patients having no T cells for interaction with B cells (Berkowska, Driessen et al. 
2011). Production of TID IgA has also been found intact in HIV patients having low CD4 
count or patients with severe T cell depletion (He, Xu et al. 2007, Levesque, Moody et al. 
2009).   
For the production of TID IgA, the second activation signal to naïve B cells is usually 
provided by members of tumour necrosis factor (TNF) family: B cell activating factor (BAFF) 
and APRIL along with other cytokines e.g. IL-4 (Litinskiy, Nardelli et al. 2002, Hardenberg, 
Planelles et al. 2007, He, Xu et al. 2007, Barone, Patel et al. 2009). Various signals required 
for activation and CSR towards IgA without any involvement from T cells are summarized in 
Figure 1-22.  
DCs and monocytes produce BAFF while APRIL is expressed by monocytes, macrophages, 
DCs and activated T cells (Mackay, Schneider et al. 2003). B cells express three types of 
receptors that could respond to BAFF and APRIL: BAFF receptor (BAFF-R), B cell 
maturation antigen (BCMA) and transmembrane activator (TACI). These receptors have 
overlapping specificities for APRIL and BAFF. APRIL binds to BCMA and TACI while BAFF 
interacts with all three receptors (Macpherson, McCoy et al. 2008).  
Mutations in the gene encoding TACI have been reported to be associated with certain 
immunodeficiencies such as common variable immunodeficiency (CVID) and IgA deficiency 
(Castigli, Wilson et al. 2005, Salzer, Chapel et al. 2005). It has been found in animals 
defective for APRIL or its receptors have abnormalities related to the plasma cell survival 
and IgA production (Castigli, Scott et al. 2004, Bossen and Schneider 2006). The 
importance of APRIL in IgA regulation is also highlighted in studies suggesting APRIL can 
promote CSR to IgA by inducing the expression of AID that is independent of interaction of 
CD40 and CD40L (Litinskiy, Nardelli et al. 2002). Thus, it is an alternate pathway of IgA 
class switching where the help provided by T cells has been substituted by APRIL. Some 
reports suggest that TID IgA generation takes place at the extrafollicular site in the LP (He, 
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Xu et al. 2007). However, LP cannot be considered as a convincing inductive site because 
there is no consensus on the expression of AID in the LP considering AID is the main 
prerequisite for the initiation of CSR (Shikina, Hiroi et al. 2004, Bergqvist, Gardby et al. 
2006, He, Xu et al. 2007). On the other hand, co expression of APRIL and AID in the human 
GALT suggest GALT could support the production of IgA in TD way but also independently 
of T cell help (Barone, Patel et al. 2009). Another study conducted on mice supports TID IgA 
generation occurring at extrafollicular sites in GALT but not in the LP (Bergqvist, Gardby et 




 mice revealed normal levels of IgA 
plasma cells in the LP although there were no GCs and CSR was evident only in PP 

































Figure 1-22: Stimulatory signals for CSR to T independent IgA. BAFF and APRIL are 
expressed by DCs, monocytes and human colonic epithelial cells (following TLR signaling), 
whereas APRIL can also be secreted by macrophages, and activated T cells. These proteins 
bind to their receptors, BAFF-R, TACI or BCMA which are all expressed by B cells.   
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Upon leaving the GALT, B cells return to the blood where they must express the gut homing 
receptors α4β7, CCR9 and CCR10 in order to emigrate into the small bowel (Hart, Ng et al. 
2010). It has been shown that retinoic acid (RA) which is the metabolite of vitamin A is 
essential for the migration of cells towards gut. After ingestion, retinal esters of vitamin A  
enter the liver and after being hydrolyzed into retinol subsequently bile gets enriched in 
retinol (Harrison and Hussain 2001, Wolf 2007). Inside the cell, alcohol dehydrogenase 
enzyme oxidizes retinol to retinal which is further oxidized by retinal dehydrogenase 
(RALDH) to RA (Mic, Molotkov et al. 2003). RA can bind to nuclear receptors including 
retinoic acid receptors and retinoid X receptors (Schug, Berry et al. 2007). Unlike DCs from 
other tissues, DCs in the GALT, express RALDH and thus induces the expression of gut 
homing receptor α4β7 and chemokine receptor CCR9 (Iwata, Hirakiyama et al. 2004, Hall, 
Grainger et al. 2011).   
Thus, IgA is essential to recognize a wide variety of antigens at mucosal sites via diversified 
BCRs generated by CSR, SHM and receptor revision and subsequent clonal expansion 
(Spencer, Barone et al. 2009).   
1.9 Aims  
The specific aims of each chapter have been mentioned in the beginning of each section but 
succinctly can be stated as follows: 
1- To determine how various biases could be observed in the ratios of in-frame to out-of-
frame gene rearrangements at the IGL locus and their significance in studying biases at 
various stages of B cell development.    
2- To determine how the repertoire of naïve B cells is forged at the IGK locus with an 
emphasis on various gene rearrangements that are selected for or against and 
consequences of retention of multiple non-functional gene rearrangements in the DNA. 
3- To determine if there is any preference for light chains to select heavy chain variable 






























2.1 Collection of blood samples and PBMC isolation 
The healthy buffy coats were purchased from the Blood Transfusion Service, Tooting, UK. 
Equal volumes of blood samples were mixed with RPMI medium (1:1). Fifteen ml of Ficoll-
Hypaque was pipetted into 50ml falcon tubes. Approximately 35ml of diluted blood was 
layered over Ficoll-Hypaque solution. Tubes were centrifuged for 25 minutes at 400G with 
slow acceleration and without brakes. Peripheral blood mononuclear cells (PBMCs) were 
removed from the interface of Ficoll and plasma and washed in RPMI medium 
supplemented with 10% FCS at 4⁰C for 5 minutes at 1200rpm. The supernatant was 
removed and cell yield was determined using haemocytometer. Cells not to be used 
immediately were resupended in FCS supplemented with 10% DMSO (freezing medium) at 
an approximate volume for storage in liquid nitrogen in 2ml cryovials at an approximate 
maximum cell density of 1 X10
10
 cells/ml.  
2.2 Working Solutions 
2.2.1 Solutions for high throughput sequencing 
2.2.1.1 Sort lysis reverse transcriptase (SLyRT) buffer 
SLyRT buffer was used to synthesize cDNA after sorting of B cells. The recipe and 
concentrations of various ingredients used for making SLyRT buffer are given in the Table 2-
1. The buffer was stored at -20⁰C. 
Table 2-1: Concentration and volume of various reagents used for making SLyRT buffer 
Reagents Initial 
concentration 
For 1 reaction 
volume (μl) 




First strand RT buffer 
(Invitrogen) 
5X 8 400 1X 
Random hexamers 
(QIAGEN) 
50 ng/μl 12 600 15 ng/μl 
Triton X-100 (Sigma) 5% 1 50 0.13% (v/v) 
RiboSafe RNase 
inhibitor (Bioline)   
40 U/μl 2.5 125 2.5 U/μl 
DTT (Invitrogen) 0.1 M 4.5 225 11.25 mM 
dNTP mix (Promega) 10 mM each 2 100 500 μM 
PCR graded water NA 6 300 NA 
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2.2.2 Solutions for agarose gel electrophoresis 
2.2.2.1 50X Tris acetate EDTA (TAE) buffer 
 In order to prepare stock solution of 50X TAE buffer, 242g TRIS base (Sigma), 57.1ml 
glacial acetic acid (Sigma) and 100ml of 0.5M EDTA (Sigma) were dissolved in 800ml of 
distilled water and the volume was adjusted to IL following complete dissolution of 
chemicals. For experiments 1X buffer was prepared from this stock solution.   
2.2.2.2 10X Tris borate EDTA (TBE) buffer  
10X TBE buffer was prepared by mixing 108g Trizma base (Sigma), 55g boric acid (Sigma) 
and 8.3g EDTA (Sigma) were dissolved in 800ml of distilled water and the final volume was 
adjusted to IL.  
2.2.2.3 Ethidium bromide stock (0.5 μl/ml)  
10mg ethidium bromide was dissolved in 1ml distilled water and was diluted 1:20 with 1X 
TBE to make up a working solution of 50ng/100ml. 
2.2.2.4 Gel loading buffer  
Gel loading buffer was prepared by dissolving 40g sucrose, 0.25g bromophemol blue and 
0.25g xylene cyanol in 100ml double distilled water.  
2.2.3 Solutions for flow cytometry 
2.2.3.1 10X Phosphate buffered saline  
Stock solution of 10X phosphate buffered saline (PBS) was prepared by mixing 80g of NaCl, 
2g of KCl, 14.4g of Na2HPO4 and 2.4g of KH2PO4 into 800ml of distilled water. After 
adjusting pH to 7.4 the final volume was made to IL with distilled water. The final solution 
was sterilized by autoclaving for 20 minutes at 120⁰C. For all experiments 1X PBS was 
prepared by diluting 10X PBS. 
2.2.3.2 RPMI-1640 medium  
RPMI-1640 medium containing 1% L-glutamine (Gibco) was supplemented with 1% 
PenStrep (Sigma), 1% amphotericin B and 10% heat inactivated (56⁰C for 30 minutes) FCS. 
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2.2.3.3 FACS buffer  
2% fetal calf serum (seraLab) was diluted in 1X PBS.  
2.2.4 Solutions for cloning 
2.2.4.1 SOC medium  
SOC medium was prepared by adding 2.0g tryptone (DIFCO), 0.5g yeast extract (DIFCO), 
1ml NaCl (58.44g/L) and 0.25ml 1M KCl (74.55g/L) in 97ml water. The solution was 
autoclaved at 120⁰C for 20 minutes. After sterilization the solution was allowed to cool and 
1ml 2M Mg
++
 stock (filter sterilized 1M MgCl26H20/1M MgSO47H20 and 1ml 2M sucrose) was 
added and volume was adjusted to 100ml with sterile water.  
2.2.4.2 IPTG stock solution (0.1M)  
Solution of IPTG (0.1 M) was prepared by adding 0.6g IPTG (Promega, UK) in 25ml distilled 
water. The solution was sterilized by passing through a 0.22μm filter using a syringe. The 
filtrate was stored in 1.5ml aliquots at -20⁰C. 
2.2.4.3 Ampicillin stock solution (50mg/ml)  
The stock solution of ampicillin was prepared by adding 1g ampicillin (Sigma, UK) in 20ml 
distilled water. The solution was sterilized by passing through 0.22μm filter using a syringe. 
The filtrate was stored in 1.5ml aliquots at -20⁰C.  
2.2.4.4 LB agar  
In order to prepare LB agar, 1g tryptone (DIFCO, UK), 0.5g yeast extract (DIFCO, UK) and 
1.5g Bacto agar (BD, UK) were dissolved in 100ml distilled water. The solution was sterilized 
by autoclaving for 20 minutes at 120⁰C. LB agar was allowed to cool for 15 minutes after 
autoclaving. Then 200μl 0.5 μl/ml ampicillin (Sigma), 200μl 0.5 μl/ml X-Gal (Promega) and 




2.3.1 Amplification of IGL gene rearrangements  
2.3.1.1 Family specific nested PCR 
Family specific PCR was performed using two rounds of nested PCR. IGL gene 
rearrangements were amplified using family specific IGLV1 and IGLV2 primers and IGLJ 
primers (Table 2-2). The PCR was conducted in 50μl volume containing 100 ng of 5’ family 
specific IGLV1 and IGLV2 primers and 100ng IGLJ primers. Ten microliters of the DNA 
sample was used for the first round and 2 μl of first-round PCR products for the second 
round. All reactions contained 200 μM of each dNTP and 2.5 mM MgCl2 in TaqDNA 
polymerase 1X reaction buffer. After hot start at 95°C for 10 min, 1 U TaqDNA polymerase 
(Promega) was added to each reaction at 60°C. The PCR programme for different IGLV 
families has been shown in Tables 2-3 and 2-4. PCR products were separated in 3.5% 
agarose gel. The product bands at 350 bp were selected for cloning and sequencing. 
 
Table 2-2: Sequences of the primers used for family specific amplification of IGLV1 
and IGLV2 families 
Primer Sequence (5’ to 3’) 























Table 2-3: The PCR programme used for the amplification of the gene rearrangements 
involving IGLV1 gene family 
Step Temperature (⁰C) Time Cycles 
Denaturation 95 30 s  
35 Annealing 52.5 (first round) 50.5 (second round) 30 s 
Elongation 72 1.5 min 
Final extension 72 5 min  
 
Table 2-4: The PCR programme used for the amplification of the gene rearrangements 
involving IGLV2 gene family 
Step Temperature (⁰C) Time Cycles 
Denaturation 95 30 s  
35 Annealing 51 (first round) 55 (second round) 30 s 
Elongation 72 1.5 min 
Final extension 72 5 min  
 
2.3.1.2 Gel electrophoresis of amplified products 
PCR products were separated in 3.5% agarose gel using 1X TBE buffer. The band of 
product size approximately 350bp was selected from each sample for further gene cloning 
and sequencing. 
2.3.1.3 Purification of PCR products 
For the purification of the amplified products QIAquick PCR purification kit was used. 
According to the manufacturer’s protocol, 5 volumes of buffer (PB) was added to one volume 
of the PCR reaction and mixed. To bind DNA, the column (QIAquick) was placed in a 2ml 
collection tube and sample was passed by centrifuging at 13,000rpm for 1 minute. Flow 
through was discarded and the column was placed in the same collection tube. To wash, 
750μl buffer (PE) was added in the column and passed by centrifuging at 13,000rpm for 1 
minute. Flow through was discarded and the column was placed in the same collection tube. 
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The column was centrifuged once more for 1 minute to remove any residual wash buffer. In 
the next step, the column was placed in a clean eppendorf. To elute DNA, 30μl buffer (EB) 
was added in the centre of the column and centrifuged after 1 minute at 13,000rp for 1 
minute.      
2.3.2 Molecular cloning of PCR products 
2.3.2.1 Ligation 
The pGEM-T vector kit (Promega) was used to ligate PCR products. The final ligation 
reaction volume was adjusted to 10μl: 5μl ligation buffer (10X), 1μl of T4 DNA ligase 1μl 
vector and 3μl of purified PCR product. All chemicals were kept on ice during reaction. The 
final ligation mixture was kept at room temperature for 2 hours or 4⁰C for overnight 
incubation. 
2.3.2.2 Transformation 
For transformation, 2.5μl of each ligation reaction mixture was mixed 25μl of competent cells 
of bacteria (JM109, Promega) in 1.5ml sterilized eppendorfs and incubated for 20 minutes 
on ice. The mixture was given a heat shock in a water bath at 42⁰C for 45 seconds and 
subsequently incubated on ice for 2 minutes. Nine hundred and fifty microliters of SOC 
medium was added to each tube followed by shaking incubation at 37⁰C for 2 hours at 
150rpm. Bacterial cells were collected by centrifugation at 200rpm at the room temperature 
for 10 minutes and supernatant was discarded. The bacterial pellet was re-suspended in 
100μl of ice cold SOC medium and spread on LB agar plates supplemented with antibiotics, 
IPTG and X-Gal. Plates were inverted and placed in an incubator at 37⁰C for overnight.  
2.3.2.3 Blue/white clone screening 
The bacteria successfully transformed with pGEM-T vector containing insert of IGLV-IGLJ 
gene rearrangement grew as white colonies. Bacteria that failed to be transformed grew as 
blue colonies. White colonies were picked with sterile pipette tips and transferred to gridded 
plate and allowed to grow overnight at 37⁰C. Pipette tips used to select colonies were rinsed 
in 15μl water in individual wells of a 96 well plate. The plates were covered with sticking seal 
and placed in a PCR machine at 95⁰C for 10 minutes. The plate was centrifuged for 10 
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minutes at 400g for 10 minutes and stored at -20⁰C. The cell debris settled at the bottom of 
the plate and the supernatant water was used as a source of cloned DNA fragment, to be 
amplified in the next step of clone screening as mentioned below.  
2.3.2.4 Clone screening by PCR 
For screening of clones 5μl of the supernatant was used as the template for a PCR reaction. 
The PCR reaction mixture included 1.5mM MgCl2, 0.2M dNTPs, 1X Taq DNA polymerase 
reaction buffer, 50ng of each M13 forward and M13 reverse primers (Table 2.4) and 0.25U 
of Taq polymerase in a total volume of 10μl. The sequences of primers and conditions for 
amplification are given in the Tables 2-5 and 2-6. 
Table 2-5: Sequences of M13 primers used for screening of transformed clones 
Primer Sequence 5’ to 3’ 
M13 forward GTAAAACGACGGCCAGT 
M13 reverse GGAAACAGCTATGACCATG 
 
Table 2-6: PCR conditions used for screening of clones to detect desired insert of 
rearranged immunoglobulin lambda light chain genes 
Stage Temperature (⁰C) Time Cycles 
Hot start 95 5 minutes  
Denaturation 95 30 seconds  
30 Annealing 45 30 seconds 
Elongation 72 5 minutes 
 
2.3.2.5 DNA sequencing 
Clones were selected from gridded plate according to the size of the cloned PCR products 
and transferred to individual wells of a 96 well plate containing LB agar supplemented with 
200μl ampicillin (0.5μl/ml). Plates were incubated at 37⁰C overnight before sending to 
Beckman and Coulter for sequencing.  
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2.3.3 Flow cytometry 
PBMCs were thawed following liquid nitrogen storage. Cells were then washed in 15ml 
RPMI 1640 medium and centrifuged at 1200rpm for 5 minutes. Cells were counted and 
immunostained in 100μl 2% FACS buffer with the volumes of antibodies as listed in the 
Tables 2-7 and 2-8. The optimal volume of antibodies for usage had previously been 
determined by titration. For staining cells were incubated for 20 minutes on ice in the dark. 
After staining 2ml 2% FACS buffer was added and centrifuged at 1200rpm for 5 minutes at 
4⁰C. Cells were resuspended in 100μl 1XPBS and stained with 1μl of viability stain for 30 
minutes. After staining cells were washed with 2ml of 2% FACS buffer. Cells were 
resuspended in 1500μl of 2% FACS buffer.  
For each experiment following controls were also prepared: 
1. Single stain control: Negative and positive beads (1:1) were stained for single antibody 
in 2% FACS buffer for 20 minutes on ice. 
2. FMO control: In order to determine the background stain noise, FMO (fluorescence 
minus one) controls were prepared for each flurochrome used in a particular experiment. 
The FMO control was prepared by staining a few cells in 2% FACS buffer on ice for 20 
minutes with all fluorescence tagged monoclonal antibodies excluding one in the 
respective tube. 
3. Isotype control: The isotype control was prepared to determine the level of non specific 
binding. For this purpose, a few cells were stained in 2% FACS buffer for 20 minutes on 
ice with control isotype tagged with the flurochrome used in a particular experiment. 
Cells for sorting were sorted into polypropylene FACS tubes containing 1.5ml of 2% FACS 
buffer. Upon completion of cell sorting, cells were centrifuged for 5 minutes at 300g and 
supernatant was removed. For flow cytometric analysis without sorting, cells were acquired 
and recorded using the FACSCanto (BD). Cell sorting was performed using the FACSAria-II 
(BD) with sort purities >90%. All flow cytometric experiments could be subsequently 




Table 2-7: Surface markers considered for the characterization of various B cell subsets 
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Mouse IgG1 k PerCP-cy5.5 BD Pharm 
IgD PE 5μl/million cells Mouse IgG1 k PE Biolegend 
CD27 APC 5μl/million cells Mouse IgG1 k APC BD Pharmingen 
CD10 APC 5μl/million cells Mouse IgG1 k APC Biolegend 
CD38 PE 5μl/million cells Mouse IgG1 k PE eBioscience 
IgA FITC 10μl/million cells Mouse IgG1 k FITC Miltenyi Biotech 
IgK APC-H7 5μl/million cells Mouse IgG1 k APC-H7 BD Pharm 
IgL Pacific blue 3μl/million cells Mouse IgG1 k pacific blue BioLegend 
Viability stain Live/Dead 
Fixable aqua 
1μl/million cells N.A.  Invitrogen 
 
B cell subset Phenotypic definition 













































































































2.3.4 High throughput sequencing  
2.3.4.1 cDNA synthesis 
The overall process of HTS is summarized in Figure 2-1. To synthesize cDNA from sorted 
populations, cells were centrifuged at 1200rpm for 5 minutes and the supernatant was 
removed. Cells were resuspended in 180μl sort lysis reverse transcriptase (SLyRT) buffer. 
Tubes were inverted several times to ensure immersion of cells in the buffer and then 
centrifuged at 3000rpm for 2 minutes to collect the contents. Twenty microliters of 500U 
(1:8) of SuperScript III reverse transcriptase (RT; Invitrogen) was added. The process of 
reverse transcription was carried out in a thermal cycler according to conditions given in 
Table 2-9. 
Table 2-9: Thermal conditions for reverse transcription 
Steps Temperature (⁰C) Time (minutes) 
Denaturation 42 10 
Annealing 25 10 
RT (extension) 55 60 
RT (termination) 72 15 
PCR tubes were centrifuged at 13,000rpm for 5 minutes after thermal cycling. The top 
fraction of supernatant was transferred to clean eppendorfs immediately without disturbing 
the debris. Samples were stored at -20⁰C. 
2.3.4.2 Genomic DNA isolation 
The genomic DNA was isolated from FACS sorted populations of B cells using DNeasy 
blood and tissue kit (Qiagen). According to the manufacturer’s protocol after FACS sorting 
cells were centrifuged for 5 minutes at 300g and resuspended in 200μl 1X PBS. After adding 
20μl of proteinase K and 200μl of lysis Buffer (AL) cells were vortexed and incubated at 
56⁰C for 20 minutes. Two hundred microliters of ethanol (96% to 100%) was added and cells 
were mixed thoroughly by vortexing. This mixture was passed through spin columns fitted in 
collection tubes by centrifugation at 8,000rpm for 1 minute.  The collection tubes filled with 
flow through were discarded. Spin columns were placed in new collection tubes and 500μl 
washing buffer (AW1) was added and centrifuged at 8,000rpm for 1 minute. Collection tubes 
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containing flow through were discarded. Spin columns were placed in new collection tubes 
and 500μl washing buffer (AW2) was added followed by centrifugation at 14,000rpm for 3 
minutes. Collection tubes containing flow through were discarded and spin columns were 
placed in 1.5ml clean eppendorfs. Two hundred microliters of elution buffer AE was added 
followed by centrifugation at 8,000rpm for 1 minute. Samples of eluted DNA were stored at -
20⁰C. 
2.3.4.3 PCR amplification for high throughput sequencing 
High throughput sequencing PCR amplification of genomic and cDNA was performed in two 
rounds, where the same primers were used in both reactions, though the second PCR 
primers were MID (multiplex identifier) tagged. Genomic (IGKV-IGKJ) and cDNA (IGKV-
IGKC) gene rearrangements were amplified using semi nested PCR. In PCR1, 25μl reaction 
mixture contained 6.25μl of cDNA, 0.625U Phusion DNA polymerase, 200μM of each 
dNTPs, 41.75nM of each upstream IGKV primers, and 250nM downstream IGKC primer in 1 
X reaction buffer. After a hot start at 98⁰C (for 30 seconds, hold at 50⁰C) Phusion DNA 
polymerase was added, followed by 15 cycles of 98⁰C (10 seconds), 58⁰C (15 seconds) and 
72⁰C (30 seconds) and 1 cycle of 72⁰C (5 minutes). 
In order to produce sufficient sample for high throughput sequencing, amplified product from 
the first round of PCR (PCR1) was re-amplified (PCR2). For the second round of PCR, the 
same primers were used as in the first round but these were modified by adding a bar code 
consisting of 10 nucleotides called multiplex identifier (MID) at the end of the primer 
sequence. The MID nucleotide sequences were designed based on the criterion that these 
should not have binding affinity anywhere in the genome. The MIDs only acted as a barcode 
and were specific for each B cell subset and individual studied.  MIDs were added to make 
experiments cost effective as this approach enabled pooling of multiple samples into 1 
sequencing sample and segregation of sequences after sequencing.  
Twenty microliters of PCR2 reaction mixture contained 2μl of PCR1 product, 0.5U Phusion 
DNA polymerase, 200μM each dNTPs, 41.75nM each upstream MID: IGKV1-6 primers, 
250nM IGKC downstream primer in 1X reaction buffer. PCR2 was performed with 
conditions: 98⁰C (30 seconds), 20 cycles of 98⁰C (10 seconds), 58⁰C (15 seconds), 72⁰C 
91 
 
(30 seconds) and 1 cycle of 72⁰C (5 minutes). Recipes and summaries for each PCR 











Figure 2-1: Schematic representation of the steps involved in the experiment of high 
throughput sequencing. B cell subsets were isolated by flow cytometry using specific 
monoclonal antibodies against cell surface markers. Gene rearrangements were amplified 
using genomic DNA (IGV-IGJ) or cDNA (IGV-IGJ) by PCR. Amplification involved two 
rounds (PCR1 and PCR2) to generate abundant sample for HTS sequencing. Because in 
the final step, amplified products from all individuals were pooled in one sample, MID tagged 
primers (purple and blue open rectangles) were used in the second round of PCR to 
distinguish various products post sequencing. MID barcodes were specific for each 
individual and B cell subset. After PCR-amplification, desired product bands were cut from 
the gel, purified, concentrated and sent for sequencing and analyzed subsequently.     
 
 
B cell subsets sorting 
IGV IGJ 
Genomic DNA isolation cDNA synthesis 
IGC IGV IGJ IGC 
IGV IGJ IGV IGJ IGC 
PCR-1 
PCR-2 
Electrophoresis, purification, concentration, 454 
sequencing, data processing, and data analysis 
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Table 2-10: Recipes and concentrations for HTS first round PCR reactions (primers without 
MID tags) 
Reagents Stock solution μl/reaction Final concentration 
GC buffer 5X 5 1X 
1:40 Phusion DNA polymerase 0.125U/μl 5 0.625 U 
dNTPs 20mM each 0.25 200μM each 
IGKV1-6 (5’) primer mix 
IGKC (3’) primer mix 
835nM 
5μM 
1.25 41.75nM each + 
250nM 
PCR water - 7.25 - 
cDNA - 6.25 ~200ng 
Volume - 25  
 
Table 2-11:  Recipes and concentrations for HTS second round PCR reactions (primers with 
MID tags) 
Reagents Stock solution μl/reaction Final concentration 
GC buffer 5X 4 1X 
Phusion DNA polymerase 1:20 0.125U/ μl 2 0.5 U 
dNTPs 20mM each 0.2 200μM each 
MID: IGKV1-6 (5’) primer mix 
MID: IGKC (3’) primer mix 
835nM 
5μM 
1 41.75nM each + 
250nM 
PCR water - 10.8 - 
cDNA - 2  
Volume - 20  
 
In order to obtain sufficient quantities of PCR product for sequencing first round of PCR 
reactions were performed eight times for each DNA sample from which second round of 
PCR reactions were carried out in duplicate (final volume per DNA sample was 20μl X 16 = 
320μl). Total PCR products from 16 second round PCRs of the same MID tag were pooled 
and heated to 95⁰C for 5 minutes. Sequences of various PCR primers used for the 
amplification of rearranged IGH, IGK and IGL loci are given in Tables (2-12 to 2-17).  
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2.3.4.4 Gel electrophoresis of MID tagged PCR products, purification, pooling and 
enrichment 
For running PCR products of high throughput sequencing PCR, 1X TAE buffer was used to 
prepare 3.5% agarose gel using 1X TAE buffer. PCR products were run for 40 minutes at 
120V and bands of target were size extracted and purified using QIAquick Gel Purification 
Kit (Qiagen). According to manufacturer’s protocol gel slices were incubated with 5 volumes 
of Buffer (QG) per amplicons type in 15ml falcon tubes at 55⁰C and vortexed frequently until 
gel slices were melted. One QIAquick spin column was used for each amplicons and 750μl 
sample solution was passed through column by centrifugation at 13,000 rpm for 30 seconds. 
Flow through was collected in another falcon tube. This process was repeated until whole 
solution was passed through the column. The flow through that was collected in another 
tube was passed through the column again. After passing the whole flow through, the spin 
column was washed with 750μl buffer (PE) by centrifugation at 13,000 rpm for 1 minute. For 
eluting DNA from the column 55μl PCR grade water was added on top of the column and 
allowed to stand for 3 minutes at room temperature. The column was centrifuged at 13,000 
rpm for 1 minute and eluted solution was collected in 1.5ml microcentrifuge tube. Additional 
55μl of PCR grade water was added and again allowed to stand for 3 minutes at room 
temperature. The column was spun at 13,000rpm for 1 minute and eluted solution was 
collected in same 1.5ml microcentrifuge tube. The concentration of eluted DNA was 
estimated using the Qubit dsDNA HS Assay kit on the Qubit 2.0 Fluorometer. After 
determining the concentration of each sample, equal quantities of DNA samples were 
pooled. The pooled products were enriched using QIAquick PCR purification kit. The 
methodology was same as used for purification of DNA products excised from agarose gel 
(described above). 
2.3.4.5 Sequence analysis 
The sequencing data was returned in .Fna format files which were then put through an 
automated analysis pipeline by Dr. David Kipling (Cardiff University) and Dr. Deborah Dunn-
Walters (King’s College London). The data was subjected to a stringent set of rules 
designed to quality control the data.  
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Sequences were assigned to the corresponding samples based on the terminal MID 
sequence. Sequences that contained a second MID sequence that was either different or 
located internally were excluded. A series of stringent quality control criteria were applied to 
exclude biologically implausible sequences. IGKV-IGKC rearrangements amplified from 
cDNA were only accepted as biologically plausible if they were over 415 nucleotides in 
length and IGKV-IGKJ rearrangements if they were over 290 nucleotides in length. 
Sequences that failed to start with a MID tag were rejected. After the initial quality control 
steps, sequences underwent immunoglobulin genotyping using the IMGT (Immunoglobulin 
immunogenetics) V-Quest (http://www.imgt.org/IMGT_vquest/share/textes/) programme. 
The IMGT directory was developed in 1989 by Marie-Paule Lefranc. It provides various 
databases and tools to analyze the BCR and TCR repertoires (Lefranc, Giudicelli et al. 
2015). In the next step, clonotype clustering was done using a clustering matrix and one 
modal sequence was selected as a unique sequence to address the questions being asked 
in this thesis. The Protpram program was used to calculate various physicochemical 
properties of CDR-3 amino acid sequences (http://web.expasy.org/protparam/) which 
includes molecular weight, theoretical PI, aliphatic index, GRAVY index and amino acid 
composition.   
The Excel spread sheets were retrieved containing information of immunoglobulin genes, 
clones and physical characteristics. Data was analyzed using pivot tables. Gene frequencies 
were compared using X
2
 tests with Bonferroni correction for multiple comparisons and the 









Table 2-12:  Sequences of primers used for the amplification of rearranged lambda light 





























Primer Sequence (5’ to 3’) Primer  Sequence (5’ to 3’) Primer  Sequence (5’ to 3’) 
MID1 IGLV1 acgagtgcgtCAGTCTGTGCTGACKCAGCC MID5 IGLV1 atcagacacgCAGTCTGTGCTGACKCAGCC MID9 IGLV1 tagtatcagcCAGTCTGTGCTGACKCAGCC 
MID1 IGLV2 acgagtgcgtCAGTCTGCCCTGACTCAGCC MID5 IGLV2 atcagacacgCAGTCTGCCCTGACTCAGCC MID9 IGLV2 tagtatcagcCAGTCTGCCCTGACTCAGCC 
MID1 IGLV3 acgagtgcgtCCTATGAGCTGACWCAGCCAC MID5 IGLV3 atcagacacgCCTATGAGCTGACWCAGCCAC MID9 IGLV3 tagtatcagcCCTATGAGCTGACWCAGCCAC 
MID1 IGLV4/5 acgagtgcgtCAGCCTGTGCTGACTCARYC MID5 IGLV4/5 atcagacacgCAGCCTGTGCTGACTCARYC MID9 IGLV4/5 tagtatcagcCAGCCTGTGCTGACTCARYC 
MID1 IGLV6 acgagtgcgtCCAGNCTGTGSTGACTCAG MID5 IGLV6 atcagacacgCCAGNCTGTGSTGACTCAG MID9 IGLV6 tagtatcagcCCAGNCTGTGSTGACTCAG 
MID1 IGLJ 1N acgagtgcgt GGMASTGGSACCAAGGTSACC MID5 IGLJ 1N atcagacacg GGMASTGGSACCAAGGTSACC MID9 IGLJ 1N tagtatcagc GGMASTGGSACCAAGGTSACC 
MID1 IGLJ 23N acgagtgcgt GGMGGAGGSACCMAGCTGACC MID5 IGLJ 23N atcagacacg GGMGGAGGSACCMAGCTGACC MID9 IGLJ 23N tagtatcagc GGMGGAGGSACCMAGCTGACC 
MID2 IGLV1 acgctcgacaCAGTCTGTGCTGACKCAGCC MID6 IGLV1 atatcgcgagCAGTCTGTGCTGACKCAGCC MID10 IGLV1 tctctatgcgCAGTCTGTGCTGACKCAGCC 
MID2 IGLV2 acgctcgacaCAGTCTGCCCTGACTCAGCC MID6 IGLV2 atatcgcgagCAGTCTGCCCTGACTCAGCC MID10 IGLV2 tctctatgcgCAGTCTGCCCTGACTCAGCC 
MID2 IGLV3 acgctcgacaCCTATGAGCTGACWCAGCCAC MID6 IGLV3 atatcgcgagCCTATGAGCTGACWCAGCCAC MID10 IGLV3 tctctatgcgCCTATGAGCTGACWCAGCCAC 
MID2 IGLV4/5 acgctcgacaCAGCCTGTGCTGACTCARYC MID6 IGLV4/5 atatcgcgagCAGCCTGTGCTGACTCARYC MID10 IGLV4/5 tctctatgcgCAGCCTGTGCTGACTCARYC 
MID2 IGLV6 acgctcgacaCCAGNCTGTGSTGACTCAG MID6 IGLV6 atatcgcgagCCAGNCTGTGSTGACTCAG MID10 IGLV6 tctctatgcgCCAGNCTGTGSTGACTCAG 
MID2 IGLJ 1N acgctcgaca GGMASTGGSACCAAGGTSACC MID6 IGLJ 1N atatcgcgag GGMASTGGSACCAAGGTSACC MID10 IGLJ 1N tctctatgcg GGMASTGGSACCAAGGTSACC 
MID2 IGLJ 23N acgctcgaca GGMGGAGGSACCMAGCTGACC MID6 IGLJ 23N atatcgcgag GGMGGAGGSACCMAGCTGACC MID10 IGLJ 23N tctctatgcg GGMGGAGGSACCMAGCTGACC 
MID3 IGLV1 agacgcactcCAGTCTGTGCTGACKCAGCC MID7 IGLV1 cgtgtctctaCAGTCTGTGCTGACKCAGCC MID11 IGLV1 tgatacgtctCAGTCTGTGCTGACKCAGCC 
MID3 IGLV2 agacgcactcCAGTCTGCCCTGACTCAGCC MID7 IGLV2 cgtgtctctaCAGTCTGCCCTGACTCAGCC MID11 IGLV2 tgatacgtctCAGTCTGCCCTGACTCAGCC 
MID3 IGLV3 agacgcactcCCTATGAGCTGACWCAGCCAC MID7 IGLV3 cgtgtctctaCCTATGAGCTGACWCAGCCAC MID11 IGLV3 tgatacgtctCCTATGAGCTGACWCAGCCAC 
MID3 IGLV4/5 agacgcactcCAGCCTGTGCTGACTCARYC MID7 IGLV4/5 cgtgtctctaCAGCCTGTGCTGACTCARYC MID11 IGLV4/5 tgatacgtctCAGCCTGTGCTGACTCARYC 
MID3 IGLV6 agacgcactcCCAGNCTGTGSTGACTCAG MID7 IGLV6 cgtgtctctaCCAGNCTGTGSTGACTCAG MID11 IGLV6 tgatacgtctCCAGNCTGTGSTGACTCAG 
MID3 IGLJ 1N agacgcactc GGMASTGGSACCAAGGTSACC MID7 IGLJ 1N cgtgtctcta GGMASTGGSACCAAGGTSACC MID11 IGLJ 1N tgatacgtct GGMASTGGSACCAAGGTSACC 
MID3 IGLJ 23N agacgcactc GGMGGAGGSACCMAGCTGACC MID7 IGLJ 23N cgtgtctcta GGMGGAGGSACCMAGCTGACC MID11 IGLJ 23N tgatacgtct GGMGGAGGSACCMAGCTGACC 
MID4 IGLV1 agcactgtagCAGTCTGTGCTGACKCAGCC MID8 IGLV1 ctcgcgtgtcCAGTCTGTGCTGACKCAGCC MID12 IGLV1 tactgagctaCAGTCTGTGCTGACKCAGCC 
MID4 IGLV2 agcactgtagCAGTCTGCCCTGACTCAGCC MID8 IGLV2 ctcgcgtgtcCAGTCTGCCCTGACTCAGCC MID12 IGLV2 tactgagctaCAGTCTGCCCTGACTCAGCC 
MID4  IGLV3 agcactgtagCCTATGAGCTGACWCAGCCAC MID8 IGLV3 ctcgcgtgtcCCTATGAGCTGACWCAGCCAC MID12 IGLV3 tactgagctaCCTATGAGCTGACWCAGCCAC 
MID4  IGLV4/5 agcactgtagCAGCCTGTGCTGACTCARYC MID8 IGLV4/5 ctcgcgtgtcCAGCCTGTGCTGACTCARYC MID12 IGLV4/5 tactgagctaCAGCCTGTGCTGACTCARYC 
MID4  IGLV6 agcactgtagCCAGNCTGTGSTGACTCAG MID8 IGLV6 ctcgcgtgtcCCAGNCTGTGSTGACTCAG MID12 IGLV6 tactgagctaCCAGNCTGTGSTGACTCAG 
MID4  IGLJ 1N agcactgtag GGMASTGGSACCAAGGTSACC MID8 IGLJ 1N ctcgcgtgtc GGMASTGGSACCAAGGTSACC MID12 IGLJ 1N tactgagcta GGMASTGGSACCAAGGTSACC 
MID4  IGLJ 23N agcactgtag GGMGGAGGSACCMAGCTGACC MID8 IGLJ 23N ctcgcgtgtc GGMGGAGGSACCMAGCTGACC MID12 IGLJ 23N tactgagcta GGMGGAGGSACCMAGCTGACC 
Table 2-13: Sequences of MID-tagged primers used for the amplification of rearranged lambda light chain genes during second round of high throughput sequencing PCR 
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Table 2-14: Sequences of primers used for the amplification of rearranged heavy chain 


























Table 2-15: Sequences of MID-tagged primers used for the amplification of rearranged heavy chain genes during second round of high throughput 
sequencing PCR 
Primer  Sequence (5’ to 3’) Primer  Sequence (5’ to 3’) 
MID3 IGHV1 agacgcactcCCTCAGTGAAGGTCTCCTGCAAGG MID8 IGHV1 ctcgcgtgtcCCTCAGTGAAGGTCTCCTGCAAGG 
MID3 IGHV2 agacgcactcTCCTGCGCTGGTGAAACCCACACA MID8 IGHV2 ctcgcgtgtcTCCTGCGCTGGTGAAACCCACACA 
MID3 IGHV3 agacgcactcGGTCCCTGAGACTCTCCTGTGCA MID8 IGHV3 ctcgcgtgtcGGTCCCTGAGACTCTCCTGTGCA 
MID3 IGHV4 agacgcactcTCGGAGACCCTGTCCCTCACCTGC MID8 IGHV4 ctcgcgtgtcTCGGAGACCCTGTCCCTCACCTGC 
MID3 IGHV5 agacgcactcCAGTCTGGAGCAGAGGTGAAA MID8 IGHV5 ctcgcgtgtcCAGTCTGGAGCAGAGGTGAAA 
MID3 IGHV6 agacgcactcCCTGTGCCATCTCCGGGGACAGTG MID8 IGHV6 ctcgcgtgtcCCTGTGCCATCTCCGGGGACAGTG 
MID3 IGHM agacgcactcGGGGAATTCTCACAGGAGAC MID8 IGHM ctcgcgtgtcGGGGAATTCTCACAGGAGAC 
MID4 IGHV1 agcactgtagCTCAGTGAAGGTCTCCTGCAAGG MID11 IGHV1 tgatacgtctCCTCAGTGAAGGTCTCCTGCAAGG 
MID4 IGHV2 agcactgtagCCTGCGCTGGTGAAACCCACACA MID11 IGHV2 tgatacgtctTCCTGCGCTGGTGAAACCCACACA 
MID4 IGHV3 agcactgtagGGTCCCTGAGACTCTCCTGTGCA MID11 IGHV3 tgatacgtctGGTCCCTGAGACTCTCCTGTGCA 
MID4 IGHV4 agcactgtagTCGGAGACCCTGTCCCTCACCTGC MID11 IGHV4 tgatacgtctTCGGAGACCCTGTCCCTCACCTGC 
MID4 IGHV5 agcactgtagCAGTCTGGAGCAGAGGTGAAA MID11 IGHV5 tgatacgtctCAGTCTGGAGCAGAGGTGAAA 
MID4 IGHV6 agcactgtagCCTGTGCCATCTCCGGGGACAGTG MID11 IGHV6 tgatacgtctCCTGTGCCATCTCCGGGGACAGTG 
MID4 IGHM agcactgtagGGGGAATTCTCACAGGAGAC MID11 IGHM tgatacgtctGGGGAATTCTCACAGGAGAC 
MID7 IGHV1 cgtgtctctaCCTCAGTGAAGGTCTCCTGCAAGG MID12 IGHV1 tactgagctaCCTCAGTGAAGGTCTCCTGCAAGG 
MID7 IGHV2 cgtgtctctaTCCTGCGCTGGTGAAACCCACACA MID12 IGHV2 tactgagctaTCCTGCGCTGGTGAAACCCACACA 
MID7 IGHV3 cgtgtctctaGGTCCCTGAGACTCTCCTGTGCA MID12 IGHV3 tactgagctaGGTCCCTGAGACTCTCCTGTGCA 
MID7 IGHV4 cgtgtctctaTCGGAGACCCTGTCCCTCACCTGC MID12 IGHV4 tactgagctaTCGGAGACCCTGTCCCTCACCTGC 
MID7 IGHV5 cgtgtctctaCAGTCTGGAGCAGAGGTGAAA MID12 IGHV5 tactgagctaCAGTCTGGAGCAGAGGTGAAA 
MID7 IGHV6 cgtgtctctaCCTGTGCCATCTCCGGGGACAGTG MID12 IGHV6 tactgagctaCCTGTGCCATCTCCGGGGACAGTG 
MID7 IGHM cgtgtctctaGGGGAATTCTCACAGGAGAC MID12 IGHM tactgagctaGGGGAATTCTCACAGGAGAC 
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Table 2-16: Sequences of primers used for the amplification of rearranged kappa light chain 
genes during first round of high throughput sequencing PCR 
Primer Sequence (5’ to 3’) 
IGKV1 CATCCAGWTGACCCAGTCTCC 
IGKV2 GATATTGTGATGACCCAGWCT 
IGKV 3 GACRCAGTCTCCAGCCACCCTG 
IGKV4 GACATCGTGATGACCCAGTCT 
IGKV5 GAAACGACACTCACGCAGTCT 

















Primer Sequence (5’ to 3’) Primer  Sequence (5’ to 3’) Primer  Sequence (5’ to 3’) 
MID1 IGKV1 acgagtgcgtCATCCAGWTGACCCAGTCTCC MID5 IGKV1  atcagacacgCATCCAGWTGACCCAGTCTCC  MID9 IGKV1  tagtatcagcCATCCAGWTGACCCAGTCTCC 
MID1 IGKV2  acgagtgcgtGATATTGTGATGACCCAGWCT  MID5 IGKV2  atcagacacgGATATTGTGATGACCCAGWCT MID9 IGKV2  tagtatcagcGATATTGTGATGACCCAGWCT  
MID1 IGKV3 acgagtgcgtGACRCAGTCTCCAGCCACCCTG MID5 IGKV3  atcagacacgGACRCAGTCTCCAGCCACCCTG  MID9 IGKV3  tagtatcagcGACRCAGTCTCCAGCCACCCTG 
MID1 IGKV4 acgagtgcgtGACATCGTGATGACCCAGTCT  MID5 IGKV4  atcagacacgGACATCGTGATGACCCAGTCT MID9 IGKV4  tagtatcagcGACATCGTGATGACCCAGTCT  
MID1 IGKV5 acgagtgcgtGAAACGACACTCACGCAGTCT MID5 IGKV5  atcagacacgGAAACGACACTCACGCAGTCT  MID9 IGKV5  tagtatcagcGAAACGACACTCACGCAGTCT 
MID1 IGKV6 acgagtgcgtGAAATTGTGCTGACTCAGTCT  MID5 IGKV6  atcagacacgGAAATTGTGCTGACTCAGTCT MID9 IGKV6  tagtatcagcGAAATTGTGCTGACTCAGTCT  
MID1 IGKJ1/4  acgagtgcgtTCCACCTTGGTCCCTYSGCCG MID5 IGKJ1/4  atcagacacgTCCACCTTGGTCCCTYSGCCG  MID9 IGKJ1/4  tagtatcagcTCCACCTTGGTCCCTYSGCCG 
MID1 IGKJ2 acgagtgcgtCTCCAGCTTGGTCCCCTGGCCA  MID5 IGKJ2  atcagacacgCTCCAGCTTGGTCCCCTGGCCA MID9 IGKJ3 tagtatcagcATCCACTTTGGTCCCAGGGCCG 
MID1 IGKJ3  acgagtgcgtATCCACTTTGGTCCCAGGGCCG MID5 IGKJ3  atcagacacgATCCACTTTGGTCCCAGGGCCG MID9 IGKJ2  tagtatcagcCTCCAGCTTGGTCCCCTGGCCA  
MID1 IGKJ5 acgagtgcgtCTCCAGTCGTGTCCCTTGGCCG  MID5 IGKJ5  atcagacacgCTCCAGTCGTGTCCCTTGGCCG MID9 IGKJ5 tagtatcagcCTCCAGTCGTGTCCCTTGGCCG  
MID1 IGKC acgagtgcgtCCTTCCACTGTACTTTGGCCTC MID5 IGKC  atcagacacgCCTTCCACTGTACTTTGGCCTC  MID9 IGKC  tagtatcagcCCTTCCACTGTACTTTGGCCTC 
MID2 IGKV1  acgctcgacaCATCCAGWTGACCCAGTCTCC  MID6 IGKV1  atatcgcgagCATCCAGWTGACCCAGTCTCC MID10 IGKV1  tgatacgtctCATCCAGWTGACCCAGTCTCC 
MID2 IGKVK2  acgctcgacaGATATTGTGATGACCCAGWCT MID6 IGKV2 atatcgcgagGATATTGTGATGACCCAGWCT MID10 IGVK2  tgatacgtctGATATTGTGATGACCCAGWCT 
MID2 IGKV3 acgctcgacaGACRCAGTCTCCAGCCACCCTG  MID6 IGKV3 atatcgcgagGACRCAGTCTCCAGCCACCCTG MID10 IGVK3  tgatacgtctGACRCAGTCTCCAGCCACCCTG 
MID2 IGKV4  acgctcgacaGACATCGTGATGACCCAGTCT MID6 IGKV4  atatcgcgagGACATCGTGATGACCCAGTCT  MID10 IGVK4  tgatacgtctGACATCGTGATGACCCAGTCT 
MID2 IGKV5  acgctcgacaGAAACGACACTCACGCAGTCT  MID6 IGKV5 atatcgcgagGAAACGACACTCACGCAGTCT MID10 IGVK5  tgatacgtctGAAACGACACTCACGCAGTCT 
MID2 IGKV6  acgctcgacaGAAATTGTGCTGACTCAGTCT MID6 IGKV6 atatcgcgagGAAATTGTGCTGACTCAGTCT MID10 IGVK6  tgatacgtctGAAATTGTGCTGACTCAGTCT 
MID2 IGKJ1/4  acgctcgacaTCCACCTTGGTCCCTYSGCCG  MID6 IGKJ1/4  atatcgcgagTCCACCTTGGTCCCTYSGCCG MID10 IGKJ1/4  tgatacgtctTCCACCTTGGTCCCTYSGCCG 
MID2 IGKJ2  acgctcgacaCTCCAGCTTGGTCCCCTGGCCA MID6 IGKJ2  atatcgcgagCTCCAGCTTGGTCCCCTGGCCA MID10 IGKJ3 tgatacgtctATCCACTTTGGTCCCAGGGCCG 
MID2 IGKJ3 acgctcgacaATCCACTTTGGTCCCAGGGCCG  MID6 IGKJ3  atatcgcgagATCCACTTTGGTCCCAGGGCCG MID10 IGKJ2  tgatacgtctCTCCAGCTTGGTCCCCTGGCCA 
MID2 IGKJ5  acgctcgacaCTCCAGTCGTGTCCCTTGGCCG MID6 IGKJ5  atatcgcgagCTCCAGTCGTGTCCCTTGGCCG MID10 IGKJ5 tgatacgtctCTCCAGTCGTGTCCCTTGGCCG 
MID2 IGKC acgctcgacaCCTTCCACTGTACTTTGGCCTC  MID6 IGKC  atatcgcgagCCTTCCACTGTACTTTGGCCTC MID10 IGKC  tgatacgtctCCTTCCACTGTACTTTGGCCTC 
MID3 IGKV1  agacgcactcCATCCAGWTGACCCAGTCTCC MID7 IGKV1 cgtgtctctaCATCCAGWTGACCCAGTCTCC MID11 IGKV1  tactgagctaCATCCAGWTGACCCAGTCTCC 
MID3 IGKV2  agacgcactcGATATTGTGATGACCCAGWCT  MID7 IGKV2 cgtgtctctaGATATTGTGATGACCCAGWCT MID11IGKV2  tactgagctaGATATTGTGATGACCCAGWCT 
MID3 IGKV3  agacgcactcGACRCAGTCTCCAGCCACCCTG MID7 IGKV3  cgtgtctctaGACRCAGTCTCCAGCCACCCTG MID10 IGKV3  tactgagcta ACRCAGTCTCCAGCCACCCTG 
MID3 IGKV4 agacgcactcGACATCGTGATGACCCAGTCT  MID7 IGKV4  cgtgtctctaGACATCGTGATGACCCAGTCT  MID11 IGKV4  tactgagctaACATCGTGATGACCCAGTCT 
MID3 IGKV5  agacgcactcGAAACGACACTCACGCAGTCT MID7 IGKV5 cgtgtctctaGAAACGACACTCACGCAGTCT MID11 IGKV5  tactgagctaAAACGACACTCACGCAGTCT 
MID3 IGKV6  agacgcactcGAAATTGTGCTGACTCAGTCT  MID7 IGKV6 cgtgtctctaGAAATTGTGCTGACTCAGTCT MID11 IGKV6   tactgagctaGAAATTGTGCTGACTCAGTCT 
MID3 IGKJ1/4  agacgcactcTCCACCTTGGTCCCTYSGCCG MID7 IGKJ1/4  cgtgtctctaTCCACCTTGGTCCCTYSGCCG MID11 IGKJ1/4 tactgagctaTCCACCTTGGTCCCTYSGCCG 
MID3 IGKJ2  agacgcactcCTCCAGCTTGGTCCCCTGGCCA  MID7 IGKJ2 cgtgtctctaCTCCAGCTTGGTCCCCTGGCCA MID11 IGKJ3 tactgagctaCTCCAGCTTGGTCCCCTGGCCA 
MID3 IGKJ3  agacgcactcATCCACTTTGGTCCCAGGGCCG MID7 IGKJ3 cgtgtctctaATCCACTTTGGTCCCAGGGCCG MID11 IGKJ2  tactgagctaATCCACTTTGGTCCCAGGGCCG 
MID3 IGKJ5 agacgcactcCTCCAGTCGTGTCCCTTGGCCG MID7 IGKJ5 cgtgtctctaCTCCAGTCGTGTCCCTTGGCCG MID11 IGKJ5 tactgagctaCTCCAGTCGTGTCCCTTGGCCG 
MID3 IGKC agacgcactcCCTTCCACTGTACTTTGGCCTC MID7 IGKC  cgtgtctctaCCTTCCACTGTACTTTGGCCTC MID11 IGKC  tactgagctaCCTTCCACTGTACTTTGGCCTC 
 






Lambda light chain gene rearrangements in 



















Previous studies from our laboratory have identified some unusual features of 
rearrangements of immunoglobulin IGL chain used by intestinal IgA plasma cells and IgA 
plasmablasts expressing high levels of β7 integrin in blood (Su, Boursier et al. 2004, Su, 
Gordon et al. 2008). It has been found that these cells are highly mutated as a result of SHM 
suggesting their development during the germinal centre reaction due to chronic antigenic 
challenge. In addition gene rearrangements involving IGLV1 and IGLV2 families, sampled 
from DNA, were significantly more often in-frame in the intestinal plasma as compared to 
frequencies in the published data of the naive mantle zone B cells (Farner, Dorner et al. 
1999). However, out-of-frame gene rearrangements if present mainly involved IGLV5 family 
when studied in IgA single gut plasma cells or cell lines. Interestingly the out-of-frame gene 
rearrangements involved less frequent use of IGLJ1 gene segment in IgA plasma cells than 
mantle zone B cells. Variation in usage of IGLJ gene segments can be a reflection of light 
chain editing or revision. IGL revision has been considered as a mechanism for the 
diversification of the repertoire in intestinal IgA plasma cells by our group and this is 
supported by identification of more recombination excision circles (RECs) involving IGLJ2/3 
than observed in naïve B cells (Su, Gordon et al. 2008). This chapter involves next 
generation sequencing to investigate the bias in IGL gene rearrangement in IgA expressing 
B cells.  
Recently it has been reported that the T2 subset of transitional B cells show tropism towards 
GALT. These bone marrow emigrant transitional T2 B cells express integrin α4β7 and get 
activated in the GALT as shown by phosphorylation status of Syk, Btk and Erk.  
(Vossenkamper, Blair et al. 2013). The consequences of this gut tropism are not fully known, 
but one possibility is that transitional B cells may be the precursors of IgA plasma cells 
forming an independent pathway of development. This will be tested in this thesis by looking 
for features of IGL gene rearrangements considered to be characteristic of IgA plasma cells 




3.1.1 Aims of this chapter 
1. Is the bias towards in-frame gene rearrangements involving IGLV1 and IGLV2 gene 
families as observed previously in IgA secreting cells also evident in transitional B 
cells? 
2. What is the distribution of in-frame and out-of-frame IGL gene rearrangement in 
mature naïve and IgA expressing B cell subsets obtained by high throughput 
sequencing?  
3. Are there any differences in the inherent biases during gene rearrangement at the 
IGL locus between mature and naïve and IgA expressing B cells?  
4. Is there any preferential selection of IGLV gene segment during the IgA response?  
5. Is there any evidence of secondary gene rearrangements in mature naïve and IgA 
expressing B cells detectable by analysis of IGLJ gene segments? 














3.2.1 Is the bias towards in-frame gene rearrangements in IGLV1 and IGLV2 genes 
observed previously in IgA secreting cells observed in transitional B cells? 
In previous studies mucosal IgA plasma cells and plasmablasts have IGL gene 
rearrangements that were biased towards in-frame rearrangements involving IGLV1 and 
IGLV2 gene families compared to the published studies of blood cells or naïve B cells in gut, 
when these were sampled in DNA by family specific PCR reactions. The first aim of this 
thesis was to determine if the excess of in-frame gene rearrangements observed in IGLV1 
and IGLV2 family in mucosal IgA expressing B cells but not naïve B cells is also observed in 
the transitional B cells.  
PBMCs from three healthy anonymous blood donors were sorted into four B cell subsets: 
transitional, mature naïve, IgA plasmablasts and IgA memory B cells. The gating strategy is 
shown in Figure 3-1 and 3-2. The DNA was extracted and gene families IGLV1 and IGLV2 
were amplified by family specific PCR and products were cloned in pGEM-T vector after 
purification. After screening clones for insert of the correct size, selected clones were 










Figure 3-1: Sorting of B cells into transitional and mature naïve B cell subsets.  Alive B 




 B cells (B). These cells were divided 


































Figure 3-2: Sorting of B cells into IgA plasmablasts and IgA memory B cells.  Alive B 
cells (A) were classified into IgA expressing lymphocytes (B). These cells were divided 
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The number of unique DNA gene rearrangements obtained after sequencing are given in 
Table 3-1. Only 10 unique sequences were obtained from IgA plasmablasts in this study 
therefore, sequences from IgA plasmablasts were included from a previous study conducted 
in our lab and used for the comparison. It was found that the ratios of in-frame to out-of-
frame gene rearrangements of transitional and naïve B cells appeared similar to naïve B 
cells in previous studies. The transitional and naïve B cells showed approximately 70% in-
frame gene rearrangements. However IgA expressing B cells had more than 85% in-frame 
gene rearrangements (Figure 3-3). Therefore no resemblance between the features of 
transitional B cells and IgA plasma cells was identified by this analysis. 
Table 3-1: Unique DNA gene rearrangements (IGLV1/2-IGLJ) derived after cloning 
 
B cell subsets Unique DNA gene rearrangements 
Transitional B cells 29 
Mature naïve B cells 31 
IgA memory B cells 27 
IgA plasmablasts (New) 10 





Figure 3-3: The ratios of in-frame to out-of-frame gene IGLV1/2 gene rearrangements 
in various B cell subsets. Transitional, naïve, IgA plasmablasts and IgA memory B cells 
were isolated from healthy blood donors. IGL genes (IGLV1/2 – IGLJ) were amplified, 
purified, cloned and sequenced. Transitional and naïve B cells have more out-of-frame gene 
rearrangements than IgA expressing B cells. Sequences of IgA plasmablasts (Previous) 



































































































Analysis of rearrangements of IGL from mature naïve and IgA expressing B cells by 
next generation sequencing 
Two major problems were encountered in the previous section. Firstly the number of 
different sequences obtained was very low. Secondly it is difficult to understand the 
significance of rearrangements of IGLV1 and IGLV2 families when the whole repertoire is 
not included in the analysis. Therefore, in order to get better insight a high throughput 
sequencing approach was used, amplifying all IGL families simultaneously. Furthermore, in 








The mature naïve and three subsets of IgA expressing B cells from three healthy individuals 
were sorted into separate tubes containing RPMI medium supplemented with FCS and 
antibiotics (streptomycin and penicillin)(Table 3-2). The gating strategy plots for identifying 

















Figure 3-4:  Sorting of B cells into IgA expressing B cells. Alive CD19
+













. Furthermore, based on 









































Table 3-2: The respective number of mature naïve and subsets of IgA expressing B cells 
derived from three healthy donors (HD) 



























































The DNA was extracted from all B cell subsets. For the amplification of rearranged IGL 
repertoire multiplex primers from IGLV to IGLJ were used. In order to distinguish various 
amplified products for the second round of PCR, primers tagged with different bar codes 
consisting of 10 nucleotides at the end called MID were used. Various tags used for the 








Table 3-3: The primer tags used for differentiating the amplified products from three healthy 
donors 



























































The amplified products of appropriate sizes (350 bp) were excised from the agarose gel and 
purified and quantified using Qubit flurorometer. Samples were sequenced using GS FLX 
Genome Titanium Sequencer 454 and resulting sequences were passed through quality 
control criteria (as described in section 2.3.6). Numbers of unique DNA gene 









Table 3-4: The respective number of unique DNA gene rearrangements derived from 
mature naïve and IgA expressing B cell subsets from three healthy donors  
B cell subset Unique IGLV-J gene rearrangements 
Mature naïve B cells 1435 

































3.2.2 What is the distribution of in-frame and out-of-frame IGL gene rearrangement 
in mature naïve and IgA expressing B cell subsets obtained by high throughput 
sequencing?  
Gene rearrangements were classified as in-frame and out-of-frame according to the 
functionality of the junction after high throughput sequencing designated by IMGT. It was 
found that there were 55% in-frame gene rearrangements in mature naïve B cells. However, 
in IgA expressing B cells 81% gene rearrangements were in the correct genetic reading 
frame (Figure 3-5).  
 
Figure 3-5: The relative distribution of in-frame and out-of-frame gene rearrangements 
in mature naïve and IgA expressing B cells. Gene rearrangements were classified 
according to the functionality of CDR-3 junction. There were relatively more in-frame gene 



















 In frame gene rearrangements


























In order to determine if this relative abundance of in-frame gene rearrangements is evident 
in different subsets of IgA expressing B cells the relative distribution was determined in each 
subset. It was found that as compared to naïve B cells there tended to be more in-frame 




IgA as shown in Figure 3-6. 
 
 
Figure 3-6: The relative distribution of in-frame and out-of-frame gene rearrangements 





exhibited overall 80% in frame gene rearrangements.  
Since there was no apparent difference in the subsets of IgA expressing cells in the ratios of 
in-frame and out-of-frame gene rearrangements they were pooled in the next series of 
analyses. It was found that IGLV5 and IGLV9 families comprised more out-of-frame gene 
than in-frame gene rearrangements in both mature naïve B cells and IgA expressing cells 
(Figure 3-7 and 3-8).  Comparing data in Figures 3-8 and 3-9 it appears that the IGLV 1, 2 
and 3 families have a greater abundance of out-of-frame gene rearrangements in naïve as 











































 In frame gene rearrangements



























Figure 3-7: Ratios of in-frame to out-of-frame gene rearrangements in mature naïve B 
cells. Mature naïve B cells were isolated from three healthy donors. IGL genes were 
amplified, purified, deep sequenced and classified as in-frame or out-of-frame. Gene families 




Figure 3-8: Ratios of in-frame to out-of-frame gene rearrangements in IgA expressing 
B cells. IgA expressing B cells were isolated from three healthy donors. IGL genes were 
amplified, purified, deep sequenced and classified as in-frame or out-of-frame. Gene families 
IGLV5 and IGLV9 had more out-of-frame than in-frame gene rearrangements. 
 













































































































The data above was expressed as relative frequencies of in-frame and out-of-frame gene 
rearrangements within families because previous data generated by family specific PCR had 
been expressed in this way. In Figure 3-9 the relative distribution of different functionalities 
(of the CDR-3 junction) out of total gene rearrangements has been shown in mature naïve 
and IgA expressing cells separately. It was found that gene family IGLV2 was abundantly 
rearranged in both subsets. However unlike mature naïve B cells, IgA expressing B cells 
appeared to have more in-frame and less out-of-frame gene rearrangements of IGLV2 family 
and this resulted in relative reduction of other gene families analyzed. 
 
 
Figure 3-9: Distribution of in-frame and out-of-frame gene rearrangements out of total 
gene rearrangements obtained from the respective mature naïve (A) and IgA 
expressing B cells (B). Gene family IGLV2 was found to be frequently rearranged. 
However, there was a reduction in the out-of-frame gene rearrangements in IgA expressing 
B cells.  
Mature naive B cells
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The next step was to determine, if the relative abundance of in-frame gene rearrangements 
involving IGLV2 family in IgA expressing B cells was evident during rearrangement with all 
IGLJ families. For this purpose, the distribution of the functionalities of CDR-3 junction was 
determined in gene rearrangements with IGLJ1 and IGLJ2/3 separately. A similar trend was 
observed during rearrangement with either IGLJ1 or IGLJ2/3 irrespective of B cell subsets. 
The gene family IGLV2 was frequently rearranged with both IGLJ1 and IGLJ2/3 with a 




Figure 3-10: Distribution of in-frame and out-of-frame gene rearrangements of 
different IGLV families with IGLJ1 out of total gene rearrangements obtained from 
respective mature naïve (A) and IgA expressing (B) B cells. Gene family IGLV2 was 
found to be frequently rearranged. However, there was a reduction in the out-of-frame gene 
rearrangements in IgA expressing B cells.  
Mature naive B cells
(Rearrngements involving IGLJ1)
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Figure 3-11:  Distribution of in-frame and out-of-frame gene rearrangements of 
different IGLV families with IGLJ2/3 out of total gene rearrangements obtained from 
respective mature naïve (A) and IgA expressing (B) B cells. Gene family IGLV2 was 
found to be frequently rearranged. However, there was a reduction in the out-of-frame gene 
rearrangements in IgA expressing B cells.  





































































































The proportions of in-frame:out-of-frame gene rearrangements in IGLV5 and 9 families in 
Figures 3-7 and 3-8 resembled the 1:2 expected ratio of IF:OF if rearrangements were all 
non functional so that the ratio would not be affected by selection into the used pool of 
sequences. To test if IGLV5 and 9 gene families are used, usage of IGL segments was 
determined by retrieving published data (references are in figure’s legend). As shown in 
Figure 3-12 none of 210 sequences used IGLV5 or 9 suggesting that despite abundant 
productive gene rearrangements IGLV5 and 9 are either not used or rarely used whether in-
frame or out-of-frame.  
 
 
Figure 3-12:  Distribution of various IGL families in the expressed repertoire (cDNA) of 
various B cell subsets (A-D). IGLV5 and 9 were absent in the expressed gene 
rearrangements and IGLV2 is the most widely used family in IgA expressing B cells 
(Wardemann, Yurasov et al. 2003, Yurasov, Tiller et al. 2006, Benckert, Schmolka et al. 
2011, Steinsbo, Henry Dunand et al. 2014). 
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3.2.3 Are there any differences in the inherent biases during gene rearrangement at 
the IGL locus between mature naïve and IgA expressing B cells?  
Six hundred and forty five out-of-frame gene rearrangements from naïve B cells were 
compared with 286 out-of-frame gene rearrangements from IgA expressing B cells. No 
difference was observed in the relative abundance of different IGLV families (Figure 3-13). 
When usage of individual IGLV gene segments was compared, again there was no 
difference in the relative rearrangement frequencies of various IGLV gene segments 
between different B cell subsets (Figure 3-14). Overall, the cluster A (comprised of IGLV2 
and 3 families) was abundantly rearranged followed by the cluster B and C. In terms of gene 
segments, IGLV2-14, IGLV2-23, IGLV2-8, IGLV2-5, IGLV9-49 and IGLV1-47 were 
frequently rearranged in both mature naïve and IgA expressing B cells. 
 
Figure 3-13: Distribution of IGLV gene families in the out-of-frame gene 
rearrangements. Comparison of relative rearrangement frequencies of IGLV gene families 
between out-of-frame gene rearrangements obtained from mature naïve and IgA expressing 
B cells. Chi squared test was performed to compare the gene frequencies with Bonferroni 
post hoc test and p values with ≤ 0.05 were considered significant (*). There was no 
difference in the relative distribution of IGLV gene families between mature naïve and IgA 
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Figure 3-14: Analysis of out-of-frame IGLV gene segments. Comparison of relative rearrangement frequencies of out-of-frame IGLV gene segments 
between mature naïve and IgA expressing B cells isolated from three healthy individuals (HD-1 to HD-3). Chi squared test was performed to compare 
the gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 were considered significant (*). There was no difference in the relative distribution 
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3.2.4 Are there any IGLV gene segments preferentially selected during the IgA 
response?  
The relative frequencies of in-frame gene rearrangements of IGLV families in naïve and IgA 
expressing B cells were compared. The IGLV2 gene family was significantly more common 
in IgA expressing B cells than naïve B cells while IGLV3 and IGLV5 gene families were 
comparatively more in mature naïve B cells (Figure 3-15). 
 
Figure 3-15: Distribution of IGLV gene families in the in-frame gene rearrangements. 
Comparison of relative rearrangement frequencies of IGLV gene families between in-
frame gene rearrangements obtained from mature naïve and IgA expressing B cells. 
Chi squared test was performed to compare the gene frequencies with Bonferroni post hoc 
test and p values with ≤ 0.05 were considered significant (*). IGLV2 gene family was 
significantly used more in IgA expressing B cells and gene families IGLV3 and IGLV5 were 
represented more in mature naïve B cells. 





 IgA were analyzed separately. It was found that the 
IGLV2 gene family was more commonly in-frame in all subsets of IgA as compared to naïve 
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Figure 3-16: Distribution of IGLV gene families in the in-frame gene rearrangements. 
Comparison of relative rearrangement frequencies of IGLV gene families between in-frame 





IgA). Chi squared test was performed to compare the 
gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 were considered 
significant (*). Gene family IGLV2 was significantly used more in IgA expressing B cells.  
 
Further investigation was done by comparing the relative usage of IGLV gene segments.  It 
was found IGLV2-14 was significantly more common in IgA expressing B cells suggesting 
preferential selection to use this segment. In contrast, IGLV2-5 and IGLV3-1 were 
significantly more abundant in the gene rearrangements of mature naïve B cells (Figure 3-
17).  
The relative distribution of IGLV gene segments was further explored in IgA subsets 




IgA subset there was 
preferential usage of gene segment IGLV2-14 though this was not statistically significant in 
the CD27
-
IgA subset. As above, gene segments IGLV2-5 and IGLV3-1 tended to be 
relatively more abundant in mature naïve B cells than in any of the other B cell subsets 
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Figure 3-17: Analysis of in-frame IGLV gene segments. Comparison of relative rearrangement frequencies of in-frame IGLV gene segments 
between mature naïve and IgA expressing B cells isolated from three healthy individuals (HD-1 to HD-3). Chi squared test was performed to compare 
the gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 were considered significant (*). Gene segment IGLV2-14 was significantly higher 
in IgA expressing B cells while IGLV2-5 and IGLV3-1 were significantly more in mature naïve B cells. The gene segments are arranged in order of their 
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Figure 3-18: Analysis of in-frame IGLV gene segments. Comparison of relative rearrangement frequencies of in-frame IGLV gene segments 
between mature naïve and IgA plasmablasts isolated from three healthy individuals (HD-1 to HD-3). Chi squared test was performed to compare the 
gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 were considered significant (*). Gene segment IGLV2-14 was significantly higher in 
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Figure 3-19: Analysis of in-frame IGLV gene segments. Comparison of relative rearrangement frequencies of in-frame IGLV gene segments 
between mature naïve and CD27
+
IgA B cells isolated from three healthy individuals (HD-1 to HD-3). Chi squared test was performed to compare the 
gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 were considered significant (*). Gene segment IGLV2-14 was preferentially more in 
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Figure 3-20: Analysis of in-frame IGLV gene segments. Comparison of relative rearrangement frequencies of in-frame IGLV gene segments 
between mature naïve and CD27
-
IgA cells isolated from three healthy individuals (HD-1 to HD-3). Chi squared test was performed to compare the gene 
frequencies with Bonferroni post hoc test and p values with ≤ 0.05 were considered significant (*). Gene segment IGLV2-14 was preferentially more in CD27
- 
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3.2.5 Is there any evidence of secondary gene rearrangements in mature naïve and 
IgA expressing B cells detectable by analysis of IGLJ gene segments? 
Rearranged IGL chain loci may retain unrearranged 5’ IGLV and 3’ IGLJ gene segments 
with correctly oriented RSS and thus providing a theoretical opportunity for the secondary 
gene rearrangements.  
In order to better understand whether IGLV gene families could be involved in secondary 
gene rearrangements in the B cell subsets studied, the relative utilization of IGLJ gene 
segments by different IGLV gene families was determined. Although there were no statistical 
differences in IGLJ usage, there were different trends of involvement of IGLJ gene segments 
with different IGLV gene families. For example, there tended to be differences in 
involvement of IGLJ1 in naïve as compared to IgA expressing B cells as there was lower 
frequency in IgA expressing B cells as compared to the naïve B cells that could be 














   
Figure 3-21: Differences in the rearrangement frequencies of various IGLJ segments 
with different IGLV gene families. The relative gene rearrangement frequencies of various 
IGLV families with different IGLJ gene segments naïve and IgA expressing B cells has been 
shown in A and B. C to F are showing relative gene rearrangement frequencies of IGLV1, 
IGLV2, IGLV5 and IGLV9 families in naïve and IgA expressing B cells. There was reduction 
in IGLJ1 usage in IgA expressing B cell (not statistically significant). There was similar usage 
of IGLJ gene segments with IGLV2 in naïve and IgA expressing B cells. There was 
negligible use of IGLJ1 in the gene rearrangements involving IGLV9 in both naïve and IgA.  
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3.2.6 Is there any evidence of a bias in light chain expression in IgA by flow 
cytometry? 
It has previously been suggested that there are more IGL expressing B cells as compared to 




B cells than CD27
+
 IgA B cells (Berkowska, Driessen et 
al. 2011). Therefore, it was decided to compare IGK to IGL ratios in different subsets of IgA 
to find out if the proportion of IGK and IGL varies. For this purpose, blood was collected from 
10 buffy coats and stained with CD19-PerCPcy5.5, CD27- APC, IgA-FITC, IGK-APC-cy7 
and IGL-Pacific blue (as described in the section 2.3.5). The data was acquired using 
flowcytometer and analyzed with Flowjo software. Consistent with previous study, it was 
found that in CD27
-
IgA B cells there was a greater proportion of IGL of total B cells as 
compared to CD27
+

















Gated on alive B cells 
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IgA B cell subsets has been 




IgA B cell 
subsets. Non-parametric (Mann-Whitney) test was used to compare the means (B). The 
IGK:IGL is significantly decreased in the CD27
-






















































3.3.1 More out-of-frame than in-frame gene rearrangements in mature naïve B cells 
In the data studied here almost 55% of total IGL gene rearrangements amplified from DNA 
extracted from naïve B cells were out-of-frame. The abundance of out-of-frame gene 
rearrangements in the repertoire of naïve B cells could suggest that receptor editing has 
occurred so that a cell can carry more than two rearrangements. The primary V(D)J gene 
rearrangement could generate a CDR-3 junction having either in-frame or out-of-frame 
functionality. If the rearrangement is autoreactive in the first place then it can also be 
replaced by editing and new rearrangement could be out-of-frame thus further adding to total 
out-of-frame gene rearrangements. When the junction is out-of-frame then it leads to the 
initiation of the receptor editing either on the same allele or second allele in an attempt to 
generate a functional BCR (Luning Prak, Monestier et al. 2011). As a result of the secondary 
gene rearrangement, specificities of BCRs can be modified which could be beneficial 
because it causes diversification of repertoire and elimination of autoreactive specificities 
(Nemazee 2006). However, non productive receptor editing defaults to clonal deletion 
(Halverson, Torres et al. 2004). Overall this editing process generates episomal fragments of 
deleted out-of-frame gene rearrangements that could be amplified by PCR resulting in the 
potential to accumulate more out-of-frame gene rearrangements in next generation 
sequencing data than may have been predicted.  Relative reduction in the proportion of out-
of-frame rearrangements in IgA could be generated by cell division that would replicate the 
chromosomes but not the episomes generated by secondary rearrangement events of 
editing process. 
It is also possible that some out-of-frame rearrangements might be generated artificially by 
the 454 sequencing method that is known to insert nucleotides at homopolymer repeats. 
This error may enhance the number of out-of-frame rearrangements observed since by 
chance; there is 2 times the possibility of rearrangements being out-of-frame than in-frame.  
However, there were consistent observations in the IgA subsets studied that were different 
to the mature naïve B cells that would have been affected equivalently by this, suggesting 
that this did not make a major impact on the data. 
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3.3.2 Gene families IGLV5 and IGLV9 are skewed towards out-of-frame gene 
rearrangements in mature naïve and IgA expressing B cells 
Unlike IGLV1 and 2 families, gene rearrangements involving IGLV5 and 9 gene families 
were mostly out-of-frame. This is consistent with previous study, however, abundance in the 
out-of-frame gene rearrangements was observed not only in IgA expressing B cells but also 
in the mature naïve B cells (Farner, Dorner et al. 1999, Su, Boursier et al. 2004). Gene 
families IGLV5 and IGLV9 are in the cluster B and C which increases the likelihood of 
involvement of these families in the secondary gene rearrangements. In this data it was 
found that IGLJ1 was not involved in the gene rearrangements involving IGLV9 family. It 
may suggest the involvement of this family in receptor editing and revision. It has been 
reported there is a stop codon at the end of IGLV9 region. Although rare, nonsense codons 
at the end of IGLV region limit functional rearrangement for these IGLV genes (Kawasaki, 
Minoshima et al. 1997, Schoettler, Ni et al. 2012). Moreover, IGLV9-49 is also known to 
exhibit intrinsic autoreactivity which may subject these rearrangements to negative selection 
before expression (Schoettler, Ni et al. 2012).  However, which factors are involved for the 
abundance of out-of-frame gene rearrangements involving IGLV5 family are not known. All 
these gene rearrangements were studied at the level of DNA. Analysis of cDNA gene 
rearrangements in various B cell subsets revealed that IGLV5 and 9 were not used to 
constitute BCR at any stage of the B cell development.  
3.3.3 Is there any evidence for receptor revision of IgA in this analysis?  
Previous studies of cell lines derived from mucosal B lineage cells and features of light chain 
excision circles have suggested that the repertoire of mucosal IgA plasma cells can be 
modified by receptor revision (Su, Gordon et al. 2008).  Re expression of RAG genes has 
been reported in vitro in mature peripheral B cells by stimulation with SAC, IL-2 and also 
with anti-CD40 antibody and IL-4 (Nagafuchi, Yoshikawa et al. 2004). Re-expression of 
RAGs in human mature B cells has also been reported and the purpose was suggested to 
increase diversification of the immune repertoire (Han, Dillon et al. 1997, Hertz, Kouskoff et 
al. 1998, Hikida and Ohmori 1998). Reactivation of RAG genes has also been found in 
mature peripheral B cells isolated from the tonsils of humans and mice (Meffre, Papavasiliou 
et al. 1998). Mature B cells can re-induce RAG genes after somatic mutation in order to 
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revise the BCR by secondary recombination for diversification and to rescue B cells from 
apoptosis by re arranging light chains (Han, Zheng et al. 1996, Nemazee and Weigert 
2000).  The transcripts of rag1 and rag2 genes and proteins have been documented in 
human GC B cells and in extra follicular areas (Giachino, Padovan et al. 1998, Girschick, 
Grammer et al. 2001, Meru, Jung et al. 2002).  In physiological conditions receptor revision 
has been proposed as a mechanism for receptor diversification to increase the diversity of 
BCRs (Meffre, Papavasiliou et al. 1998). Expression of TdT has also been found in mature B 
cells in the periphery to add random nucleotides at the junction and thus diversification of 
repertoire (Komori, Okada et al. 1993). 
No evidence of receptor revision was observed in this study however since no significant 
biases in IGLJ segment usage were observed in any B cell subset analysed or any IGLV 
segments used by them.  It is known that IgA producing cells in blood are not all mucosal 
and mucosal IgA producing cells were not studied in this thesis. It would be interesting to 
know if the mucosal B cell subset in blood that expresses higher levels of α4β7 integrin 
would have generated a different profile.  
3.3.4 CD27
-
IgA B cells have lower IGK/IGL ratio than CD27
+
IgA B cells 
It is possible that CD27
+
 IgA and CD27
- 
IgA represent distinct subsets of IgA memory B 
cells.  It has been suggested that CD27
- 
IgA memory B cells could be generated as a result 
of TID responses in the gut because of the presence of these cells in CD40L deficient 
patients. TID IgA responses have been observed both in human and mouse, both 
systemically in the splenic marginal zone and locally in the gastrointestinal system 
(Fagarasan, Kinoshita et al. 2001, Bergqvist, Gardby et al. 2006). Potential mediators of 
CD40-independent IgA CSR are BAFF and APRIL (Litinskiy, Nardelli et al. 2002). High 
frequency of IGL expressing B cells in CD27
-
IgA is consistent with the previous study that 
suggested a broad IGL repertoire may be beneficial for responses in the human 
gastrointestinal tract (Berkowska, Driessen et al. 2011). It gives a clue that IGK and IGL 
expression changes during developmental stages which conceptually could be observed by 
the initiation of IGL gene rearrangements in IGK expressing B cells or on the previously 
unrearranged IGL locus. No differences in the profile of IGL repertoire was observed in this 
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 subsets of IgA according to any of the parameters 
studied.  Despite this and although it has been shown that the same clone of B cells can be 




IgA expressing B cell subsets, the consistent differences 
in IGK:IGL ratio between studies is consistent with the idea that the these subsets of IgA 
producing cells may have a different derivation. 
3.4 Conclusions 
1. No bias was observed towards in-frame gene rearrangements involving IGLV1 and 
IGLV2 gene families in transitional B cells as observed previously in IgA secreting 
cells.  
2. There were more in-frame gene rearrangements overall in IgA expressing B cells as 
compared to mature naïve B cells. This trend was consistent in all subsets of IgA 
expressing B cells: IgA plasmablasts, CD27
+
 IgA and CD27
-
IgA.  
3. There were no differences in the profile of out-of-frame gene rearrangements 
between naïve and IgA expressing B cells. 
4. The gene segment IGLV2-14 is preferentially used more in IgA expressing B cells 
as compared to mature naïve B cells.  
5. There is no evidence of the secondary rearrangement as revealed by the 
comparison of IGLJ gene segments. However, there was a trend of less usage of 
IGLJ1 by IgA expressing B cells as compared to naïve B cells.  
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B cell development is characterized by a well defined order of rearrangements at IGH, IGK 
and IGL chain loci. Somatic recombination of IGHD and IGHJ genes is followed by 
recombination of IGHV and rearranged IGHD-J segments. Gene rearrangement involves 
removal of nucleotides by exonucleases and addition of nucleotides by TdT. Hence there is 
only a 1/3 chance of having a correct genetic reading frame and 2/3 attempts would yield out 
of frame gene rearrangements (Hardy and Hayakawa 2001, Santos, Arumemi et al. 2011). If 
the rearrangement is productive (in frame with no stop codons) this newly synthesized μHC 
is expressed on the cell surface with SLC (VpreB and λ5) and transmembrane proteins Igα 
and Igβ. Expression of this pre-BCR on the cell surface is considered a critical signal for IGH 
exclusion of the second allele. If rearrangement is not successful, the process is repeated on 
the second allele. Upon pre-BCR signalling cells undergo proliferation and there is down 
regulation of RAG and SLC. Signalling also induces transcription factors such as NF-κB, 
Spi-B and IRF-4 as well as re-expression of RAG that results in the activation of κ enhancers 
that initiates rearrangement at the IGK locus (van Zelm, van der Burg et al. 2005). 
In humans there are about 40 (out of 76) functional IGKV gene segments and 5 IGKJ gene 
segments (Figure 1-4). Rearrangement proceeds by alignment of one IGKV allele to IGKJ 
on one allele. The productive gene rearrangements may be translated into protein that could 
be expressed as part of a functional antigen receptor. B cells expressing surface 
immunoglobulin can be influenced by a variety of selective forces resulting in their 
preferential expansion or deletion from the repertoire. However, if the genetic rearrangement 
is non productive due to being out of frame or having stop codons it would not be translated 
into a protein; their presence in the cell does not influence the fate of the cell. Therefore 
these gene rearrangements reflect intrinsic biases in factors such as transcriptional activity 
or RSS sequence that influence the rearrangement process (Foster, Brezinschek et al. 
1997). If gene rearrangement is not successful then the IGK locus is inactivated by 
rearrangement of the KDE and gene rearrangement process of IGL locus starts (van der 
Burg, Tumkaya et al. 2001, Vela, Ait-Azzouzene et al. 2008). KDE is non-coding DNA 
located 25 kb downstream of IGKC. The RSS heptamer located 5’ of the KDE is separated 
from the nonamer by a 23bp sequence. The RSS configuration resembles that found 5’ of 
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each IGKJ segment. The target of the KDE is an RSS composed of a heptamer separated 
from a nonamer by 30 bp spacer. There are two ways of KDE rearrangement. It can undergo 
RSS mediated site specific recombination with intronic RSS located between distal IGKJ and 
IGKC. On the other hand KDE can also recombine with the RSS of an upstream IGKV 
segment that has not been rearranged. As a result of these mechanisms there is a deletion 
of IGKC, iEk and 3’Ek enhancers (Siminovitch, Bakhshi et al. 1985, Nayar, Paklet et al. 
2010). Consequently there is inactivation of IGK locus by deletion. It has also been found 
that iRSS can also inactivate the IGK locus independently with an intermediate step of 
rearrangement to IGKJ downstream to the non productive gene rearrangement (Feddersen, 
Martin et al. 1990, Feddersen, Martin et al. 1990, Langerak, Nadel et al. 2004). 
Gene rearrangement proceeds in an ordered fashion and is initiated at IGL locus if both 
alleles of IGK locus fail to produce a functional protein. Interestingly it has been found that 
non productive gene rearrangement in terms of DNA sequence at the IGK locus is not the 
only factor to initiate gene rearrangement at IGL locus. Approximately 30% of mature naïve 
B cells expressing IGL on the surface had undergone productive gene rearrangement at the 
IGK locus already according to the sequence of the rearranged allele. However, these 
rearrangements were not selected to constitute functional BCR rendering them non 
productive in functional terms (Brauninger, Goossens et al. 2001). These productive 
rearrangements of IGK in IGL expressing B cells are referred to as aberrant productive gene 
rearrangements in this thesis. They are of interest because despite being apparently 
functional according to sequence they have been selected against and are not used to 
generate BCR. 
One of the characteristic features of the IGK locus is the orientation of IGKV gene segments. 
Most of the IGKV gene segments like IGKJ segments are in the reverse orientation. 
However, the rest of the IGKV segments are in the forward orientation as shown in Figure 1-
4 (Foster, Brezinschek et al. 1997, Schoettler, Ni et al. 2012). Of note, in this thesis IGKV4-1 
and IGKV5-2 are in the forward orientation. Complete classification of IGKV genes according 
to the orientation on chromosome has been given in Figure 1-4. The different orientation of 
IGKV ultimately determines the consequences of rearrangement. If IGKV gene segments 
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are in the same orientation as IGKJ gene segments then alignment of the two RSS regions 
loops out the intervening DNA. The intervening DNA is excised from the chromosome and 
cannot be used for further rearrangement (Figure 4-1). However, when IGKV and IGKJ gene 
segments are in the opposite orientation, alignment of the RSS regions
form the intervening DNA into a coiled configuration. As a result after recombination the 
coiled region is retained in the chromosome in an inverted orientation (Figure 4-2).  
Various biases have been reported in the usage of IGKV and IGKJ segments in the B cell 
repertoire (Jackson, Kidd et al. 2013). However, comparison of productive rearrangements 
with expressed rearrangements has not been reported so far. It is noteworthy that not all 
productive rearrangements are used to encode BCR.  
The experiment in this chapter is designed to allow analysis of selection that may occur after 
gene rearrangement and before maturation to mature naïve B cells. In this study 5 groups of 
sequences were analyzed. 
 
1. Productive DNA gene rearrangements  
2. Non productive DNA gene rearrangements  
3. Expressed cDNA gene rearrangements  
4. Aberrant productive DNA gene rearrangements 







From IGK expressing mature naïve B cells 
From IGL expressing mature naïve B cells 
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The schematic representation of the experiment and functional relevance of different 
rearrangements from different subsets is given in Figure 4-3. In addition to IGK genes usage 
CDR-3 characteristics were also compared. The CDR-3 region is a major contributor to 
antigenic specificity. The physicochemical properties of the CDR-3 region such as CDR-3 
length, amino acids distribution, GRAVY index, aliphatic index, isoelectric points were also 



















4.1.1 Aims of this chapter 
The aims of investigation in this chapter were to ask: 
1. Does the expressed IGKV gene repertoire mimic the productive DNA gene 
rearrangements in IGK expressing B cells? This will be addressed by comparing 
productively rearranged DNA and cDNA from IGK producing B cells. 
2. Does the expressed IGKJ gene repertoire reflect the productive DNA gene 
rearrangements in IGK expressing B cells? This will be addressed by comparing 
productively rearranged DNA and cDNA from IGK producing B cells. 
3. What are the inherent biases during DNA gene rearrangement process at IGK 
locus? This will be visualized by studying non productively unselected gene 
rearrangements. 
4. Is there any selection for or against of IGKV gene segments during rearrangement 
and expression? This will be studied by comparing productive gene 
rearrangements from IGK and IGL expressing mature naïve B cells. 
5. Is there any difference in the characteristic of CDR-3 region of aberrant 
productive, productive and expressed repertoire? For this purpose following 
characteristics of CDR-3 region were analyzed: 
i. CDR-3 length 
ii. Relative distribution of amino acids 
iii. GRAVY indices 
iv. Isoelectric points 

















Figure 4-1: Schematic representation of IGKV to IGKJ gene rearrangement having same orientation. (A) Various gene loci are shown on long 
arm of chromosome 2. IGKV gene segments (green), IGKJ gene segments (yellow), intronic RSS (brown), enhancers (red), constant region (purple) 
and KDE (olive green). Arrows indicate the direction of transcription. (B) When IGKV and IGKJ gene segments are in the same orientation there is 
juxtaposition and subsequently excision of intervening DNA (excised DNA) and RSS of the rearranged genes. In this example rearrangement of 
IGKV1-5 with IGKJ-2 has been shown. (C) After excision of intervening DNA, IGKV1-5 and IGKJ-2 has formed a coding joint which can be 
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Figure 4-2: Schematic representation of IGKV to IGKJ gene 
rearrangement having different orientation. (A) Various gene loci are 
shown on long arm of chromosome 2. IGKV gene segments (green), IGKJ 
gene segments (yellow), intronic RSS (brown), enhancers (red), constant 
region (purple) and KDE (olive green). Arrows indicate direction of 
transcription. (B) When IGKV and IGKJ gene segments are in the opposite 
orientation there is coiling of IGKJ segment so that their transcription 
orientation can be matched. In this example rearrangement of IGKV4-1 
with IGKJ-2 has been shown. (C) After coiling of DNA, IGKV4-1 and IGKJ-
2 can be rearranged and intervening DNA is retained in the inverted 



















































































Figure 4-3: Flow chart showing various stages of experiment and data interpretation. 
The PBMCs from three healthy individuals were sorted into mature naïve B cells according 
to surface light chain expression. Genomic DNA and cDNA was extracted from IGK 
expressing and genomic DNA from IGL expressing mature naïve B cells and amplified 
(arrows indicate binding sites of the primers). Sequences were retrieved and passed through 
quality control. Functional relevance of different sets of gene rearrangements is shown.  
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The PBMCs were isolated from the blood of three healthy individuals. Cells were stained 
with flurochrome tagged monoclonal antibodies against CD19-PerCPcy5.5, CD27-APC, IgD-
PE-cy7, kappa-APC-cy7, lambda-Pacific blue and live/dead-Amcyan. The gating strategy for 




Figure 4-4: Example of sorting B cell subsets into mature naïve B cells expressing 
either IGK or IGL light chain. PBMCs were stained with monoclonal antibodies and sorted 
using FACS. Lymphocytes were gated first and doublets were excluded. Cells were first 
gated on alive CD19
+










) were divided according to surface expression of light chains (IGK or IGL). 
149 
 
















) were sorted in to separate tubes containing RPMI medium supplemented with 
FCS and antibiotics (penicillin and streptomycin). Mature naïve B cells expressing IGK were 
divided into two fractions for the extraction of DNA (genomic repertoire) and cDNA 
(expressed repertoire). In order to analyze the IGK rearrangements carried by mature naïve 
B cell expressing IGL only genomic DNA was extracted. The number of cells used to acquire 
the sequences is given in Table 4-1.   
Table 4-1: The respective number of mature naïve B expressing either IGK or IGL derived 
from each donor 
Samples Mature naïve B cells expressing 
IGK 
Mature naïve B cells expressing 
IGL 
HD-1 65,955 37,479 
HD-2 274,790 204,037 
HD-3 362,997 296,590 
 
For the amplification of rearranged (genomic) and expressed (cDNA) repertoire, primers 
were used from IGKV to IGKJ and IGKV to IGKC respectively. In order to distinguish 
amplified products from different individuals for the second round of PCR, primers were 
tagged with different barcodes consisting of 10-nucleotides sequence of MID. Different tags 









Table 4-2: The primer tags used for differentiating the amplified products from different 
individuals 
Sample MID tags used to distinguish products 
HD-1 IGK expressing mature naïve B cells (DNA)   MID-1 
IGK expressing mature naïve B cells (cDNA) MID-2 
IGL expressing mature naïve B cells (DNA)   MID-3 
HD-2 IGK expressing mature naïve B cells (DNA)  MID-5 
IGK expressing mature naïve B cells (cDNA) MID-6 
IGL expressing mature naïve B cells (DNA)   MID-7 
HD-3 
 
IGK expressing mature naïve B cells (DNA)   MID-9 
IGK expressing mature naïve B cells (cDNA) MID-10 
IGL expressing mature naïve B cells (DNA)   MID-11 
 
Excess primers were removed after running on agarose gel. Amplified products of required 
sizes (genomic: 350bp, cDNA: 450bp) were excised from the agarose gel and purified and 
quantified using Qubit fluorometer. Samples were pooled and concentrated. Sample was 
sequenced using GS FLX Genome Titanium Sequencer 454. Resulting sequences were 
passed through quality control criteria (section 2.3.6.5).  
From three donors collectively 1,027 unique gene rearrangements were acquired from 
genomic DNA (IGKV-JK) and 4,360 gene rearrangements from cDNA (IGKV-CK) of IGK 
expressing mature naïve B cells. From mature naïve B cells expressing IGL on the cell 
surface 2,459 genomic DNA (IGKV-JK) gene rearrangements were obtained. Based on 
CDR-3, IGKV, IGKJ and IGKC genes usage only one gene rearrangement was selected in 
the analysis (Table 4-3).   
Gene rearrangements from genomic DNA of mature naïve B cells expressing IGK on the cell 
surface were further divided into productive and non productive sequences according to the 
functionality of the junction. If the junction between IGKV to IGKJ was in the correct genetic 
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reading frame with no stop codons, rearrangements were classified as productive 
sequences. If they were out of frame or had stop codons they were classified as non 
productive sequences. In order to analyze the expressed IGK repertoire of mature naïve B 
cells, cDNA was also isolated. Non productive IGKV-CK gene rearrangements were 
excluded from the data analysis.  
Rearrangements of IGK from mature naïve B cells expressing IGL on cell surface were also 
divided according to the functionality of junction. As these gene rearrangements were from 
cells that expressed IGL not IGK on the cell surface they were not used to constitute 
functional BCR in these cells. Therefore, such productive DNA gene rearrangements in IGL 
expressing B cells were classified as aberrant productive sequences. Like IGK expressing 
B cells, if the genetic reading frame was incorrect or had stop codons such sequences were 
classified as non productive sequences. The percentages of aberrant productive, 
productive and non-productive gene rearrangements from each cell type are shown in 
Figure 4-5. The relative number of sequences derived from each donor for each subset is 





Figure 4-5: Classification and respective percentages of genomic DNA gene rearragments 
at IGK locus obtained from mature naïve B cells expressing expressing either IGK (A) or IGL 
















A- Genomic DNA  gene rearrangements in IGK 







B-  Genomic DNA  gene rearrangements in IGL 
expressing mature naive B cells 
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Table 4-3: The respective number of unique gene rearrangements derived from mature 
naïve B cells (sorted according to surface light chain expression) from three healthy donors 
(HD) 
 VJC gene rearrangements HD-1 HD-2 HD-3 Total 
1 Productive DNA gene rearrangements from 
IGK expressing mature naïve B cells  
329 81 76 486 
2 Non productive DNA gene rearrangements 
from IGK expressing mature naïve B cells  
364 124 53 541 
3 Expressed gene rearrangements from IGK 
expressing mature naïve B cells (cDNA) 
1071 2787 502 4360 
4 Aberrant productive DNA gene 
rearrangements from IGL expressing 
mature naïve B cells (DNA) 
469 28 109 606 
5 Non productive DNA gene rearrangements 
from IGL expressing mature naïve B cells  












4.2.1 Does the expressed IGKV gene repertoire resemble the productive DNA gene 
rearrangements? 
In order to create the light chain of the BCR, gene rearrangement starts first at the IGK locus 
at the pre B cell stage during B cell development in the bone marrow. Productive gene 
rearrangements are translated into functional protein. Selection pressures are imposed on 
the productive gene rearrangements in the bone marrow and some of the productive 
rearrangements are not ultimately used to constitute BCR. Furthermore, receptor editing by 
secondary gene rearrangements may occur if gene rearrangement at first allele 
rearrangement is selected against. As a consequence, productive gene rearrangements 
may accumulate in a cell and may not all encode protein. To test this, the relative usage of 
IGKV families and IGKV gene segments was compared between productive DNA gene 
rearrangements with the expressed DNA gene rearrangements. 
Differences were observed between the profile of expressed genes and the profile of 
productive gene rearrangements in DNA. It was found that overall rearrangements using the 
IGKV3 family were relatively more in cDNA as compared to DNA. On the other hand IGKV4 
family was significantly lower in frequency in the expressed repertoire (Figure 4-6). This was 
true even when individual donors were analyzed separately (data not shown). This suggests 
that productive gene rearrangements of IGKV4 family accumulate in a cell but are not 






Figure 4-6: Distribution of IGKV families in the productive and expressed gene 
rearrangements. Comparison of relative rearrangement frequencies of IGKV gene 
families between productive and expressed gene rearrangements of IGK expressing 
mature naïve B cells. Chi squared test was performed to compare the gene frequencies 
with Bonferroni post hoc test and p values with ≤ 0.05 were considered significant (*). IGKV3 
was significantly increased while IGKV4 was significantly reduced in the expressed 
repertoire.  
The relative frequency of IGKV gene segments was then compared between productive 
rearrangements in DNA with the expressed gene rearrangements from cDNA. The gene 
segments IGKV3-15 and IGKV3-20 were found significantly more in the expressed 
repertoire. In contrast to this, rearrangements using IGKV4-1 rearrangements were 
significantly more abundant in DNA as compared to cDNA (Figure 4-7). In order to validate 
the pooled data the sequences from each individual were analyzed separately. It was found 
that in all individuals there was more utilization of at least one IGKV3 family member 
although not the same in each case. IGKV4-1 was consistently less abundant in the cDNA 
relative to the productive rearrangements in DNA (Figure 4-8).  
 








Productive gene rearrangements (DNA)
Expressed rearrangements (cDNA)

















Figure 4-7: Distribution of IGKV gene segments in productive and expressed gene rearrangements. Comparison of relative rearrangement 
frequencies of IGKV gene segments in the productively rearranged and expressed cDNA of mature naïve B cells expressing IGK. Chi 
squared test was performed to compare the gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 were considered significant (*). 
The gene segments IGKV3-20 and IGKV3-15 were significantly more in the expressed repertoire. Usage of gene segment IGKV4-1 was significantly 







































































































































































































































































































































































































































































































Productive gene rearrangements (DNA)
Expressed gene rearrangements (cDNA)
*

























































































































































































































































































































































































































































































































Productive gene rearrangements (DNA)
Expressed gene rearrangements (cDNA)




















Figure 4-8: Analysis of IGKV segments usage. Comparison of relative rearrangement 
frequencies of IGKV gene segments in the productively rearranged and expressed 
DNA of mature naïve B cells expressing IGK in three healthy donors (HD-1 to HD-3). 
Chi squared test was performed to compare the gene frequencies with Bonferroni post hoc 
test and p values with ≤ 0.05 were considered significant (*). The gene segments IGKV3-11, 
IGKV3-20 and IGKV3-15 were significantly more in the expressed repertoire. Usage of gene 
segment IGKV4-1 was significantly decreased in the expressed repertoire. The gene 
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4.2.2 Does the expressed IGKJ gene repertoire reflect the productive DNA gene 
rearrangements? 
The differences observed in IGKV segment frequency between DNA and cDNA is consistent 
with receptor editing and accumulation of multiple gene rearrangements that are not 
expressed. Receptor editing can be investigated by analysis of IGKJ segments usage. 
However, it must be borne in mind those loci where segments (IGKV and IGKJ) are in the 
same orientation, editing may not be reflected by representation of downstream IGKJ gene 
segments since segments are not always deleted. The IGK locus includes genes in both 
forward and reverse orientations and gene rearrangements with reverse transcriptional 
orientation can be retained on the same chromosome. These rearrangements can 
simultaneously be inactivated by the KDE. On the other hand, gene rearrangements 
involving IGKV gene segments having forward orientation result in the deletion of intervening 
DNA as an episome that is retained by the cell. Usage of IGKJ genes was compared 
between productive DNA rearrangements with the expressed DNA gene rearrangements. It 
was found in the genomic repertoire that there was a bias towards more usage of IGKJ2 and 
IGKJ5 gene segments and in the expressed repertoire there was significantly more usage of 








Figure 4-9: Analysis of IGKJ segments usage. Comparison of relative rearrangement 
frequencies of IGKJ gene segments in the productive and expressed gene 
rearrangements of mature naïve B cells expressing IGK. Chi squared test was 
performed to compare the gene frequencies with Bonferroni post hoc test and p values with 
≤ 0.05 were considered significant (*). Gene segment IGKJ1 and IGKJ4 were significantly 
used more in the expressed repertoire (cDNA). However, IGKJ2 and IGKJ5 were used more 
in the productive genomic repertoire (DNA).  
The sequences from each individual were then analyzed separately. It was found that all 
three individuals showed the trend of more usage of IGKJ1 and IGKJ4 while reduction in the 
usage of IGKJ5 in the expressed repertoire. However, decrease in the usage of IGKJ2 in the 
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Figure 4-10: Analysis of IGKJ segments usage. Comparison of relative rearrangement 
frequencies of IGKJ gene segments in the productive and expressed gene 
rearrangements of mature naïve B cells expressing IGK in three healthy donors (HD-1 
to HD-3). Chi squared test was performed to compare the gene frequencies with Bonferroni 
post hoc test and p values with ≤ 0.05 were considered significant (*). The gene families 
IGKJ1 and IGKJ4 were used more in the expressed repertoire (cDNA). However, IGKJ5 
family were used more in the productive genomic repertoire (DNA).  
Data in Figures 4-7 and 4-8 show that gene segments of IGKV3 family were represented 
significantly more frequently in the expressed repertoire as compared to the productive gene 
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rearrangements and vice versa for IGKV4. It was therefore considered possible that different 
IGKV genes may be edited differently and this might be reflected in differences of IGKJ 
rearranged to different IGKV gene segments. Therefore, the relative usage of IGKJ families 
was compared in individual gene segments IGKV3-11, IGKV3-15, IGKV3-20, IGKV1-39 and 
IGKV4-1. The rationale for selecting these gene segments has been summarized in Table 4-
4 based on Figure 4-7. 
 A similar trend was found in the distribution of IGKJ4 and IGKJ5 in all IGKV gene segments. 
IGKJ5 was used more in the productive gene rearrangements while IGKJ4 was used more 
in the expressed repertoire. However, in IGKV1-39 there was no difference in the usage of 
IGKJ5 (Figure 4-11).  
Table 4-4: Frequency distribution of selected IGKV gene segments in DNA and cDNA 
IGKV gene 
segment 
Features of usage in DNA and cDNA 
IGKV1-39 Commonly rearranged but there was no difference in the rearrangement 
frequency between DNA and cDNA. 
IGKV3-11 Commonly rearranged but there was no difference in the rearrangement 
frequency between DNA and cDNA. 
IGKV3-15 Commonly rearranged and the gene rearrangements were more abundant 
in cDNA than DNA.  
IGKV3-20 Commonly rearranged and the gene rearrangements were more abundant 
in cDNA than DNA. 
IGKV4-1 Commonly rearranged and the gene rearrangements were more abundant 




















































































Figure 4-11: Analysis of IGKJ segments usage during rearrangements involving 
IGKV3-11, IGKV3-15, IGKV3-20, IGKV1-39 and IGKV4-1. Comparison of relative 
rearrangement frequencies of IGKJ gene segments in the productive and expressed gene 
rearrangements of mature naïve B cells expressing IGK during rearrangement involving 
selected IGKV gene segments. Chi squared test was performed to compare the gene 
frequencies with Bonferroni post hoc test and p values with ≤ 0.05 were considered 
significant (*). The gene families IGKJ1 and IGKJ4 were used more in the expressed 
repertoire. However, IGKJ5 family was used more in the productive genomic repertoire 
(DNA) as compared to the expressed repertoire (cDNA).  
IGKV3-20



















4.2.3 What are the inherent biases during DNA gene rearrangement process? 
The differences between the frequencies of productively rearranged and expressed gene 
segments suggest that editing occurs during the development of functional IGK repertoire 
resulting in the accumulation of unused productive gene rearrangements. The profile is 
complex however due to forward and reverse transcription orientations of the IGKV gene 
segments relative to IGKJ gene segments on the chromosome. To understand editing and 
segment selection further, comparison to other groups of sequences was made. 
As non productive gene rearrangements are not translated into protein, their presence does 
not influence the fate of the B cells expressing them. Hence, analyses of non productive 
gene rearrangements permit an assessment of the inherent biases in rearrangement that 
contribute to the composition of repertoire. If this assumption is correct, then both sets of 
independently derived non productive rearrangements of IGK from IGK or IGL expressing B 
cells should resemble each other. Consistent with this, frequencies of gene rearrangements 
of IGKV gene segments were similar in the cells irrespective of surface light chains. The only 
exception was IGKV1-5 which was found to be significantly more in IGK expressing B cells.  
It was found that IGKV gene rearrangements in the proximal cluster tend to rearrange more 
frequently. The most common rearranged gene segments in order of their abundance were 
found to be IGKV4-1, IGKV3-11, IGKV1-39, IGKV3-20 IGKV1-33, IGKV1-5, IGKV5-2, 
IGKV3-7, IGKV1-37, and IGKV3D-11. IGKV3D-11 was the only rearranged gene from the 








Figure 4-12: Analysis of IGKV segments usage. Comparison of relative rearrangement frequencies of IGKV gene segments in the non-
productively rearranged DNA (IGKV-IGKJ) of mature naïve B cells expressing either IGK or IGL. Chi squared test was performed to compare 
the gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 were considered significant (*). It was found that gene segment IGKV1-5 
was significantly rearranged more in the IGK expressing B cells. All other IGKV gene segments were found to be rearranged at similar frequencies. 
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4.2.4 Is there any selection for or against IGKV gene segments? 
The decision to rearrange the IGL locus is generally considered to be made once the gene 
rearrangement at the IGK locus is unsuccessful on both maternal and paternal alleles. 
However, productive gene rearrangements of IGK locus have been identified in IGL 
expressing B cells in this study (Figure 4-5) and previously, therefore it was considered that 
aberrant productive rearrangements of IGK derived from IGL expressing B cells have been 
selected against during B cell development.  
The relative usage of IGKV families and IGKV gene segments was compared between 
productive gene rearrangements from IGK expressing naïve cells with aberrant productive 
gene rearrangements from IGL expressing naïve B cells. It was found that there were 
significantly more rearrangements involving IGKV5 gene family in the aberrant productive 
rearrangements. However, there was no difference in the frequency of rearrangements of 
other IGKV gene families (Figure 4-13). 
 
Figure 4-13: Distribution of IGKV gene families. Comparison of relative rearrangement 
frequencies of IGKV gene families between productive and aberrant productive DNA 
gene rearrangements of mature naïve B cells expressing either IGK or IGL. Chi 
squared test was performed to compare the gene frequencies with Bonferroni post hoc test 
and p values with ≤ 0.05 were considered significant (*). Significantly more productive 
rearrangements utilizing IGKV5 family were found in IGL expressing mature naïve B cells. 
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In terms of gene rearrangement frequencies of IGKV gene segments it was found that three 
IGKV gene segments, IGKV3D-11, IGKV1-37 and IGKV5-2 were significantly more frequent 
in the aberrant productive rearrangements suggesting that they were selected against 
(Figure 4-14). Productive rearrangements of IGKV gene segments such as IGKV1-39, 
IGKV3-15, IGKV3-11 and IGKV1-5 were significantly more frequent in IGK expressing B 
cells. This could imply that there is bias in the favour of these IGKV gene segments 
(selected for). 
To investigate this further, the frequencies of these IGKV gene segments in the non 
productive rearrangements, productive, aberrant productive and used sequences in cDNA 
were compared (Figure 4-15). Also included was IGKV3-7 that is known to be defective due 
to a non functional splice acceptor site and IGKV4-1 that appeared to be selected against by 
comparison of cDNA and productive gene rearrangements in DNA. It was found that gene 
rearrangements involving segments IGKV3D-11, IGKV1-37 and IGKV5-2 were more in the 
productive gene rearrangements of IGL expressing B cells than IGK expressing B cells. 
Furthermore, the gene rearrangements involving these segments were not found in the 
cDNA. However, the frequencies of gene rearrangements involving IGKV4-1 were similar in 
the IGK and IGL expressing B cells but cDNA was significantly reduced. 
On the other hand, gene segments that were selected for (IGKV1-39, IGKV3-15, IGKV3-11 
and IGKV1-5) were more in the productive gene rearrangements and cDNA of IGK 





Figure 4-14: Analysis of IGKV segments usage. Comparison of relative rearrangement frequencies of IGKV gene segments in the productively 
rearranged DNA of mature naïve B cells expressing either IGK or IGL. Chi squared test was performed to compare the gene frequencies with Bonferroni 
post hoc test and p values with ≤ 0.05 were considered significant (*). Gene segment IGKV1-39, IGKV3-15, IGKV3-11, were significantly more productively 
rearranged in IGK expressing mature naïve B cells. Gene segments IGKV3D-11, IGKV1-37 were significantly rearranged more productively in the DNA of IGL 








































































































































































































































































































































































































































































































Productive DNA gene rearrangements from IGK-expressing
Productive DNA rearrangements from IGL-expressing



























Figure 4-15: Analysis of IGKV gene segments (IGKV3D-11, IGKV5-2, IGKV1-37, IGKV3-
7 and IGKV4-1) selected against during rearrangement at IGK locus. Chi squared test 
was performed to compare the gene frequencies with Bonferroni post hoc test and p values 
with ≤ 0.05 were considered significant (*). However, IGKV3D-11, IGKV5-2, IGKV1-37 and 
IGKV3-7 were more in the productive rearrangements of IGL expressing B cells. 
Furthermore, these rearrangements were not found in the expressed repertoire. There was 
no difference in the rearrangement frequencies of IGKV4-1 between IGK and IGL 















































































































































































































































































































































































































Figure 4-16: Analysis of IGKV gene segments (IGKV3-11, IGKV3-15, IGKV1-39, and 
IGKV1-5) selected during rearrangement at IGK locus. Chi squared test was performed 
to compare the gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 
were considered significant (*). Frequencies of non productive gene rearrangements indicate 
all segments were frequently rearranged. However, there were significantly more productive 
rearrangements in IGK expressing than IGL expressing B cells. Furthermore, these 














































































































































































































4.2.5 Is there any difference in the characteristic of CDR-3 region of aberrant 
productive, productive and expressed repertoire?  
The CDR-3 region encompasses the junction of IGKV-IGKJ region. It contributes to 
determination of the antigenic specificity. It has been found that after antigenic selection 
shorter CDR-3 is selected. Longer CDR-3s have been found to be associated with DNA 
binding autoantibodies. In this section CDR-3 characteristics of the non productive, 
productive, aberrant productive and expressed DNA gene rearrangements were compared 
to see if selection is apparent in this data. It was hypothesized that there might be a 
difference in the CDR-3 characteristics of the aberrant productive rearrangements that could 
potentially affect antigen recognition or subsequent pairing with IGH negatively. The 
following features of CDR-3 were compared: 
1. CDR-3 length 
2. Relative distribution of number of amino acids 
3. GRAVY indices 
4. Isoelectric points 














4.2.5.1 CDR-3 length (amino acids) 
The mean length of CDR-3 region was compared among non productive, aberrant 
productive, productive and expressed gene rearrangements. The mean length of CDR-3 
was found to be 8.4 amino acids, 8.9 amino acids, 9.3 amino acids and 9.2 amino acids in 
the non productive, aberrant productive, productive and expressed gene rearrangements 
(Figure 4-17). The CDR-3 length of non productive and aberrant productive rearrangements 
was significantly shorter than productive and expressed gene rearrangements.  
 
Figure 4-17: The mean CDR-3 length of non productive, aberrant productive, 
productive and expressed DNA rearrangements. Non parametric tests were used to 
compare the means. The CDR-3 length of non productive and aberrant productive gene 
rearrangements was significantly shorter than productive and expressed gene 
rearrangements. 
4.2.5.2 Relative distribution of number of amino acids 
The physicochemical properties of proteins are affected by the number of amino acids in the 
CDR-3 region. Therefore the relative distribution of the number of amino acids in different 
sets of gene rearrangements was compared. It was found in the aberrant productive DNA 
gene rearrangements that there were some differences in the relative proportion of  different 
number of amino acids. The mean CDR-3 length was found to be 9 amino acids in the 








































































aberrant productive rearrangements there were more sequences that were larger or shorter 
than this (Figure 4-18). 
 
 
Figure 4-18: The relative distribution of amino acids in the non productive, aberrant 
productive, productive and expressed DNA gene rearrangements. 
There was a difference in the relative proportion of CDR-3 amino acids in the expressed and 
aberrant productive rearrangements. Therefore, ensuing CDR-3 characteristics were 
compared according to the number of amino acids (8, 9, 10, 11 amino acids) because these 




































































































































4.2.5.3 GRAVY indices 
GRAVY index indicates the solubility of the proteins. Positive values indicate a protein is 
hydrophobic while negative values indicate a hydrophilic protein. The GRAVY index is 
calculated by adding the hydropathy value for each residue and dividing by the length of the 
sequence (Kyte and Doolittle 1982). Due to variation in the proportion of amino acids in the 
aberrant productive, productive and expressed repertoire GRAVY indices were compared for 
each group (8, 9, 10,11 amino acids). In the group of 8, 9 and 10 amino acids there was no 
difference in the GRAVY indices. However, in the group of CDR-3 consisting of 11 amino 
acids the GRAVY index (more hydrophilic) of the productive and expressed repertoire was 
significantly lower (Figure 4-19). 
 
 
Figure 4-19: The GRAVY indices of CDR-3 regions having 8, 9 10 and 11 amino acids. 
ProtPram was used to determine the aliphatic index of the CDR-3 region and the grand 
average hydropathy (GRAVY) index. Non parametric tests were used to compare the 






















































































































































































































































































































4.2.5.4 Isoelectric point 
The isoelectric point is the pH at which a particular molecule or surface carries no 
net electrical charge.  The net charge on the molecule is affected by the pH of its 
surrounding environment and can become more positively or negatively charged due to the 
gain or loss, of protons respectively. Immunoglobulins vary in their isoelectric points ranging 
within pH 4 to 9. Isoelectric points were compared among aberrant productive, productive 
and expressed repertoire for each group of amino acids in CDR-3. No significant differences 




Figure 4-20: The isoelectric point of CDR-3 regions having 8, 9 10 and 11 amino acids. 
Non parametric tests were used to compare the means. No significant differences were 











































































































































































































































































































4.2.5.5 Aliphatic indices 
The aliphatic index of a protein is defined as the relative volume occupied by aliphatic side 
chains (alanine, valine, isoleucine, and leucine). It may be regarded as a positive factor for 
the increase of thermostability of globular proteins. Aliphatic indices were compared for each 
group of CDR-3 amino acid lengths (8, 9, 10 and 11). It was found that irrespective of the 
CDR-3 length, aliphatic indices of productive and expressed repertoire were less than the 




Figure 4-21: The aliphatic indices of CDR-3 regions having 8, 9, 10 and 11 amino 
acids. Non parametric tests were used to compare the means. Significant differences were 
observed irrespective of CDR-3 lengths. Aberrant productive gene rearrangements have a 



















































































































































































































































































































4.3.1 The rearrangement frequency of IGKV4-1 differs between DNA and the 
expressed repertoire 
In this chapter, productive rearrangements of IGK were compared between DNA and the 
expressed cDNA in the same sorted population of IGK expressing mature naïve B cells. It 
was found that gene segment IGKV4-1 was abundantly rearranged in the DNA but 
significantly reduced in the expressed repertoire and this segment was the only with these 
properties. This was initially considered to be surprising since productive rearrangements 
encode the expressed repertoire. The possibility that this could be an artefact due to PCR 
protocols used for DNA and cDNA was considered. It was thought unlikely however, since 
the same set of variable region primers were used for both PCR reactions.  
The gene segment IGKV4-1 was found to be consistently abundantly rearranged in the DNA 
of all individuals. Some molecular and topological features may tend to favour the relatively 
high rearrangement frequency of IGKV4-1 in the DNA. The gene segment IGKV4-1 is 
present in the inverted orientation and is in very close proximity to the IGKJ gene segments 
(Foster, Brezinschek et al. 1997). Germline transcripts of IGKV4-1 have been found in pre B 
cells and fetal bone marrow cells implying that this segment is readily available for 
recombination (Martin, Huang et al. 1991).  
Previously gene segment IGKV4-1 has been reported to be over represented in the B cells 
that were in the process of receptor editing (Meffre, Davis et al. 2000). The ligated receptor 
may stimulate further gene rearrangements that replace previous receptor genes on the 
same allele. Several secondary gene rearrangements are possible on the same allele unless 
the cell gets exhausted after the deletion of the most downstream IGKJ5 gene segment 
(Bergman and Cedar 2004). 
The gene segment IGKV4-1 has also been implicated in the expressed repertoire of some 
autoimmune diseases such as diabetes and SLE (Dorner, Foster et al. 1998, Woodward and 
Thomas 2005). Therefore, it is quite possible that IGKV4-1 is abundantly rearranged due to 
its accessibility and proximity to the IGKJ segments but it might not pass selection criteria 
and this can lead to the receptor editing. 
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The inverted transcriptional orientation of IGKV4-1 could favour the accumulation of the 
rearrangements as inverted DNA on the same chromosome. For example if the primary 
productive gene rearrangement takes place between IGKV4-1 and IGKJ2 gene segments 
then it would result in the inversion of  intervening DNA (as depicted by the inversion of 
IGKJ1 in Figure 4-22). If for some reason, primary potentially productive IGKV4-1-IGKJ2 
rearrangement is selected against then there could be two further possibilities: 
1. The downstream IGKJ gene segments (IGKJ3, IGKJ4 or IGKJ5) can rearrange with any 
upstream IGKV gene segment of proximal cluster. It will result in the deletion of 
intervening DNA including productive joint IGKV4-1-IGKJ2 rearrangement. The deleted 
part is retained as an episome. Rearranged IGKV4-1-IGKJ2 could be amplified from the 
naïve B cells (Figure 4-22A). 
 
2. An inverted gene segment IGKJ1 still retains the capability to rearrange with any 
upstream IGKV gene segment by inversion. In this way the secondary gene 
rearrangement and primary selected against IGK4-1-IGKJ2 rearrangement can be 
retained on the same chromosome (Figure 4-22B). Consequently, 2 rearrangements 
































Figure 4-22: Theoretical accumulation of gene rearrangements of IGKV4-1 that have 
been selected against by editing. The arrows indicate the transcriptional orientation of 
various gene segments. (A) The primary non selected gene rearrangement between IGKV4-
1 and IGKJ2 may be followed by the secondary gene rearrangement of an upstream IGKV1-
5 and downstream IGKJ4. This results in the deletion of intervening DNA but retained as an 
episome within a cell. (B) The primary gene rearrangement between IGKV4-1 and IGKJ2 
may be followed by the secondary gene rearrangement of upstream IGKV1-5 and inverted 
IGKJ1 gene segment. This results in the retention of secondary gene rearrangement 
between IGKV1-5 and IGKJ1. Various productive and unselected productive gene 
rearrangements can be amplified from one chromosome and not distinguished by PCR.  
IGKJ-3 IGKJ-1 
Primary gene rearrangement 
IGKV1-5 IGKV4-1 IGKJ-2 IGKJ-4 IGKV1-6 IGKJ-5 
IGKJ-5 IGKJ-4 IGKJ-3 IGKJ-2 IGKV4-1 IGKJ-1 IGKV1-5 IGKV1-6 
Primary gene rearrangement (selected against) 
Secondary gene 
rearrangement 













IGKJ-1 IGKJ-5 IGKJ-4 IGKJ-3 IGKJ-2 IGKV4-1 IGKV1-5 IGKV1-6 
Primary gene rearrangement 
IGKJ-1 IGKJ-5 IGKJ-4 IGKJ-3 IGKJ-2 IGKV4-1 IGKV1-5 IGKV1-6 
Primary gene rearrangement (selected against) 
Secondary gene rearrangement 
Primary gene rearrangement (selected against) 
 
IGKJ-5 IGKJ-4 
Productive (Selected gene rearrangement) 









In either case multiple selected against productive and productive coding joints would 
remain inside the cell and could potentially be detected by PCR. After all possible gene 
rearrangements on one allele, the process of gene rearrangements can be initiated on the 
second allele. Rearrangements of IGKV4-1 could also accumulate in a cell if they were not 
favoured when rearranged on the first allele so that the cell moves on to rearrange the 
second allele. 
Overall and despite the mechanism, higher frequency of IGKV4-1 in the DNA versus cDNA 
suggests selection against and use of this segment.  
4.3.2 The gene segments IGKJ5 is abundantly rearranged in the DNA but IGKJ4 is 
predominant in the expressed repertoire 
There were some differences in the relative usage of IGKJ gene segments between the 
productive and expressed repertoire. It was found in the productive gene rearrangements 
that there was a significant bias towards usage of IGKJ5 while the expressed repertoire was 
skewed towards IGKJ4 usage. This trend was consistent among all individuals. The same 
pattern was found when usage of IGKJ genes was compared in different IGKV families 
between DNA and cDNA. The most commonly used IGKJ segments were IGKJ1 and IGKJ2 
followed by IGKJ4 and IGKJ5 respectively. The least used segment was IGKJ3. This pattern 
of IGKJ usage in the expressed repertoire is consistent with previous studies (Gay, 
Saunders et al. 1993, Weber, Blaison et al. 1994, Collins, Wang et al. 2008). 
Conventionally usage of upstream IGKJ gene segments suggests receptor editing (Foster, 
Brezinschek et al. 1997). However, this might not be reflected at the IGK locus. The IGK 
locus includes genes in both forward and reverse orientations and gene rearrangements 
with reverse transcriptional orientation can be retained on the same chromosome (Zheng, 
Wilson et al. 2004). These rearrangements can simultaneously be inactivated by the KDE 
(Graninger, Goldman et al. 1988, Vela, Ait-Azzouzene et al. 2008). On the other hand, gene 
rearrangements involving IGKV gene segments having forward orientation result in the 
deletion of intervening DNA as an episome that is retained by the cell.  
There could be a technical reason that can generate bias in IGKJ usage. For the 
amplification of genomic and cDNA, the same IGKV primers were used for the 5’ end. 
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However, for the 3’ end IGKJ and IGKC primers were used for DNA and cDNA respectively. 
This could affect IGKJ usage but not IGKV. 
4.3.3 There are some inherent biases in the tendency of segments to rearrange at 
IGK locus 
Non productive gene rearrangements are not influenced by any preimmune selection 
pressure and can predict base level of gene rearrangements. There was no difference in the 
non productive gene rearrangements at IGK locus irrespective of the surface BCR except 
relative usage of IGKV1-5. The gene segment IGKV1-5 was found more in the 
rearrangements from the cell expressing IGK chain and it was consistent among all three 
individuals.  
The data indicates that IGKV genes in the proximal cluster tend to rearrange more frequently 
and this is consistent with other studies (Foster, Brezinschek et al. 1997, Jackson, Kidd et al. 
2013). The distal cluster is in the inverted orientation and inversional gene rearrangement 
may be less efficient than the deletional gene rearrangement which may affect the 
rearrangement frequencies (Gauss and Lieber 1992). Several molecular mechanisms have 
been reported that may affect non random utilization of IGKV genes such as distance of 
IGKV genes from IGKJ segments, transcriptional orientation, efficiency of transcription, 
promoter strength, enhancer activity, spacer length and sequence, RSS efficiency and 
accessibility of individual segments to recombination machinery (Nadel, Tang et al. 1998, 
Feeney, Tang et al. 2000). Recently it has been found that accessibility of immunoglobulin 
genes is determined by the post translational epigenetic modifications of regional histone 
cores. Acetylation of histones has also been correlated with a bias in IGK gene 
rearrangements (McMurry and Krangel 2000, Spicuglia, Franchini et al. 2006). Furthermore, 
accessibility to recombination correlates with transcription. The transcription factors STAT5 
and E2A have been implicated to increase the accessibility of IGK locus (Mandal, Powers et 
al. 2011). However, the precise relationship between IGK recombination and transcription is 





4.3.4 Selection pressures shape IGK repertoire in mature naïve B cells 
Generally gene rearrangement proceeds to IGL locus after failure to produce a successful 
rearrangement at IGK locus. The data presented show 25% IGK gene rearrangements in 
IGL expressing B cells were technically productive (aberrant) gene rearrangement. The 
presence of such non functional productive IGK gene rearrangements has been found in 
humans and mice previously (Retter and Nemazee 1998, Brauninger, Goossens et al. 
2001). Since these rearrangements were not used by the cell but instead a decision was 
made to start rearrangement at IGL locus these rearrangements were classified as aberrant 
productive and selected against.  
Gene segments IGKV3D-11, IGKV1-37, IGKV1-27 IGKV3-7 and IGKV5-2 were selected 
against during the development of IGK repertoire. The rearrangements involving these 
segments were significantly more frequent in the productive gene rearrangements of IGL 
expressing B cells than IGK expressing B cells. Two other gene segments, IGKV1-27 and 
IGKV3-7 were also more in the productive rearrangements of IGL expressing B cells 
although this was not statistically significant.  
The gene segment IGKV1-27 has a defective RSS due to a single base pair substitution at 
the 4
th
 position of heptamer (Lautner-Rieske, Huber et al. 1992). The gene segment IGKV1-
37 is structurally defective in that it encodes glycine in place of cysteine at position 88. The 
gene segment IGKV3-7 is defective in acceptor splice site (Pargent, Meindl et al. 1991). This 
suggests that structural abnormality or mutation in the regulatory elements can render 
productive rearrangement as non functional or aberrant. However, it is not known which 
particular factors are responsible for not selecting the gene rearrangements involving 
IGKV5-2 and IGKV3D-11.  The gene segments which appeared to be selected against were 
not found in the cDNA which further emphasizes the rejection of these rearrangements 
during selection. 
Gene segments IGKV3-11, IGKV3-15, IGKV3-20, IGKV1-39 and IGKV1-5 appeared to be 
selected for during rearrangement. The gene rearrangements involving these segments 
were significantly more in the productive gene rearrangements derived from IGK expressing 
B cells than IGL expressing B cells. Over representation of these segments in the productive 
182 
 
and expressed gene rearrangements is consistent with previous studies (Foster, 
Brezinschek et al. 1997, Collins, Wang et al. 2008, Jackson, Kidd et al. 2013). In addition to 
this, the comparison of productive and expressed gene rearrangements revealed IGKV3-20 
and IGKV3-15 were more in the cDNA than DNA. When different individuals were analyzed 
separately all showed the trend of more utilization of IGKV3 family in the expressed 
repertoire than DNA. These findings suggest that biased appearance of these segments 
may be related to the events after rearrangement at the IGK locus and is therefore 
dependent on the expression of IGK on the cell surface. Subtle differences in the 
transcription rates that may occur could also play a role in the over representation of these 
segments in cDNA, but it is not known if this is a feature of the expressed repertoire (Foster, 
Brezinschek et al. 1997).  
4.3.5 Differences in the CDR-3 region 
In addition to changes in the repertoire of IGKV and IGKJ segments usage, there were also 
some differences in the CDR-3 region in the groups of sequences studied. During 
rearrangement, the junction of IGKV and IGKJ is modified due to the activity of 
exonucleases and transferases. The CDR-3 region is the major determinant of antigen 
specificity and the shorter CDR-3 lengths have been associated with the selection of 
memory B cell population after GC reaction. However, longer CDR-3 lengths of IGH have 
been implicated in some pathological states (Aguilera, Melero et al. 2001, Miqueu, Guillet et 
al. 2007, Wu, Kipling et al. 2010). The mean CDR-3 length in the productive and expressed 
gene rearrangements was found to be 9 amino acids (27 nucleotides). Consistent with this, 
several previous studies have found that the CDR-3 regions of expressed human IGK are 
usually 27 nucleotides in length (Bridges, Lee et al. 1995, Tomlinson, Cox et al. 1995, 
Foster, Brezinschek et al. 1997). On the other hand, mean CDR-3 length of non productive 
and aberrant productive rearrangements was shorter than productive and expressed gene 
rearrangements significantly. Previously no difference was found between the CDR-3 length 
of productive and non productive gene rearrangements which is inconsistent with our 





Overall, the data in this chapter identifies gene segments that are selected for and against 
during B cell development in the bone marrow when fate decisions are made whether to 
express a functionally rearranged IGK gene or move on to rearrange the IGL locus. Gene 
segments IGKV3D-11, IGKV1-37, IGKV1-27, IGKV3-7 and IGKV5-2 are clearly selected 
against at this point. Gene segment IGKV5-2 is selected against, but this has not been 
reported previously. Gene segments IGKV3-11, IGKV3-15, IGKV3-20, IGKV1-39 and 
IGKV1-5 appear to be favoured in the used repertoire. Gene segment IGKV4-1 is very 
interesting because it appears to be frequently rearranged but selected against as it is 
significantly reduced at the time of expression.  IGKV4-1 has been linked with autoimmune 
diseases such as SLE where it appears to be over represented, and it is possible that 
breakage of the mechanisms that normally select this segment could be associated with the 
pathogenesis of autoimmune diseases. Based on the objectives of this chapter, following are 
the concluding points: 
1. The expressed repertoire of IGKV gene repertoire can be different from the 
productive gene rearrangements in DNA due to retention of unused gene 
rearrangements. 
2. The expressed repertoire of IGKJ gene repertoire can be different from the 
productive gene rearrangements in DNA. 
3. The inherent biases at the IGK locus are similar in IGK and IGL expressing B cells. 
4. Gene segments IGKV3D-11, IGKV1-37, IGKV1-27 IGKV3-7 and IGKV5-2 are 
selected against while gene segments IGKV3-11, IGKV3-15, IGKV3-20, IGKV1-39 
and IGKV1-5 are selected for at the IGK locus.  
5. The CDR-3 characteristics of aberrant productive gene rearrangements are different 








Immunoglobulin heavy chain variable region of 
mature naïve B cells expressing either kappa or 
lambda light chain 
5.1 Introduction 
It is known that there is non-random usage of IGHV, IGHD and IGHJ gene segments in VDJ 
rearrangements of IGH expressed by human B cells. In the mature naïve B cell repertoire 
different IGHV gene segments are used with frequencies that range approximately from as 
little as 0.1% to 10% of all rearrangements (Boyd, Gaeta et al. 2010, Glanville, Kuo et al. 
2011). Also, some gene segments tend to be used with approximately equivalent 
frequencies in different individuals, for example gene segment IGHV1-46 is apparent in 
around 3% of rearrangements, IGHV3-21 in around 5% and IGHV3-49 in around 1% (Boyd, 
Gaeta et al. 2010, Briney, Willis et al. 2012, Watson and Breden 2012). Biased usage has 
also been reported for IGHD gene segments where IGHD3-22 and IGHD4-4/11 are the most 
frequently used segments (Benichou, Glanville et al. 2013). Usage of IGHJ segments is also 
skewed with IGHJ4 and IGHJ6 being the most commonly used IGHJ gene segments (Volpe 
and Kepler 2008, Larimore, McCormick et al. 2012, Watson and Breden 2012).  
Various factors are known to contribute to variability in IGH gene segment usage. It has 
been found in a murine model that IGHV gene segments that are proximal to the IGHD gene 
segments are rearranged preferentially (Yancopoulos, Desiderio et al. 1984). It has been 
reported in the human fetal liver there are some biases in the usage of IGHV, IGHD and 
IGHJ gene segments depending upon their proximity on the chromosome. For example 
IGHV6-1 gene segment which is close to the IGHD gene segments on the chromosome tend 
to rearrange more frequently. Similarly the IGHDQ-52 gene segment which is close to the 
IGHJ gene segments rearranges preferentially (Jung, Giallourakis et al. 2006, Schelonka, 
Szymanska et al. 2010). Various factors that may affect the preferential rearrangement of 
IGHV gene segments include the RSS strength associated with each segment that is 
determined by the actual sequence of the RSS and also differential accessibility of individual 
IGHV gene segments that is defined by local transcriptional activity (Jung, Giallourakis et al. 
2006). The proximal gene segments are more accessible to the RAG proteins. It has been 
found that variations in the canonical RSS can decrease the efficiency of gene 
rearrangement that in turn decreases the frequency at which a gene segment is chosen for 
the rearrangement process (Jung, Giallourakis et al. 2006).  Transcription factor Pax5 is 




the IGHV gene rearrangements. It regulates promoter contraction at IGH locus and mediates 
recombination of distal IGHV gene segments with rearranged IGHDJ gene segments. (Fuxa, 
Skok et al. 2004, Venigalla, McGuire et al. 2013). 
 Analysis of gene rearrangements taking place in the bone marrow during human B cell 
development indicates that non random usage of different IGH gene segments starts at an 
early stage. In early pre B cells when there is no surface Ig receptor, IGHV3-23, IGHV4-34 
and IGHV4-59 dominate in the repertoire. In late pre B cells productively rearranged heavy 
chains pair with surrogate light chain and are expressed as pre BCR (Geier and Schlissel 
2006, Meng, Yunk et al. 2011). It has been found that there are differences in the ability of 
different IGH gene segments to pair with surrogate light chain. Some IGH transcripts form 
stable complexes with surrogate light chain and preferentially proliferate. In this way 
additional biases in the usage of IGH gene segments are generated that are independent of 
the cellular ligands and antigens (Rao, Riggs et al. 1999, Meng, Yunk et al. 2011). However, 
it is not known if properties of the rearranged IGH influence subsequent binding to either IGK 
or IGL light chain and if this would affect the final IGH repertoire.  
After successful VDJ gene rearrangement at the IGH locus, the light chain locus starts to 
rearrange IGKV and IGKJ gene segments first at the IGK locus and if this is not successful 
then at the IGL locus. After successful gene rearrangement of either light chain, IGH protein 
is expressed on cell surface with either IGK or IGL as a mature BCR. In order to maintain 
central tolerance and immunocompetency, BCRs are then exposed to ligands in the bone 
marrow that results in positive or negative selection of cells (von Muenchow, Engdahl et al. 
2014). In this way certain IGHV gene segments are selected for or against in the repertoire.  
For example, in one study it was found that the IGHV3-11 gene segment was well 
represented at the pre B cell stage but not in the mature naïve B cells. On the other hand, 
IGHV3-20 gene segment was well represented in the mature naïve B cells but not in pre B 
cells (Kraj, Rao et al. 1997). This implies that certain IGHV, IGKV and IGLV genes are 
selected according to their specificities. This shows that biases in IGH gene segments usage 
can be generated at different stages of B cell development. However, it is not known if there 




expressing either IGK or IGL light chains. Structurally, BCRs have both conserved FR and 
less-conserved CDRs. CDR-3 encompasses the junctions of rearranged IGH VDJ genes. As 
a consequence, the CDR-3 of IGH is highly variable in its physicochemical properties. Acidic 
and basic amino acids encoded by the CDR-3 sequence can affect the thermostability 
(Aliphatic index) and hydrophobicity (GRAVY index) of BCR. However, it is not known if the 
physicochemical properties of IGH peptide acquired during rearrangement can favour 
pairing of IGH with either IGK or IGL. 
5.1.1 Aims of this chapter 
It is not known if the properties of VDJ rearrangement at IGH locus influence the subsequent 
pairing with IGK or IGL. The aims of the investigation in this chapter were to ask: 
1. Is there any preference for productively rearranged IGH having particular IGHV, 
IGHD or IGHJ gene segments to be expressed with IGK or IGL light chains? 
2. Do physicochemical properties of CDR-3 region of IGH influence preferential pairing 
with IGK or IGL light chains? 
5.2 Results 
Lymphocytes from three anonymous blood donors were used for this study. PBMCs were 
isolated, washed and stored as viable cells in liquid nitrogen. Cells for sorting were thawed 
and stained using CD19-PerCP cy5.5, CD27-APC, IgD-PE-cy7, kappa-APC-cy7, lambda-


















shown in Figure 5-1.  
The number of cells derived from each donor that were used further for RNA isolation is 
indicated in Table 5-1. 
Table 5-1: Number of mature naïve B cells isolated from individual donors. 
Donor Mature naïve B cells 
expressing IGK 
Mature naïve B cells 
expressing IGL 
HD-1 122,077 90,000 
HD-2 101,342 66,409 












Figure 5-1: Example of sorting B cell subsets into mature naïve B cells expressing 
either IGK or IGL light chain. PBMCs were stained with monoclonal antibodies and sorted 
using FACS (A) Lymphocytes were gated first (B) Doublets were excluded (C) Gated on 
alive CD19
+




 B cells (E) Gated on mature naïve B cells by 
excluding CD38
hi








) were sorted 










Sorted cells were suspended in SLyRT buffer. Superscript enzyme was added and cDNA 
was generated by reverse transcription. After reverse transcription, cDNA was stored at -
20⁰C. In order to analyze the IGH repertoire of mature naïve B cells expressing IGK or IGL, 
IGHVDJ gene rearrangements were amplified from IGVH to IGCμ by semi nested PCR. MID 
tagged primers were used in the second round of PCR to distinguish amplicons generated 
from different individual donors and from the two subsets of sorted B cells expressing IGK or 
IGL.  For this experiment six different MID tagged primers were used as follows: 
1- Healthy donor 1 
a. Mature naïve B cells expressing IGK (MID 3) 
b. Mature naïve B cells expressing IGL (MID 4) 
2- Healthy donor 2 
a. Mature naïve B cells expressing IGK (MID 7) 
b. Mature naïve B cells expressing IGL (MID 8) 
3- Healthy donor 3 
a. Mature naïve B cells expressing IGK (MID 11) 
b. Mature naïve B cells expressing IGL (MID 12) 
Raw data was received and our collaborators subjected the data to quality control as 
discussed in materials and methods (section 2.3.6.5). The number of unique IGH VDJ gene 
rearrangements from each donor is shown in Table 5-2. The number of sequences obtained 
from donor 2 was only 24 out of total 984 sequences derived from mature naïve B cells 
expressing IGK. This was a matter of concern since this could potentially bias the data when 
sequences from all individuals were pooled. This could cause artefacts since data is 
expressed as number of rearrangements of each family and the denominator for IGK and 
IGL expressing sequences was different for donor 2.  However, pooling of sequences is 
common in studies such as this one and was therefore used with the caveat that anything 






Table 5-2: Number of unique DNA sequences derived from each donor. Numbers in 
parenthesis indicate the amount (nano grams) of cDNA used to generate these sequences 
after amplification. 
Donor IGH VDJ rearrangements from 
mature naïve B cells 
expressing IGK 
IGH VDJ rearrangements from 
mature naïve B cells 
expressing IGL 
HD-1 647 (450) 627 (370) 
HD-2 24 (406) 384 (571) 
HD-3 313 (351) 178 (389) 
Total 984 1189 
 
5.2.1 Is there any preference for productively rearranged IGH having particular IGHV, 
IGHD or IGHJ gene segments to be expressed with IGK or IGL light chains? 
Variability in heavy chain peptide chain is encoded by IGHV, IGHD and IGHJ gene 
segments. 
Usage of IGHV gene families 
In order to determine if there is any preference for IGK or IGL to pair with certain IGHV gene 
families, IGHV family usage was compared between IGH genes of mature naïve B cells 
expressing either IGK or IGL. In pooled data from three individual donors, IGHV1 and IGHV2 
were found to be associated significantly more with IGL. On the other hand IGHV3 and 
IGHV6 paired significantly more with IGK.  It was found that the most frequently used IGHV 
families in both groups were IGHV3 and IGHV4 from three pooled donors followed by 
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Figure 5-2: The frequencies of IGHV family usage. Comparison of relative 
rearrangement frequencies of IGHV gene families of in the expressed repertoire of 
mature naïve B cells associated with either IGK or IGL. Chi squared test was performed 
to compare the gene frequencies with Bonferroni post hoc test and p values of ≤ 0.05 were 
considered significant (*). IGHV1 and IGHV2 families were used more frequently in IGL 
expressing B cells where as IGHV3 and IGHV6 families were used more commonly with IGK 
expressing B cells.  
If the differences in IGHV family usage are generally biologically relevant, they should be 
observed in each donor individually. Therefore, data from each donor was analyzed 
separately (Figure 5-3). IGHV1 family was found to be associated more with IGL in the two 
individuals that contributed most sequences, but this was not statistically significant in either 
case. There was a trend of more usage of IGHV2 family with IGL in all three donors but it 
was not statistically significant. IGHV3 family tended to be associated more with IGK in two 
individuals only. IGHV6 family was expressed more with IGK in one person only however, 
usage was the same in both IGK and IGL expressing mature naïve B cells in the other two 
individuals. The significant features observed in the pooled data were therefore not all 
consistent between all individuals that contributed to the data. Since some significant biases 




individual donors. Therefore, in order to better understand this, the relative usage of IGHV 




Figure 5-3: The relative frequency of IGHV family usage in three separate donors. 
Comparison of relative rearrangement frequencies of IGHV gene families of in the 
expressed repertoire of mature naïve B cells associated with either IGK or IGL. Chi 
squared test was performed to compare the gene frequencies with Bonferroni post hoc test 
and p values with ≤ 0.05 were considered significant (*). Of the differences that appeared 
significant when all three datasets were pooled, only a tendency of IGHV2 to be more 
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Usage of IGHV gene segments 
When usage of individual gene segments was analysed, some IGHV gene segments 
showed biases in preferential pairing with IGK or IGL. It was found that IGHV3-30-3 and 
IGHV6-1 gene segments were significantly associated more with the IGK. On the other 
hand, IGHV1-18 gene segment was preferentially paired with the IGL as shown in Figure 5-
4. 
 
Figure 5-4: Analysis of IGHV segments usage. Comparison of relative rearrangement 
frequencies of IGHV gene segments in the expressed repertoire of mature naïve B 
cells associated with either IGK or IGL. Chi squared test was performed to compare the 
gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 were considered 
significant (*). IGHV3-30-3 and IGHV6-1 segments were associated significantly more with 
IGK and IGHV1-18 was associated significantly more with IGL.  
If the differences in IGHV family usage are consistent and biologically relevant and not a 
consequence of the sequence numbers that affect the denominators in the pooled data 
differently for IGK and IGL, they should be observed in each donor individually. Therefore, 
each individual was analyzed separately to look for biases in preferential pairing of IGHV 
segments with light chains (Figure 5-5). Significant biases in IGHV gene usage were 
observed in individuals, but these were confined only to that particular individual. Of the 
three significant differences that were observed in the pooled data, the IGHV6-1 gene 
segment was preferentially associated with IGK only in one individual while other two 
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cells. On the other hand, IGHV1-18 was found to be associated more with IGL in the two 
individuals that contributed most sequences to the overall data pool.  This reached statistical 
significance for donor 1, and may therefore be a genuine finding.  In contrast, the bias 
observed in the IGHV3-30 segment was only observed in the pooled data and not in 
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Figure 5-5: Analysis of IGHV segments usage in separate individuals (A-C). 
Comparison of relative rearrangement frequencies of IGHV gene segments in the 
expressed repertoire of mature naïve B cells associated with either IGK or IGL. Chi 
squared test was performed to compare the gene frequencies with Bonferroni post hoc test 
and p values with ≤ 0.05 were considered significant (*). There were no consistent 





Usage of IGHJ gene segments 
There are 6 IGHJ gene segments. Relative usage of IGHJ genes in the expressed repertoire 
of mature naïve B cells expressing either IGK or IGL was compared. There was no 
difference in the usage of IGHJ gene families expressed with either IGK or IGL (Figure 5-6). 
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 Figure 5-6: The frequencies of IGHJ family usage. Comparison of relative 
rearrangement frequencies of IGHJ gene families of in the expressed repertoire of 
mature naïve B cells associated with either IGK or IGL. Chi squared test was performed 
to compare the gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 
were considered significant (*). No differences were observed in the relative usage of IGHJ 
segments by IGK and IGL expressing mature naïve B cells. 
Usage of IGHD gene families 
There are 7 IGHD gene families to encode the variable region of heavy chain.  Usage of 
IGHD families in association with light chains was compared. No differences were observed 
in the usage of IGHD families of heavy chain associated with either IGK or IGL (Figure 5-7). 
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Figure 5-7: The frequencies of IGHD family usage. Comparison of relative 
rearrangement frequencies of IGHD gene families of in the expressed repertoire of 
mature naïve B cells associated with either IGK or IGL. Chi squared test was performed 
to compare the gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 
were considered significant (*). No differences were observed in the relative usage of IGHD 
gene families by IGK and IGL expressing mature naïve B cells. 
 
Usage of IGHD gene segments 
There are 23 IGHD gene segments that encode for the variable region of heavy chain. As 
noticed above there was no preference of IGL to be expressed with any particular IGHD 
family. In order to get more insight, usage of IGHD gene segments used in IGH VDJ 
rearrangements was compared from IGK or IGL expressing B cells. Frequency of usage of 
different IGHD genes in heavy chains associated with either IGK or IGL was also found to be 
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Figure 5-8: The frequencies of IGHD gene segments usage. Comparison of relative 
rearrangement frequencies of IGHD gene segments of in the expressed repertoire of 
mature naïve B cells associated with either IGK or IGL. Chi squared test was performed 
to compare the gene frequencies with Bonferroni post hoc test and p values with ≤ 0.05 
were considered significant (*). No differences were observed in the relative usage of IGHD 

















5.2.2 Do physicochemical properties of CDR-3 of IGH influence preferential pairing 
with IGK or IGL light chains? 
The gene rearrangement process generates highly diverse sequences in IGH and it was 
considered possible that certain features may favour the association with either IGK or IGL 
during B cell development. Therefore physicochemical properties of the heavy chain CDR-3 
that contain the junctional region of rearranging segments and non templated inserted 
nucleotides were analysed in B cells expressing IGK or IGL.  
CDR-3 length (Amino acids) 
The CDR-3 length in the heavy chain genes of mature naïve B cells associated with either 
IGK or IGL ranged from 8 to 25 amino acids. The average length was 15 amino acids 
(Figure 5-9). 
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Figure 5-9: Average length of CDR-3 region in different B cell subsets. Non parametric 
tests were used to compare the means. No differences were observed in the CDR-3 length 


















































N nucleotides insertion 
During the rearrangement process at the IGH locus, random nucleotides can be inserted into 
the VH-DH and DH-JH junctions mediated by TdT. The N nucleotides at both junctions were 
pooled for the analysis. There was no difference in the number of nucleotides inserted in the 
IGH associated with either IGK or IGL. N nucleotides inserted at the junctions ranged from 5 
to 30 nucleotides. The average number of nucleotides inserted at the junctions was 12 
nucleotides (Figure 5-10). 
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Figure 5-10: N nucleotides insertion in different B cell subsets. Non parametric tests 
were used to compare the means. No differences were observed in the N-nucleotides 





Aliphatic and GRAVY indices 
Aliphatic index is a measure of the relative volume occupied by aliphatic side chains (valine, 
isoleucine, and leucine) that has been regarded as a positive factor for the increase of 
thermostability of globular proteins. GRAVY index indicates the solubility of proteins (Kyte 
and Doolittle 1982). There was no difference in these indices of CDR-3 regions of IGH 
expressed with either IGK or IGL. The mean GRAVY index was -0.48 in mature naïve B 
cells expressing either IGK or IGL. The mean aliphatic index of CDR-3 of IGH associated 
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Figure 5-11: The aliphatic index (a) and GRAVY index (b) of CDR-3 regions of different 
B cell subsets. ProtPram was used to determine the aliphatic index of the CDR-3 region 
and the grand average hydropathy (GRAVY) index. Non parametric tests were used to 
compare the means. No differences were observed in the aliphatic index and GRAVY index 
of the IGH chain associated with either IGK or IGL chain. 
A. Aliphatic indices 




Amino acids at the junction 
Amino acid composition of the CDR-3 region was similar in mature naïve B subsets 
expressing either Iight chain. Negatively charged amino acids constituted up to 13% of the 

































































































Figure 5-12: Amino acids composition of CDR-3 regions. Percentage of positive and 
negatively charged amino acids was calculated in the total number of amino acids in CDR-3. 
Non parametric test was used to compare the means. No differences were observed in the 
amino acid composition of the IGH chain associated with either IGK or IGL chain. 
 
A- Negatively charged amino acids 





The aim of this chapter was to ask whether properties of the VDJ rearrangement of the IGH 
bias subsequent choice of pairing with either IGK or IGL. To answer this question, 984 IGH 
VDJ gene rearrangements expressed with IGK were compared with 1189 IGH VDJ gene 
rearrangements expressed with IGL in the mature naïve B cells isolated from three healthy 
individuals. Essentially no consistent robust bias in pairing of IGH VDJ rearrangements with 
either IGK or IGL was observed.   
Analysis of the pooled data from three individual donors revealed some differences in the 
usage of IGHV gene families in the IGH repertoire expressed with either IGK or IGL. IGHV3 
and IGHV6 families were found to be expressed more with IGK on the other hand IGHV1 
and IGHV2 were preferentially expressed more with IGL. In order to understand this better, 
usage of different IGHV gene segments was compared. It was found that IGHV3-30-3 and 
IGHV6-1 gene segments were expressed more with IGK while IGHV1-18 gene segment 
preferentially paired with IGL. However, most of these findings were not consistent when 
individuals were analyzed separately. The one exception was considered to be a possible 
bias towards pairing of IGHV1-18 in B cells using IGL. Evidence for such a bias was 
therefore sought in data from other groups.  A study from Wardemann et al., (Wardemann, 
Yurasov et al. 2003)  was able to identify heavy and light chain pairings in individual B cells 
by analysis of heavy and light chain sequences from single cells (Figure 5-13). When 
supplementary data from this paper was analyzed a slight bias towards the association of 
IGHV1-18 with IGL was observed. However, IGHV1-18 was not a commonly used segment 
in this dataset. Overall this indicates that preferential pairing of IGHV gene segments with 
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Figure 5-13: Analysis of supplementary data from Wardemann et al., (Wardemann, 
Yurasov et al. 2003) of single cells showing relative IGH gene usage by IGK and IGL 
gene segments. Comparison of relative rearrangement frequencies of IGHV gene 
segments in the expressed repertoire of mature naïve B cells associated with either 
IGK or IGL. Chi squared test was performed to compare the gene frequencies with 
Bonferroni post hoc test and p values with ≤ 0.05 were considered significant (*). 
It is interesting that individual donors had significant tendencies to associate IGHV gene 
segments with IGK and IGL such as gene segment IGHV6-1 was significantly associated 
with IGK in one individual but in other two individuals there was no difference. Similarly 
IGHV3-23 gene segment was significantly associated more with IGK in one of the 
individuals. IGHV3-13 was also significantly associated with IGK in one individual while this 
segment was negligible in the expressed repertoire of other two individuals. Gene segment 
IGHV1-18 was found to be expressed more with IGL in two individuals. These differences in 
expression might reflect the selection of specific gene rearrangements in the expressed 
repertoire as this experiment was done using cDNAs rather than bias in the rearrangement 
process. There was a limitation in the data set that for one of the individuals (HD-2) number 
of sequences were not balanced between IGK and IGL as described in results section. 
IGHD gene usage was also compared between IGH expressed with either IGK or IGL. The 
most frequently used family was IGHD3 followed by IGHD6 and IGHD2. However, there was 
no difference in the usage of IGHD family or individual gene segments in the IGH expressed 




IGHD gene segments was compared. The most commonly used IGHD segments were 
found to be IGHD3-10, IGH6-13, IGHD6-19, IGHD3-22 and IGHD1-26. However, IGHD 
gene segments were found to be used at the similar frequencies in IGH expressed with any 
light chain. IGHJ usage was compared between IGH expressed with different light chains. 
The most commonly used IGHJ family was IGHJ4 followed by IGHJ6 and IGHJ3. But there 
was no difference in the frequencies of usage of IGH expressed with either IGK or IGL. This 
implies that there is no influence of IGH VDJ repertoire in the selection of light chain during 
the course of B cell development. 
The non templated junctional N and P nucleotides make a major contribution to the 
physicochemical properties of the CDR-3. It was therefore considered possible that certain 
physicochemical features could favour association with either IGK or IGL. However, there 
was no difference in the junctional properties such as CDR-3 length, amino acid 
composition, N- nucleotides insertion, and hydrophobicity and thermostability indices.  
The literature shows that in some malignancies, antigens can select certain combinations of 
rearranged genes that can result in some biases in the expressed repertoire.  In one study 
on CLL patients it was found that preferential pairing is determined by conserved CDR-3 
region of IGH such as IGHD2-2/IGHJ6 encodes CLL69B motif that preferentially binds to the 
IGKV1-39. In other cases IGHD2-2/IGHJ6 encodes motif CLL69D that binds with IGKV3-1 
and IGHD3-3/IGHJ6 encodes CLL69C that preferentially binds IGL3-9. In another study it 
was found IGHV3-21 is dominant and preferentially rearranged with IGL2-14 and IGLJ3. The 
finding of combined use of one certain IGH and light chain gene indicates that these 
segments have been preferentially rearranged in this cohort of CLL patients due to antigen 
mediated selection (Stamatopoulos, Belessi et al. 2005, Widhopf, Goldberg et al. 2008). 
However, this is not a feature of normal healthy B cells. 
After the IGH peptide passes the checkpoint at pre BCR stage then gene recombination 
starts at the IGK locus. If the rearrangement is not successful at both IGK alleles then it 
results in the deactivation of IGK locus by KDE which allows the deletion of non functional 






Data in this chapter indicates that only non functionality at the IGK locus leads to gene 
rearrangement at the IGL locus. Following are the concluding points of this chapter: 
1. There is no preference for productively rearranged IGH having particular IGHV, 
IGHD or IGHJ gene segments to be expressed with either IGK or IGL light chains. 
However, some biases may exist on individual basis.  
2. The physicochemical properties of CDR-3 region of IGH do not influence preferential 











































Overall in this thesis, some features of light chain gene rearrangements have been 
highlighted in the context of gene selection during B cell development. The following are the 
salient features: 
1. Data in this thesis has identified that a cell can carry multiple gene rearrangements 
of light chain that can appear functional according to IMGT that may not be used. 
Solely investigation of gene rearrangements at the DNA level is not sufficient to 
provide an evidence of positive and negative selection of gene segments into the 
selected repertoire. Within each cell multiple DNA gene rearrangements can be 
retained. Some of these DNA gene rearrangements would potentially be expressed 
to constitute the BCR, however, if DNA gene rearrangements had been selected 
against during development then there could also have been the accumulation of 
these unused DNA gene rearrangements within a cell. However, such potentially 
expressed and unused DNA gene rearrangements cannot be differentiated after 
amplification by PCR because IMGT would display a productive CDR-3 junction for 
both and that can be misleading in the context of selection in the expressed 
repertoire. In chapter 4, several such aberrant productive gene rearrangements 
have been highlighted. Therefore, determination of relative frequencies of gene 
rearrangement at both DNA and RNA level can give better understanding of 
selection pressures of individual gene segments.  
 
2. Gene rearrangements generated by editing may exist in the cell as episomal 
segments. When a cell divides, the episome will transfer to one of the daughter 
cells resulting in apparent biases in the repertoire. DNA editing is the prominent 
mechanism during establishment of naïve B cell repertoire. Thus, as a 
consequence of this process, several out-of-frame DNA gene rearrangements could 
accumulate inside the cell after excision from the chromosome. Previous studies 
have identified some biases in the ratios of in-frame and out-of frame DNA gene 




locus (Farner, Dorner et al. 1999, Richl, Stern et al. 2008). However, based on the 
data of chapter 3 of this thesis it can be suggested that the ratios of in-frame to out-
of-frame gene rearrangements varies at different development stages of B cells. 
This was evident as there was relative abundance of out-of-frame DNA gene 
rearrangements in the naïve B cells as compared to IgA expressing B cells. It can 
be suggested there was a dilution of out-of frame excised circles as a result of 
multiplication during B cell maturation process. Thus, differences in the ratios of in-
frame to out-of-frame gene rearrangements are more likely the reflection of 
developmental stage following cell division rather than a characteristic feature of the 
locus or gene segments. 
High throughput sequencing experiments constituted an integral part of each 
chapter in this thesis. In order to retrieve a large number of sequences it was 
important to harvest a large number of cells from each sample. To meet this 
requirement, the strategy of using healthy buffy coat samples was employed. 
However, these buffy coats were procured from anonymous samples; therefore, the 
data was not available to us regarding ethnicity, clinical history, age, and gender. As 
these factors can modulate the immune system, utilization of these buffy coats 
imposed some limitations on the interpretation of the data. 
Future directions 
Chapter 3: It was observed that there was a significant reduction in the out-of-frame gene 
rearrangements in IgA expressing B cells. In future it would be interesting to know if the 
mucosal B cell subset in blood expressing higher levels of α4β7 integrin would have 
generated a different profile of gene rearrangements at the IGL locus. Additionally, changes 
in the surface expression of IGK:IGL in IgA subsets could be traced further to investigate if 
the reduction in IGK expressing cells observed in CD27
-
IgA  is a consequence of initiation of 
the secondary gene rearrangements at the IGL locus in IGK expressing CD27
-
IgA  cells. 
Chapter 4: It was found that the profile of productive DNA gene rearrangements can be 
different from the expressed DNA gene rearrangements at the IGK locus. Moreover, 




rearrangements at the IGL locus and this feature has implications in the selection for or 
against of individual IGKV gene segments. For future studies selection processes could be 
compared with autoimmune diseases to determine if there is any defect in the selection of 
IGKV gene segments in pathological conditions. This study determined the IGK repertoire of 
naïve B cells; observations can also be extended by comparing naïve repertoire of IGK gene 
rearrangements with the repertoire of antigen experienced B cells in the periphery.    
Chapter 5: There was no difference in the IGH gene rearrangements expressed in either 
IGK or IGL expressing naïve B cells. In future, it might be worthwhile to extend the 
investigation by comparing the expressed DNA gene rearrangements with genomic DNA 
gene rearrangements to determine positive and negative selection of individual gene 
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a  b  s  t  r  a  c  t
The  unique  speciﬁcity  of the  B  cell  receptor  is generated  by  an  ordered  sequence  of gene  rearrangement
events.  Once  IGH  genes  have  rearranged,  rearrangement  at the IGK  locus  is  initiated  followed  by  the  IGL
locus if functional  IGK  rearrangement  is  not  achieved.  Receptor  speciﬁcity  can  subsequently  be  altered
by  secondary  light  chain  editing  based  on the  features  of  the  heavy  and  light  chain  combination.  The  ﬁnal
proﬁle  of expressed  genes  is not  random  and  biases  in this  proﬁle  are  associated  with  several  autoimmune
diseases.  However,  how  and when  biases  are  created  is not  known.
To increase  our  understanding  of  the  processes  of selection  and  editing  of IGK  rearrangements,  we
compared  four groups  of rearrangements  of  IGK acquired  by next  generation  sequencing.  First,  expressed
rearrangements  of  IGK  from  cDNA  of IGK  expressing  B  cells.  Second,  productive  rearrangements  of IGK
from  DNA of the same  kappa  expressing  B cells.  Third,  non-productive  rearrangements  of  IGK  from  DNA
of IGK  and  IGL expressing  B cells,  and fourth  productively  rearranged  IGK from  DNA  of  IGL  expressing  B
cells.  The  latter  group  would  have  been  rejected  during  B cell  development  in favour  of  rearrangement
at  the IGL  locus  and  are  therefore  selected  against.
We  saw  evidence  that rearranged  IGK  segments  can  be  selected  at a  checkpoint  where  the decision  to
rearrange  the  IGL locus  is  made.  In  addition,  our data  suggest  that  mechanisms  regulating  the  expression
or  not  of IGK  rearrangements  may  also  contribute  to repertoire  development  and also  that  this  latter
component  of  the  selection  process  is  defective  in SLE.
©  2015  Elsevier  Ltd. All  rights  reserved.
1. Introduction
The unique speciﬁcity of individual B cells for antigen is deter-
mined by the sequences of the expressed IGH and IGK or IGL light
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chain genes. The sequences are created by an ordered succession of
rearrangement events starting with rearrangement of variable (V),
diversity (D) and joining (J) segments of IGH.  Successful expres-
sion of the pre-B cell receptor excludes recombination events on
the second IGH allele and also activates enhancers that initiate
rearrangement of the IGK locus. If functional rearrangement is not
achieved on either allele at the IGK locus, then IGK is inactivated
by deletional rearrangement with kappa deleting element (KDE)
and gene rearrangement proceeds at the IGL locus (Hardy and
Hayakawa, 2001; Santos et al., 2011).
The ﬁnal shape and speciﬁcity of the BCR can potentially be
altered many times during early B cell development by secondary
editing rearrangements of segments upstream and downstream of
an original V-J rearrangement of IGK or IGL (Wardemann et al., 2003;
Yurasov et al., 2005b). Receptor editing may  occur if the receptor as
http://dx.doi.org/10.1016/j.molimm.2015.01.017
0161-5890/© 2015 Elsevier Ltd. All rights reserved.
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a whole is autoreactive, and development of autoimmune diseases
may  result from a failure to edit the BCR effectively (Panigrahi et al.,
2008). Autoimmune diseases are frequently associated with biases
in light chain gene segment usage, e.g., there is an over represen-
tation of IGKV4-1 in systemic lupus erythematosus (SLE) (Dorner
et al., 1998; Woodward and Thomas, 2005), celiac disease (Steinsbø
et al., 2014) and type 1 diabetes (Woodward and Thomas, 2005).
The IGK locus includes gene segments in forward and reverse
orientations, relative to the downstream gene segments. For
example, the IGKV4-1 and IGKV5-2 genes most proximal to
the J segments are in reverse transcriptional orientation com-
pared to the other proximal IGKV genes (Foster et al., 1997;
http://www.imgt.org/IMGTrepertoire/; Schoettler et al., 2012).
When IGKV4-1 or IGKV5-2 recombine with IGKJ the DNA coils to per-
mit  alignment of the recombination signal sequences (RSS). After
rearrangement, the intervening DNA between IGKV and IGKJ is not
released as an episomal fragment, but instead the rearrangement
is inserted in inverted orientation adjacent to or among the J seg-
ments. This rearrangement can be retained on the chromosome
even after secondary editing rearrangements. It is therefore pos-
sible that KDE rearrangements to the intronic recombinant signal
sequences (RSS) may  not remove the edited gene rearrangements
of IGK that have been selected against and cells may  accumulate
more than one unused rearrangement on a single chromosome.
Therefore B cells can accumulate rearrangements that have been
excluded from the functional repertoire. It is also possible that
‘same orientation’ secondary IGK rearrangements that excise exist-
ing rearrangements as episomes may  still be ampliﬁable by PCR.
This would be apparent as a high relative frequency of produc-
tive DNA rearrangements of an IGK gene segment compared to
expressed sequences in cDNA and can be considered to be a conse-
quence of accumulation of rearrangements in DNA that have been
selected against during B cell development. Therefore, rearrange-
ments of V genes that occur relatively more frequently in DNA com-
pared to cDNA from the same cells may  have been selected against.
Our aim was to analyse IGKV gene selection in humans and how
this might be altered in SLE. To do this we have studied four groups
of IGK sequences (1–4 in Fig. 1). The ﬁrst group of sequences (1)
was PCR ampliﬁed from cDNA of IGK expressing B cells. These are
considered to be the gold standard indication of actual IGKV gene
expression in the B cell population in our study. The second group
of sequences (2) was productive IGK gene rearrangements from
DNA of the same, sorted IGK expressing mature naïve B cell subset
used for cDNA preparation. The third group of sequences studied (3)
was the DNA rearrangements that were unproductive due to being
out of frame or having a stop codon. The B cells expressing these
genetic rearrangements of the IGK locus are not selected since they
do not encode any protein. Their proﬁle therefore reﬂects the intrin-
sic biases in the efﬁciency of rearrangement of IGKV gene segments
determined, e.g., by transcriptional activity and RSS sequence and
not the properties of the IGKV segment encoded (Foster et al., 1997).
The fourth group (4) of sequences studied was productive DNA rear-
rangements of IGK from sorted IGL expressing B cells from the same
donors as the IGK expressing cells. Since the B cells can change
from rearrangement of IGK to rearrangement of the IGL locus at
the pre-B stage, this group of productive rearrangements has been
rejected during B cell development (Brauninger et al., 2001). This
is summarised in Fig. 1.
By comparing these four groups of sequences we observed that
some IGKV segments are consistently selected either for or against
expression during early B cell development. We therefore com-
pared the rearrangement proﬁle of the four groups of sequences
in six healthy controls and three patients with SLE. Whereas the
overall imprint on repertoire selection at the DNA level is similar
including the switch from IGK to IGL gene rearrangements, there
are differences between health and SLE when comparing DNA and
cDNA from IGK expressing B cells. This implies that mechanisms of
gene silencing rather than detection of self-reactivity per se may
be defective in SLE.
2. Materials and methods
2.1. B-cell isolation and cell sorting of naïve B cells
Peripheral blood mononuclear cells were isolated from six
healthy donors, and three SLE patients using Ficoll-Paque Plus (GE
Fig. 1. Flow chart showing groups if IGKV gene rearrangements analysed and functional relevance. Genomic DNA and RNA were extracted from IGK and IGL  surface expressing
mature  naïve B cells. Four groups of sequences are depicted and functional relevance of different subsets of IGKV gene rearrangements analysed are illustrated.
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Healthcare). Samples from three ANA+ patients with SLE were
collected through the King’s College London Infectious Diseases
Biobank and written consent was obtained in accordance with
Guy’s Hospital research ethics committee. The SLE patients were
females aged 40 (Afro-Carribean, 12 years history of SLE, treated
with mycophenolate mofetil and hydroxychloroquine, nephritis),
59 (Caucasian, 4 years history of SLE, treated with Leﬂunomide,
arthritis) and 32 (Caucasian, 3 years history of SLE, treated with
prednisolone and hydroxychloroquine, arthritis).
PBMCs were stained with CD19-PerCP-Cy5.5 (BD PharMin-
gen), kappa light chain-APC-H7 (BD PharMingen) and lambda light
chain-Paciﬁc Blue (Biolegend), CD27 APC (BD PharMingen), IgD
PE-Cy7 (BD Biosciences), and LIVE/DEAD Fixable Aqua (Life Tech-
nologies) for 15 min  at 4 ◦C before cell sorting on the FACSAria
machine (BD Biosciences PharMingen.) IGK expressing B mature
naïve B cells (CD19+ IgD+ CD27− IGK+) and IGL expressing B mature
naïve B cells (CD19+ IgD+ CD27− IGL+) were collected separately
into 180 l of Sort-Lysis RT buffer (SLyRT) (Wu  et al., 2010). B cells
for sequencing of genomic DNA were collected in RPMI. Genomic
DNA was extracted using QIAGEN DNasey Blood and Tissue Kit (see
suppliers instructions). Unlike healthy control samples, SLE cases
did not always show clear segregation of IGK- and IGL-expressing
cells due to apparent light chain inclusion in some cases (Fraser
et al., unpublished). The cases used in this study were those where
discrete IGK- and IGL-expressing populations could be isolated.
2.2. cDNA synthesis and Ig PCR
To synthesise cDNA, 500U SuperScript III reverse transcriptase
(RT; Invitrogen) in 20 l were added to 180 l of cells in SLyRT
buffer that contained 300 ng pd(N)6 (Qiagen) in 60 l. RT was per-
formed at 42 ◦C (10 min), 25 ◦C (10 min), 50 ◦C (60 min) and 72 ◦C
(15 min). Ig genes were ampliﬁed using semi-nested polymerase
chain reaction (PCR). In PCR1, a 25-L reaction mix  contained
6.25 L of cDNA, 0.625 U Phusion DNA polymerase (NEB), 200 M
each dNTPs, 41.75 nM each upstream IGK primers, 250 nM down-
stream IGKC primer in 1× reaction buffer. After a hot start at 98 ◦C
(for 30 s, hold at 50 ◦C) Phusion DNA polymerase was added, fol-
lowed by 15 cycles of 98 ◦C (10 s), 58 ◦C (15 s), 72 ◦C (30 s), and 1
cycle of 72 ◦C (5 min). PCR2 was then used to amplify from PCR1
products using primers having 10-base multiplex-identiﬁer (MID)
tails. MID  tags enabled nine different samples to be pooled into one
sequencing sample and individual experimental samples were later
separated by sequence analysis of the MID  tags. Twenty microlitres
of PCR2 reaction mix  contained 2 l of PCR1 products, 0.5 U Phusion
DNA polymerase, 200 M each dNTPs, 41.75 nM each upstream
MID: IGK 1–6 primers, 250 nM IGKC downstream primer in 1× reac-
tion buffer. PCR2 was performed at: 98 ◦C for (30 s), 20 cycles of
98 ◦C (10 s), 58 ◦C (15 s), 72 ◦C (30 s), and 1 cycle of 72 ◦C (5 min).
Primer sequences are given in Supplementary Tables S1 and S2.
2.3. Preparation of MID  PCR products for next generation
sequencing
To produce sufﬁcient DNA for sequencing while minimising PCR
ampliﬁcation, repeats of PCR1 (eight sample aliquots) and PCR2
(two sample aliquots from each of the eight PCR products) were
performed for each individual experimental sample. PCR Primers
were removed from the 16 pooled products by gel electrophoresis
and using QIAquick Gel Puriﬁcation Kit. Samples to be pooled for
sequencing were mixed in equal quantities and concentrated using
QIAquick PCR Puriﬁcation Kit (QIAGEN) before sequencing on the
Roche 454 Titanium Sequencer (Agowa GmBH). Accuracy of the
method as a whole was determined using analysis of results from a
control Ig gene and was <1 error per 300 bp, or 1 per 1300 bp if indels
(a known issue with the sequencing platform) were discounted
(18).
2.4. Sequence analysis
Sequences were assigned to the corresponding samples based
on the terminal MID  sequence. Sequences that contained a sec-
ond MID  sequence that was either different or located internally,
or sequences that had no MID  tag were excluded. A series of strin-
gent quality control criteria were applied to exclude biologically
implausible sequences (Wu  et al., 2010). IGKV-C rearrangements
ampliﬁed from cDNA were only accepted as biologically plausible
if they were over 415 nucleotides in length and IGKV-J rearrange-
ments ampliﬁed from the DNA of IGK- or IGL-expressing B cells
were accepted providing they were over 290 nucleotides in length.
Sequences that had IGK with either IGKJ or IGKC were rejected, as
were sequences with multiple IGV gene primer motifs. Clonally
related sequences were identiﬁed by sorting based on their CDR3
nucleic acid sequences with IGK and IGKJ gene use as secondary
identiﬁers and only one was  included in the data.
Analyses were performed in Excel (Microsoft). Proportions were
compared using 2 tests with Bonferroni correction for multiple
comparisons and with Student’s t-test of the mean values with
GraphPad Prism.
Data are expressed as frequencies throughout the manuscript.
The frequency in each case is the percentage of the IGK V or J seg-
ment of the total number of sequences in the group analysed.
3. Results
Clustering of complementarity determining region 3 sequences
identiﬁed a total of 20,160 unique rearrangements of IGKV- J for
analysis in this study. Individual donors contributed different num-
bers of sequences to the total as indicated (Table 1). Of note, and
consistent with other studies (Brauninger et al., 2001; Goossens
et al., 2001), approximately 25% of rearrangements of sequenced
IGK segments from IGL expressing B cells were productively rear-
ranged. These gene rearrangements have been selected against
during B cell development and are referred to as rejected productive
DNA rearrangements (Fig. 1).
3.1. Comparison frequencies of rearrangements involving IGKV
genes in cDNA and DNA from IGK and IGL sorted B cells from six
healthy donors
Initially, the proﬁle of IGKV gene rearrangements in cDNA and
DNA of IGK expressing B cells from each of the six healthy donors
was determined when sequences from all donors were pooled
(Fig. 2A) or analysed individually (Figure S1). There was a relatively
greater frequency of rearrangements of genes from the proximal
cluster closer to the constant region segments compared to the
distal cluster. The rearranged IGK genes that were consistently
signiﬁcantly relatively more abundant in DNA than cDNA in the
pooled data and consistent in six donors were IGKV1-37, IGKV5-2
and IGKV4-1. In contrast rearrangements involving IGKV1-15 and
IGKV3-11 segments were relatively more abundant in cDNA than
DNA.
Next, productively rearranged IGKV genes from DNA of IGK and
IGL expressing B cells were compared. Genes that had been selected
against are those where black bars is taller than grey bars in both ﬁg-
ures; i.e. they were more abundant in DNA than cDNA in Fig. 2A and
more abundant in IGL than IGK expressing B cells in Fig. 2B. Some
genes known to be non-functional showed this selection proﬁle
including IGKV1-37 that is non-functional due to the replacement
of cysteine at position 104 in framework region 3 with glycine,
which is consistent with our interpretation of the data (Pargent
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Fig. 2. Comparison of relative frequencies of rearrangements of IGKV gene segments with data from six healthy controls. (A) Comparison of PCR amplicons from DNA (black
bars)  or cDNA (grey bars) of mature naïve B cells expressing IGK. Where the frequency of rearrangements is higher in DNA than cDNA this gene is more abundantly present
in  DNA than expressed, consistent with retention of unused, edited segments in the cell. (B) Productive DNA rearrangements of IGKV gene segments from IGK (grey bar) and
IGL  (black bar) expressing mature naïve B cells. Where frequency of IGKV gene segments is higher in IGL expressing B cells, these IGKV genes have been selected against.
Gene segments which are more abundant in IGK that IGL expressing B cells are selected for. Zero values (see Fig. S1) were excluded from this ﬁgure. Statistical analysis was
performed using 2 analysis adjusted using the Bonferroni correction. p-Values are indicated as *p < 0.05, **p < 0.005 and ***p < 0.0005.
et al., 1991). Based on this deﬁnition of segments that are selected
against, it is apparent that expression of IGKV5-2 is strongly selected
against during early B cell development so that despite being rela-
tively frequently rearranged they are rare in cDNA.
Genes that had been selected for are those where the grey bars
are taller than the black bars in Fig. 2A and B. They were less abun-
dant in DNA compared to cDNA in Fig. 2A and more common in IGK
than IGL expressing B cells in Fig. 2B. An example of a gene that
appears to be selected for was IGKV3-11.
Gene segment IGKV4-1 is of particular interest. Although it was
consistently and signiﬁcantly selected against by comparison of
DNA and cDNA in health (Figs. 2A and S1), there was no evi-
dence of selection against this segment when rejected productive
rearrangements of IGKV from IGL expressing cells and productive
rearrangements of IGK from IGK expressing cells were compared
(Fig. 2B).
3.2. Analysis of IGKV gene selection in SLE
We  compared IGKV sequences from three SLE patients in
Fig. 3A and B, applying the same principles already introduced
in Fig. 2A and B. Rearrangement frequencies of individual gene
segments indicate selection against IGKV1-37, IGKV5-2 in SLE as
in health. In general, however, the differences between DNA and
cDNA observed in health, Fig. 2A, were not so apparent in SLE
in Fig. 3A. For example, there was no difference between the
frequencies of the IGKV4-1 gene in Fig. 3A as observed in health in
Fig. 2A.
We  next focused on the selection proﬁle of individual genes of
interest that showed different hallmarks of selection. IGKV3-11 was
selected because it consistently appeared to be favoured. IGKV1-37
was selected because it is non-functional due to the replacement of
cysteine with glycine in framework region 3 and therefore selected
against for reasons we can understand (Fig. 4A–D). It is apparent by
comparison of data relating to IGKV5-2 with the ‘control’ proﬁles of
IGKV3-11 and IGKV1-37 that IGKV5-2 had the proﬁle of a gene that
had been selected against during B cell development in health and
SLE (Fig. 4C and H). This segment has low frequencies in the cDNA
pool compared to DNA, and rearrangements are more abundant in
productive rearrangements in DNA from IGL than IGK expressing
B cells in both health and SLE. IGKV1-17 is illustrated because it
showed selection against in health, but not in SLE. IGKV4-1 (Fig. 4E
and J) could not be clearly assigned as either selected for or against
by any of the criteria that identiﬁed selection in other gene seg-
ments by analysis of groups of rearrangements ampliﬁed from DNA
alone. However, frequencies of IGKV4-1 were consistently and sig-
niﬁcantly lower in cDNA than in DNA from the same cells in health
but interestingly, not in SLE.
Since the pooled data suggested that the lower frequency of
IGKV4-1 in cDNA compared to DNA in health, was  not so marked
in SLE, the frequencies of IGKV4-1 in cDNA and DNA in individual
blood donors in health and SLE was analysed (Fig. 5). Whilst the
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Fig. 3. Comparison of relative frequencies of rearrangements of IGKV gene segments with data from three SLE patients. (A) Comparison of PCR amplicons from DNA (black
bars)  or cDNA (grey bars) of mature naïve B cells expressing IGK. Where the frequency of rearrangements is higher in DNA than cDNA this gene is more abundantly present
in  DNA than expressed, consistent with retention of unused, edited segments in the cell. (B) Productive DNA rearrangements of IGKV gene segments from IGK (grey bar) and
IGL  (black bar) expressing mature naïve B cells. Where frequency of IGKV gene segments is higher in IGL expressing B cells, these IGKV genes have been selected against.
Gene  segments which are more abundant in IGK that IGL expressing B cells are selected for. Zero values were excluded from this ﬁgure. Statistical analysis was  performed
using  2 analysis adjusted using the Bonferroni correction. P-Values are indicated as *p < 0.05, **p < 0.005 and ***p < 0.0005.
lower frequency of IGKV4-1 in cDNA compared to DNA is apparent
in all six donors in health and is statistically signiﬁcant as a popu-
lation, this was not observed in two of the three patients with SLE.
3.3. Comparison of IGKJ segment usage in health and SLE
We  investigated the use of IGKJ segments in productively rear-
ranged DNA and cDNA from healthy donors and donors with SLE
(Fig. 6). There was a signiﬁcant tendency to use IGKJ1 and IGKJ4
and not to use IGKJ5 in cDNA compared to DNA in health and SLE.
This did not differ between IGKV genes analysed (data not shown).
IGKJ2 was rearranged signiﬁcantly less in DNA of patients with SLE
compared to controls.
4. Discussion
Our study has identiﬁed selection biases for and against the
expression of individual IGKV gene segments during the develop-
ment of the mature naïve B cell repertoire in healthy individuals
and patients with SLE. The frequency of non-productive rear-
rangements of individual IGKV segments identiﬁes the proﬁle of
rearrangement biases with no selection (Foster et al., 1997). When
IGKV segments are selected against, their frequencies are above
this threshold in the rejected productive DNA gene rearrange-
ments of IGKV genes from IGL expressing B cells. In addition, they
are below the threshold in productive DNA from IGK express-
ing B cells. The frequency of segments that have been selected
against is then lowest in the cDNA. Gene segments selected against
according to these criteria include IGKV3-7, IGKV1-37 and IGKV5-
2. Selection against rearrangements of IGKV1-37 and IGKV3-7 is
expected because IGKV1-37 is non-functional due to the replace-
ment of cysteine at position 104 in framework region 3 with glycine
and IGKV3-7 has a mutation in an acceptor splice site (Pargent
et al., 1991). The reason for stringent selection against IGKV5-2 is
less clear. The IGKV genes that are selected into the developing
repertoire tend to be the most commonly used in previous stud-
ies including IGKV1-39, IGKV3-20, IGKV3-11, IGKV1-5 (Collins et al.,
2008; Foster et al., 1997; Jackson et al., 2013).
Although IGHV undoubtedly contributes to auto-antigen recog-
nition in SLE, frequently emphasis of the role of IGKV gene segment
usage has been given (Ibrahim et al., 1995; Manheimer-Lory et al.,
1995a; Suzuki et al., 1996). The gene IGKV4-1 was of considerable
interest and had a selection proﬁle quite different to any other
gene in health. The high frequency of rearrangement of IGKV4-1
may  be related to its proximity to IGKJ. Germline transcripts of
IGKV4-1 have been found in pre B cells and foetal bone marrow
cells, showing that this gene segment is readily available (Martin
et al., 1991). In DNA from healthy donors, rearrangements of IGKV4-
1 were the most frequent rearrangements detected, but they were
signiﬁcantly less frequent in cDNA. This suggests strongly that
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Fig. 4. Selection proﬁle of ﬁve IGKV genes in health and SLE. Comparison of relative frequencies of rearrangements from four groups of PCR amplicons: non-productive
rearrangements of IGK expressing B cells, rejected DNA (=productive DNA rearrangements in IGL expressing B cells), productive DNA rearrangements of IGK expressing
B  cells and expressed cDNA of IGK expressing mature naïve B cells were compared. Selection proﬁles: selection for IGKV3-11 in (A) health and (F) SLE. Selection against
IGKV1-37 in (B) health and (G) SLE. Selection against IGKV5-2 in (C) health and (H) SLE. Selection against IGKV1-17 in expressed cDNA repertoire in (D) health and apparently
less  selected against in SLE (I). Selection against IGKV4-1 in expressed cDNA repertoire in (E) health and apparently less stringently selected against in SLE (J).
IGKV4-1 is selected against in health. However, rearrangements of
IGKV4-1 were neither more nor less abundant in the productively
rearranged DNA from IGK or IGL expressing B cells, or when com-
pared to non-productive DNA rearrangements. This is in agreement
with a study comparing productively and non-productively rear-
rangements in genomic DNA of CD19+ sorted cells in health (Dorner
et al., 1998). The unusual features of IGKV4-1 observed are not likely
to be purely consequence its inverse orientation. IGKV5-2 is in the
same orientation as IGKV4-1 and is also a J-proximal gene adjacent
to IGKV4-1 on unrearranged chromosome 2. However, there is a
strong imprint of selection against the usage of IGKV5-2 through-
out in our model, which is similar to genes known to be functionally
defective.
The higher frequency of rearrangements of IGKV4-1 in DNA from
IGK expressing cells compared to cDNA in health was consistent in
all six healthy blood donors and was  statistically signiﬁcant when
compared as a population. However, this was  not observed in two
of three patients with SLE where the frequencies of IGKV4-1 in the
productive rearrangements from DNA and cDNA of IGK expressing
B cells were approximately the same. Differences in coding region
functionality and gene editing for a particular gene segment were
observed when comparing SLE patients with varying clinical fea-
tures (Suzuki et al., 1996). Over-expression of IGKV4-1 has been
observed in some patients with SLE (Dorner et al., 1998; Yurasov
et al., 2005a, 2005b), and it is possible that the aberrant proﬁles of
IGKV-J rearrangements in SLE may  be due to defects in regulating
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Fig. 5. Selection proﬁle of IGKV4-1 gene segment. Selection proﬁle of IGKV4-1 in the
expressed cDNA repertoire of six healthy individuals and three SLE patients from
DNA and cDNA of IGK expressing mature naïve B cells. Selection against expression of
IGKV4-1 in health but not in SLE. Statistical analysis in was performed using Student’s
t-test, p < 0.05. p-Values are indicated as *p < 0.05.
IGK locus inactivation. Several studies have been undertaken inves-
tigating the possibility of aberrant receptor editing in patients with
SLE (Bensimon et al., 1994). Suzuki et al. (1996) analysed receptor
editing for IGVK1-17 segment (A30) in health and patients with SLE
with and without nephritis. It has been shown that IGKV1-17 is fre-
quently used in cationic anti-DNA antibodies in SLE patient with
nephritis, suggesting failure in secondary gene rearrangement for
these groups of patients. Consistent with this we observed more
abundant IGKV1-17 in DNA than cDNA in health, but less so in SLE.
Dorner et al. (1998) showed in their study by comparing IGKV-J
gene distribution that receptor editing was  not defective in early,
untreated SLE patients when compared to healthy individuals.
Consistent with this study, there was no difference between the
rearrangements of IGKV genes between health and SLE when the
samples from DNA were compared across this study. Reduced fre-
quency of rearrangement of the KDE has been reported in SLE as a
surrogate measurement for receptor editing (Panigrahi et al., 2008).
It is also possible, that inefﬁcient rearrangement of the KDE could
permit expression of gene rearrangements in SLE that would not
be expressed in health.
The relative use of up and down stream IGKJ segments has been
used to indicate receptor editing or revision in previous studies
(Dorner et al., 1998; Yurasov et al., 2006). However, this is difﬁcult
to interpret at the IGK locus due to the different orientations of gene
segments. We  observe a consistently higher frequency of IGKJ5 and
lower frequency of IGKJ1 in DNA compared to cDNA in health and
SLE which is consistent with previous studies (Dorner et al., 1998;
Manheimer-Lory et al., 1995a, 1995b). However, in a study from
Fig. 6. Comparison of relative frequencies of rearrangements of IGKJ gene segments. Data from PCR amplicons from productive DNA and expressed cDNA of IGK expressing
mature naïve B cells from health and SLE (A and B). Selection bias is apparent for IGKJ1, IGKJ2 and IGKJ3 for both health and SLE. Comparison of relative frequencies of
rearrangements of IGKJ gene segments from PCR amplicons from productive DNA of health and SLE (C) and expressed cDNA from health and SLE (D) of IGK expressing mature
naïve  B cells showing a similar proﬁle. Statistical analysis was performed using 2 analysis adjusted using the Bonferroni correction. Signiﬁcance is indicated as *p < 0.05.













































































































































































































































































































































































Yurasov et al. (2006) bias was observed towards the usage of IGKJ
distal segments in SLE patients with an active disease proﬁle. This
did not differ between any of the gene segments analysed and was
broadly similar between health and SLE.
The differences between rearrangements of IGKV in ampliﬁed
DNA and cDNA that we  observed in this study are not the conse-
quence of PCR primers used to generate them, as primer mixes used
for V segments were identical. The proﬁle of IGKJ segments was  not
different when different IGKV segments were studied separately
and any biases in IGKJ binding would not have resulted in biases in
IGKV. A shortcoming of the study is the unequal numbers of rear-
rangements analysed. However, the data in general was consistent
across all six healthy donors studied. The number of sequences and
also the number of patients with SLE studied was relatively low
and it will be important to follow the concepts described here using
other models in the future.
In conclusion we  found differences in the expressed IGKV B cell
repertoire between health and SLE that were not apparent in DNA
alone. Gene segments that appear to be selected against are more
abundant in cDNA in patients with SLE than in health. Our data
implies that selection of IGK genes into the B cell repertoire is reg-
ulated at different stages of B cell development. Choices are made
during B cell development, e.g., at the stage when cell fate deci-
sions are made to either edit IGK or rearrange the IGL locus. These
appear to be similar between health and SLE since the imprints of
these processes are apparent in the DNA rearrangements analysed.
Our data suggest that the activity of the KDE itself can contribute to
the composition of the expressed repertoire and that this is inefﬁ-
cient in SLE. There are numerous genetic polymorphisms associated
with SLE that relate to B cell signalling including those in Blk and
BANK1 that could be associated with B cell activity and the regula-
tion of gene rearrangements including KDE (Castillejo-Lopez et al.,
2012; Deng and Tsao, 2010; Jarvinen et al., 2012). Our data suggest
that factors that regulate expression of productive rearrangements
of IGKV-J,  that have been selected against, such as rearrangement
of the KDE or the intronic RSS, may  be involved in shaping the
expressed repertoire of IGKV genes, and that this process may  be
aberrant in some way  in SLE.
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